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SUMMARY 
Pericardial bioprosthetic valves have shown good long-term 
clinical follow-up results over a period of 13 years with a low 
incidence of thrombo-embolism and calcification, and good haemodynamic 
function. However, doubts remain about the long-term durability of 
these valves and a significant incidence of primary tissue failure has 
been reported and this has been observed in our clinical series in 
Glasgow. I have identified tears in leaflets of explanted valves 
close to the edge of the cloth-covered stent which have caused 
prolapsed leaflets and large regurgitation. 
The performances of four pericardial valves, the Ionescu-Shiley 
Standard, IonescuShiley Low Profile, Hancock and Mitral Medical 
pericardial valves have been evaluated in my test apparatus in an 
attempt to gain understanding of the mechanisms of these primary 
tissue failures. A hydrodynamic function test apparatus has been 
developed which allowed pressure difference, regurgitation and energy 
loss across the valve to be measured, and leaflet dynamics to be 
studied. Durability tests were carried out with Rowan Ash 
accelerated fatigue testers. The valve function and leaflet dynamics 
were dependent on the method of leaflet fixation, and the leaflet 
geometries and the coaption sutures used to close the leaflets 
together at the top of the posts. These could also affect the 
durability of the valves. However, accelerated fatigue test results 
showed premature failure for all four types of valves with tears in 
the leaflets caused by abrasion at the edge of the cloth-covered 
frames. In the Ionescu Shiley Standard valve, tears were also seen 
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at the ccmnissure stitches. Although in these laboratory tests the 
mechanism of failure was abrasion and thinning of the leaflets as they 
were pulled over the edge of the cloth-covered frame, care has to be 
taken when extrapolating these results to clinical practice as 
biological effects, such as blood deposits on the cloth and tissue 
ingrowth, can reduce the abrasion to the leaflets at the edge of the 
frame. These processes are variable and leaflet abrasion on the 
cloth-covered frames remains the major cause of primary tissue failure 
in clinically explanted valves. 
The new three leaflet pericardial valve which I have developed 
has improved durability and oomparable function in vitro to existing 
valves. The valve is based on a unique twin frame design. The 
inner support frame is covered with a single piece of bovine 
pericardium to reduce abrasion to the leaflets at the edge of the 
frame and has an array of radially-projecting pins and studs onto 
which the leaflets are mounted. The outer frame is covered with 
polyester cloth and this is located over the same radial pins to 
retain the leaflets in position. The assembled valve is secured with 
a fine locking ring in the base of the valve. The sewing ring is 
constructed from polyester cloth and can be positioned towards the 
inflow aspect of the valve in the aortic position to give a 
supra-annular configuration and away from the inflow aspect in the 
mitral position to reduce the length of post projecting into the 
ventricle. The posts on the outer frame are rounded to reduce the 
risk of damage of the ventricular wall, and a protective suture can be 
placed across the top of the posts to reduce the risk of suture- 
snaring during implantation in the mitral position. 
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The mechanical properties of the pericardial tissue used for the 
leaflets have been investigated and fixation conditions analysed to 
produce uniform cross-linking throughout the tissue. Prototype 
valves have been tested with different leaflet geometries and 
differing methods of leaflet fixation, and an optimal leaflet geometry 
has been developed. The flexing position of the leaflet was moulded 
during fixation in a shape defined by two cylindrical surfaces which 
intersect in a spherical surface in the centre of the leaflet. This 
gave a stable closed position with deep coaption between the leaflets 
and synchronous movement of the leaflets to a uniform open position. 
Prototype valves have been manufactured in sizes 19 to 31 Mn. 
Hydrodynamic tests on the prototype valves have shown comparable 
pressure difference, regurgitation and energy loss to other 
pericardial valves. Accelerated fatigue testers have shown greatly 
improved durability with eight out of nine valves cycled to over 400 
million cycles, the equivalent of 10 years without failure. 
Implantation of size 25 mm valves in the mitral position in seven 
sheep for over three months has shown good short-term in vivo 
function. A randomised clinical trial is planned comparing a porcine 




1.1 The function of natural heart valves 
The four natural heart valves perform a similar but important 
mechanical function in allowing the blood to flow in one direction 
only. The mitral and tricuspid valves (atrio-ventricular valves) 
allow blood to flow into the ventricles from the left and right 
atria, whilst the aortic and pulmonary valves (the ventriculo-arterial 
valves) allow blood to flow out of the ventricles into the arterial 
systems. The sequence of the valves' opening and closing in the left 
ventricle is shown in Figure 1.1. As the muscular ventricle 
contracts, the pressure rises and the atrio-ventricular valve closes 
under the back pressure. Subsequently, the ventriculo-arterial valve 
opens to allow forward flow into the arterial system. At the end of 
systole, the ventricle relaxes and the ventriculo-arterial valve 
closes under the back pressure from the arterial system. As the 
ventricular pressure falls to almost zero, the atrio-ventricular valve 
opens to allow the ventricle to fill with blood from the atrium. 
A normal valve has little resistance to forward flow and closes 
rapidly with little reverse flow. A valve will not function 
correctly if it becomes obstructive to forward flow (stenotic) or it 
fails to close correctly, allowing significant regurgitation. There 
are several causes of valve malfunction. Rheumatic fever is often 
followed by a chronic fibrosing reaction in the valve leaflets, 
causing stenosis due to stiffening of the leaflets and/or 
regurgitation. Infective endocarditis can cause a rapid degeneration 
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of the valve leaflets producing holes and tears and a large 
regurgitation. Stenosis of the valve leaflets can also be caused by 
calcification or, in a few cases, by congenital abnormalities in which 
the leaflets are not correctly formed. 
The valves in the left heart are replaced most frequently. 
Stenosis and regurgitation in the mitral valve causes increased 
pressure in the atrium and pulmonary veins which results in lung 
congestion. Stenosis of the aortic valve causes an increase in the 
ventricular pressure during systole, left ventricular hypertrophy, and 
ultimately, ventricular failure. Aortic regurgitation also causes 
left ventricular hypertrophy, dilation of the ventricle and rapid loss 
of arterial pressure during diastole (1). These conditions can be 
detected by listening to the heart sounds, by radiology, nuclear 
medicine imaging, echocardiography, or by cardiac catheterisation. 
1.2 History of valve replacement 
Valve replacement first became feasible in 1954 when man-made 
materials were placed in the descending aorta (2) and extracorporeal 
circulation was developed (3). The first mechanical aortic valve was 
successfully implanted in 1960 (4) and this was soon followed by a 
mitral valve replacement (5). The first homograft tissue valves were 
implanted in 1962 (6,7) and at this early stage in valve surgery the 
division between mechanical valves and tissue valves was already 
established. Following the success of the ball and cage valve, a 
tilting disc mechanical valve was developed in 1968 (8) and a 
bileaflet valve was subsequently produced in 1976 (9). There have 
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also been significant developments in tissue valves. In the late 
sixties valves were fabricated from dura mater and fascia lata (10). 
The first bioprosthetic valve was produced in 1970 when a porcine 
aortic valve was chemically treated with glutaraldehyde and mounted 
inside a cloth-covered frame (11). In 1976 a three leaflet valve 
fabricated from glutaraldehyde-treated pericardium was developed 
(12). There are currently over twenty different valves available 
commercially. The majority of these fall into five main categories, 
three types of mechanical valves and two types of tissue valves (13). 
The ball and cage valves were the first mechanical valves 
implanted. The Starr-Edwards valve (Figure 1.2) has been the most 
widely-used ball and cage valve. It has shown good durability and 
has the largest clinical follow-up (14). The valve has been improved 
by changing the material used for the ball and also the covering 
material on the struts. Its main disadvantages are that it is very 
obstructive to forward flow, it can cause haemolysis, and thrombus can 
build up on the struts. 
The tilting disc valve shown in Figure 1.3 was designed to give 
less obstruction to forward flow than the ball and cage valve and to 
reduce the profile height of the valve (8). It has since been 
improved with the introduction of a pyrolytic carbon disc and an 
increased opening angle of 70° (15). There has been an occasional 
mechanical failure due to strut fracture, but overall the valve has a 
good clinical follow-up (16). Other tilting disc valves use 
different mechanisms for pivoting and retention of the disc. 
The bileaflet mechanical valve (Figure 1.4) was developed in 1976 
to give an improved forward flow pattern through the valve (17). 
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This valve has shown good clinical follow-up (18). The durability of 
all three types of mechanical valves is good, with only occasional 
cases of mechanical failure due to poor design or manufacture, or 
valve dysfunction caused by tissue ingrowth or clot formation. The 
main disadvantage of all these mechanical valves is that there is a 
significant incidence of thrombosis and haemolysis, and the patients 
require long-term anticoagulation therapy (19). These problems are 
caused by the central rigid occluder causing highly disturbed flow 
patterns and the use of synthetic materials which do not have ideal 
blood compatability. 
There are two types of bioprosthetic tissue currently in use. 
The porcine valve consists of a three-leaflet porcine aortic valve 
which has been chemically-treated with glutaraldehyde and sutured 
inside a cloth-covered support frame (Figure 1.5). The 
glutaraldehyde treatment cross-links the collagen in the valve 
leaflets, reduces its antigenicity and prevents biological degradation 
(20). More recently it has been shown that glutaraldehyde treatment 
can alter the mechanical properties of the tissue (21). Two valves, 
the Carpentier-Edwards and the Hancock porcine valves, have shown good 
long-term clinical results (22,23). As the whole porcine valve is 
mounted inside a support frame the orifice of the valves is rather 
small. This gives higher pressure drops during forward flow. The 
valve performance has been improved slightly with low pressure 
fixation of the leaflets which give greater tissue extensibility and 
modification to the orifice to remove the muscle shelf on the right 
coronary leaflet (24). 
The second type of tissue valve is the three-leaflet pericardial 
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valve (Figure 1.6). The leaflets are fabricated from bovine 
pericardium, which has been treated with glutaraldehyde, and are 
sutured onto the outside of a cloth-covered frame (25). This gives a 
larger orifice for forward flow than the porcine valves (26). The 
long-term clinical follow-up on these valves has been reported to be 
good (27) but there has been a significant incidence of leaflet 
failure due to tearing close to the edge of the cloth-covered frame in 
both the mitral (28,29) and aortic (30) positions. Unpredictable 
durability is the main disadvantage of both types of tissue valves. 
Figure 1.7 shows a Hancock porcine valve explanted after eight years 
with a tear in the belly of one leaflet, and Figure 1.8 shows a 
Carpentier-Edwards valve explanted after five years with a tear at the 
commissure causing a prolapsed leaflet. An Ionescu-Shiley 
pericardial valve explanted after four years with a tear in the 
leaflet at the top of a post is shown in Figure 1.9. Tissue ingrowth 
can also cause problems by obstructing the valve orifice (Figure 
1.7). Calcification can seriously reduce the lifetime of a tissue 
valve by making the leaflets less flexible and obstructive and this 
can also result in leaflet tears. Figure 1.10 shows a heavily 
calcified Carpentier-Edwards valve explanted after six years. An 
additional disadvantage of tissue valves is that variation in the 
biological tissue and the precision required in valve assembly can 
cause high rejection rates in production. These disadvantages have 
to be compared with the disadvantages of mechanical valves (19). It 
is clear that the ideal heart valve prosthesis does not exist (31,32). 
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1.3 Current developments in valve technology 
There have been few new developments in mechanical valve design 
since the introduction of the bileaflet valve in 1978 (18). The 
Bjork-Shiley valve has been modified recently to eliminate mechanical 
weakness in the struts. There have however been significant 
developments wih tissue valves (33). Anticalcification treatments 
have been developed (34,35) which are currently being tested in 
clinical trials for both porcine and pericardial valves. As 
calcification is a long-term failure node, the results of these trials 
will not be available for several years. Although several new 
porcine valves have been developed (36) the designs show little 
improvement over clinically-proven valves. Low pressure fixation of 
the tissue has been used to improve pressure gradients, and to improve 
durability and modified orifice, supra-annular and composite valves 
have also been developed. Major improvements in this type of valve 
may be dependent on finding a more durable valve from a different 
animal (37). 
There have been signficant changes in valves fabricated from 
pericardium. Four new pericardial valves have been commercially 
developed since 1980; the Ionescu-Shiley Low Profile (ISLP), the 
Hancock Pericardial valve (HP), the Mitral Medical valve (MM) and the 
Edwards Pericardial valve (EP). All the valves have undergone 
initial clinical trials with up to three years follow-up in some cases 
(38). These valves have a lower post height or profile than the 
original Ionescu-Shiley valve which reduces the risk of damage to the 
ventricular wall from the tips of the posts in the atrio-ventricular 
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position. The Ionescu-Shiley Low Profile, Hancock, and Mitral 
Medical valves mount the pericardial leaflets by suturing them to the 
outside of a cloth-covered frame. There are significant differences 
between these three valves in the design of the frames and leaflets, 
and also in the technique used for preparing tissue. The Edwards 
Pericardial is fundamentally different to the other valves as the 
leaflets are sutured inside and underneath an egiloy wire frame. The 
in vitro function of all four valves is reported to be similar (39) 
but initial results in clinical trials show that there are significant 
differences in the performance of these valves. In a clinical trial 
in Glasgow of 105 Ionescu-Shiley Low Profile and 98 Hancock 
Pericardial valves started in 1982 (40,41 - Appendix II) there have 
been six Ionescu-Shiley Low Profile valves explanted due to primary 
tissue failure and two Hancock valves explanted due to primary tissue 
failure. Five of the Ionescu-Shiley Low Profile valves explanted had 
torn leaflets adjacent to the top of the post and the sixth valve had 
a leaflet which stretched abnormally circumferentially at the free 
edge (Figure 1.11). In all six cases the damaged leaflets were 
prolapsed below the other two leaflets causing large regurgitation. 
Close examination of these explanted valves did not reveal any clear 
indication of the cause of the primary tissue failure. The Hancock 
group showed two similar failures with tears in the leaflets adjacent 
to the top of the posts causing the leaflet to prolapse (Figure 
1.12). Primary tissue failures have been reported from other 
clinical centres (42) with this valve. The clinical experience with 
the Mitral Medical valve is limited but one Centre has shown no 
primary tissue failure with three years follow-up (43). 
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Likewise, with the Edwards pericardial valve, limited clinical trials 
have shown no valve failures (30,44,45). 
Some laboratory investigations have been carried out into the 
mode of failure of pericardial valves using accelerated fatigue 
testers. Gabbay has shown early failures in fatigue testers (46) 
with the Standard Ionescu-Shiley valves and has compared his results 
with his clinical experience (47). Similar failures have been 
reported by other Centres (27,48). Gabbay proposes that abrasion of 
the leaflets on the cloth is the main cause of the failures. This 
may be an explanation for early failures in vitro, but may not be true 
in vivo if blood deposits and host tissue smooth over the cloth, or if 
host tissue reinforces the leaflets. Walker and Scotten have also 
identified similar failures in vitro in the Ionescu-Shiley and Mitral 
Medical valves (49,50). In each case tissue failure close to the edge 
of the frame was the common factor. Cosgrove (30) proposes that 
tissue failure with the Ionescu-Shiley valve in the aortic position 
originates from the comnissure stitches close to the top of the posts, 
whereas Martin proposes failures due to abrasion on the buttress on 
the outside of the post (51). Shiley Incorporated have indicated 
that two dimensional flexion of the leaflet close to the edge of the 
frame, or bending of the tissue around the top of the post, may cause 
mechanical tears (52). This would be consistent with some 
theoretical stress analysis (53). More recently, however, Ionescu 
has reported improved durability of the Ionescu-Shiley Low Profile 
valve over the Standard lonescu-Shiley valve (27). He also describes 
further developments with a Mark 3 Ionescu-Shiley valve which uses 
pericardial patches to cover over the cloth at the edge of the frame 
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in the area over which the leaflet flexes. This new valve has shown 
improvement in durability and has undergone restricted clinical trials 
(54). In a bicuspid pericardial valve, Black et al have shown that 
placement of sutures close to areas of tissue flexion can 
significantly reduce the durability of the tissue (55). A new 
bicuspid pericardial (56) and monoscusp (57) valve are also under 
development. 
The general clinical experience of the new pericardial valves is 
good and they show better haemodynanic (26) and hydrodynamic (39) 
function than the porcine valves. Several reports have suggested 
that their long-term clinical durability is variable but laboratory 
tests have been unable to predict clinical lifetimes (27,58,59). 
In particular, leaflets are likely to fail close to the edge of the 
frame. Three possible causes have been suggested - abrasion of the 
leaflets on the cloth-covered frame, tears originating from sutures, 
and bending or flexion stresses at the edge of the leaflet. In 
addition, failures have been seen clinically due to abnormal extension 
of the tissue. The variable durability seen in vivo and in vitro 
between the different types of valves is probably due to the 
differences in design and construction and may also vary with valve 
size and the position in which the valve is used. The failure modes 
require further investigation and analysis in order that a more 
durable pericardial valve can be developed. 
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1.4 outline 
The design, construction and function of existing pericardial 
valves will be investigated with particular reference to their 
mechanical function and durability. The function of the valves will 
be investigated in detail in a pulsatile flow test apparatus and the 
construction, design, and tissue preparation methods used will be 
analysed. This information will be used in an attempt to explain the 
failures seen clinically in Glasgow and other Centres and also the 
results of fatigue studies being carried out in Glasgow and elsewhere. 
These studies will form the basis for the design construction and 
evaluation of an improved three-leaflet pericardial valve which will 
have better mechanical durability than existing valves. The new 
valve design will be tested in the pulsatile flow test apparatus and 
fatigue testers in the laboratory, and will undergo animal studies. 
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2.1 Laboratory tests 
Laboratory tests have been carried out primarily to assess the 
mechanical function and durability of prosthetic heart valves. The 
function of existing commercial valves has been assessed in a number 
of centres by measuring pressure difference across the valve during 
forward flow, regurgitant volumes and energy losses under pulsatile 
and steady flow conditions (60,61,62). Fluid velocity fields around 
prosthetic valves have also been studied using flow visualisation and 
laser doppler anemanetry (63,64) in attempts to predict areas of 
thrombus formation and haelnolysis. High speed cinb photography has 
also been used to study valve dynamics (65,66). Accelerated fatigue 
tests have been used to study the mechanical durability of valves and 
some mechanisms of failure have been identified (51). Conditions for 
these tests have not been standardised, and different approaches have 
been used to simulate canplex physiological cardiovascular mechanics. 
However, little effort has been directed towards incorporating 
biological effects into these tests (67). Materials used in 
prostheses have been assessed for biocompatiblity, thranbogenicity, 
antigenicity, toxicity and calcification, and animal tests have been 
used for final assessment of the prostheses prior to clinical 
implantation (68). 
The laboratory tests can give very detailed information about 
valve performance and are an important stage in the development of a 
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new prosthesis. The test methods and apparatus which I have 
developed to analyse valve function and durability are described in 
this chapter. 
2.2 Review of function test apparatus and methods 
The apparatus and methods currently used to test the function of 
prosthetic heart valves have became more sophisticated than the 
initial test rigs developed in the 1960's (69,70). Current test 
apparatus can be considered in four sections. 
i Pump 
ii Test sections and valve chambers simulating the left atrium, 
ventricle and aortic root 
iii Afterload simulating the aorta, systemic and peripheral 
circulation. 
iv Measuring instruments and data processing 
Two different types of pulsatile pump have been used to drive the 
test rigs, neither of which perfectly models the complex pumping 
action of the left ventricle (71). Positive displacement pumps have 
been used to produce flows in the rig which are independent of load, 
whereas pressure generators have been used to control the ventricular 
pressure, but the volume displaced is always dependent on the load. 
The ventricle can be considered a combination of both these systems, 
as during systole the source impedance is about ten times the load so 
can be approximated by a positive displacement pump (72), whereas 
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during diastole, flow through the mitral valve is primarily controlled 
by the atrial pressure. The displacement pumps used have varied from 
simple reciprocating sinusoidal pumps (73,74,75,76) to servo- 
controlled piston pumps (77,78) which can be programmed to simulate 
physiological flow waveforms. The pressures. generated by these pumps 
are dependent on the load and dynamic characteristcs of the test 
apparatus. Pressure generators have produced physiological pressure 
waveforms (79,80,81,82) but the flow through the valve under test is 
difficult to control. Elastic components have been introduced into 
some positive displacement pump chambers (83,84) whilst other systems 
have allowed positive displacement pumps to fill under static pressure 
(85,86). 
The chambers used for testing the valves are a critical part of 
the apparatus. Geometry affects both the boundary conditions for flow 
and inertia and resistance of the fluid flow, which combined with the 
compliance in the system determine the dynamic pressure or flow 
waveforms produced in the test rig. Cylindrical rigid test sections 
have been widely used (79,80,87) and only the geometry close to the 
valve has been modelled on physiological data. Uniform flow patterns 
are produced by flow straighteners upstream of the valve under test. 
These systems have the following advantages: 
They provide reproducible flow patterns; an electromagnetic 
flowmeter can be used to measure instantaneous flow through the valve; 
and there is good visibility of the valve under test: 
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while the main disadvantages are that flow patterns in the left 
ventricle are not modelled and the inertia of the fluid in the rigid 
tubes can distort the pressure waveforms. 
The ventricle has been modelled with a shaped rigid chamber 
(74,88) or a flexible ventricle (78,81,89,90). In both these cases 
it is more difficult to determine the flow through the valve under 
test. 
A simple lumped parameter afterload has been used to simulate the 
arterial system and peripheral circulation (91,92,93). A compliant 
aorta (62,72), curved aorta (94) and branching arterial tree (95) have 
all been modelled in different studies. A 4% water glycerine 
solution has been used to match the density and viscosity of blood but 
it can affect the mechanical properties of some tissue valves. It has 
been shown that viscous losses are small (94,80) and that a 
physiological saline can produce satisfactory results. 
Microcomputers have been extensively used to digitise, store and 
analyse pressure and flow signals fron the test rigs (63,77,96). The 
mean pressure difference across the valve during forward flow is a 
more reproducible measurement than peak pressure (97) and this should 
be plotted as a function of root mean square (RMS) forward flow 
(63,98). Root mean square (RMS) flow is used as the pressure 
difference across an orifice is proportional to the flow squared. The 
mean pressure difference across large valves is low (typically 1 to 2 
mmHg) and has to be measured while the pressure in the ventricle 
oscillates up to 150 mmHg. Pulsatile flow pressure measurements have 
been supplemented with steady flow pressure measurements which can be 
made with greater accuracy (89,99,100). Similarly, the leakage 
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through a closed valve is small (1 to 5 ml. s-1) and can often be 
measured more accurately under a static back pressure (61). The 
position of the pressure measurements, area of the test sections and 
valve orientation can all affect the pressure measurements (88,100). 
The flow through the valve has been measured directly with an 
electromagnetic flow probe (61,80,87) but can also be derived from the 
pump signal (62). If the flow is measured directly the regurgitation 
while the valve is closing and when the valve is closed, and the 
energy losses across the valve, can be calculated (78,80). 
Most test rigs have been manufactured from polished acrylic to 
allow good visibility of valve dynamics, and high speed cinL and still 
photography (65,79) have been used to record valve movements. Small 
particles, gas bubbles or dye injection, have been used for flow 
visualisation (79) and laser doppler anemametry has been used to 
measure fluid velocity fields downstream of valves (63,64,101,102, 
103). 
2.3 Theory of fluid flow 
The relationship between the pressure across and flow through 
heart valves and also the flow patterns and dynamic forces which 
affect opening and closure of the valves have been described in 
detail. In engineering studies the pressure differences across 
orifices of known geanetry has been accurately predicted for a range 
of flows in order that flow can be metered fran the pressure 
measurements. For a simple orifice plate in a pipe (Figure 2.1) 
assuring steady streamline flow and an incanpressible inviscid fluid 
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with no loss of mechanical energy, the pressure difference beteween 
points 1 and 2 can be predicted from Bernoulli's equation (104). ' 
A 
ý 
Pl, P2 are the pressure at points 1 and 2, Q is flow, /Q is 
density of the fluid and Al A2 is the cross sectional area of 
flow. If Ao is the orifice area then A2 = CcAo, Cc < 1. 
Loss of static pressure is due to conversion of potential energy 
to kinetic energy. If snail viscous losses occur and an empirical 
constant Cv (which is less than one) is used to account for these 
losses, then 
_d aa ,- 
Pa ýaýý-ý- 
ý! - ý= vCýAo Aý' ý 
If Al Ao and a discharge coefficient is defined as 
Cd = Cv Cc then 
ý -ý _ 'ýap Qa 1d Cda A; 
a 
3 
Downstream of the orifice the pressure is more difficult to 
predict as there is significant turbulence and energy loss. Equation 
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3 has been used to predict the area Ao of stenotic mitral valves 
(105,106). However, several assumptions have to be made to calculate 
the discharge coefficient for in vivo measurements. 
Under pulsatile flow conditions the pressure difference across a 
test valve has been described by equation 4 (90,98,107,108,109) 
' '0401 -+ ,ogda4 aGdAo dt 
where B is a constant dependent on the inertia of the fluid between 
the pressure measurement points. The pressure at point 3 downstream 
of the aortic valve has also been predicted (110). 
Equation 4 reduces to equation 3 if pressure and flow 
measurements are made at the time of peak flow (dQ/dt = 0) or if a 
time average of the signals is taken between the points of zero flow. 
Under either of these conditions the area of the valve can be 
expressed as: 




Unlike the fixed geometry of an orifice plate where Cd can be 
defined precisely, the discharge coefficient will vary from valve to 
valve. This is eliminated if an effective orifice area is used (87). 
EOA = CdAQ 
aýý 
In tissue valves Ao increases with flow as the increased pressure 
difference forces the leaflets to open wider (62) in these cases. 
Pº_Pa _ Qc 
1.5 4 C< -a 
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The inertial forces shown as (BdQ/dt) in equation 4 play an 
important role in the closure of the valve. During the deceleration 
phase of forward flow this term becomes negative and P2 becomes 
greater than Pl. This reverse pressure starts the closure of the 
valve whilst there is still forward flow (111,112) so reducing the 
amount of dynamic regurgitation. This early closure has also been 
attributed to vortex formation within the sinuses of the aortic valve 
(113,114) but this has been contradicted by experimental evidence 
(112). 
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2.4 Function test methods 
The pulsatile flow test apparatus which has been developed has 
been described in detail elsewhere (115, Appendix 2) and is shown in 
Figure 2.2. Essential features of the apparatus were: 
The pulsatile flow was produced by a servo-controlled piston pump 
(Cardiac Development Laboratories] (78) which was controlled by a 
programmable waveform generator. 
The flow through either valve was measured with an electromagnetic 
flowmeter (Gould SP2201) which was modified to give a frequency 
response of -6dB at 100 Hz. 
The valves were mounted in rigid test chambers and pressure 
measurement ports were positioned every 25 mm downstream and upstream 
of the valves (Figure 2.3). 
The mean differential pressure across the valve under test was 
measured with a differential transducer (Gaeltec 3CT special) and 
direct pressure measurements were made on the atrial, ventricular and 
aortic test sections to establish the correct test conditions. 
The fluid medium used for all tests was physiological saline (0.9% 
sodium chloride solution). 
Five different flow conditions were used for the tests which varied 
from a stroke volume of 60 ml and rate of 60 min-1 to a stroke 
volume of 80 ml and 120 min -1 (Figure 2.4). These correspond to 
cardiac outputs of between 3 and 8.5 1 min-1. 
Seven signals (four pressure, flow and the displacement and velocity 
of the pump) were collected for a period of 20 seconds on an Apple 11 
computer. Details of the computer software will be reported 
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elsewhere (116, Appendix III)). The canputer calculated the average 
waveform for each of the seven signals. These were stored on a 
floppy disk and plotted on an Anadex printer. 
The canputer calculated the mean pressure difference, mean forward 
flow and root mean square forward flow (RMS) and effective orifice 
area for different time intervals during forward flow. It also 
calculated the volume of fluid passing through the valve during 
forward flow, and the regurgitant volumes (dynamic regurgitation while 
the valve was closing, static regurgitation while the valve was 
closed). The energy loss during each phase of the cycle was also 
calculated as described in Appendix N. 
Visual recordings of valve movements were made from a Panasonic AI 
video camera, JN video cassette recorder CR 6650 and Barco colour 
monitor. Valves were viewed from the end and the side of the test 
sections and movements analysed with still frames every 20 ms. Valve 
movements were also recorded using synchronised flash photography. 
An electronic delay unit triggered from the pump signal was used to 
f ire an electronic flash gun linked to a 35 mm SLR camera. This 
allowed still photographs to be taken every five ms while the valve 
was opening or closing. 
Pulsatile flow measurements were supplemented by steady flow pressure 
difference measurements and static back pressure leakage 
measurements. The test apparatus used for the tests is shown in 
Figure 2.5. The steady flow test rig was a modification of the 
pulsatile flow test rig. The pump produced a static pressure 
difference between the two reservoirs which in turn produced a steady 
flow through the two valves. In the column test apparatus, a static 
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back pressure of 100 mmHg was applied to the valve and the leakage 
measured by collecting the fluid leaking through the closed valve. 
2.5 Standard test conditions 
Variation in results from different test apparatus show that 
condition of the test can significantly affect the results. The main 
factors affecting the forward flow pressure difference results are 
time interval during forward flow used to average the signal, 
position of the pressure measurements and valve orientation, whereas 
the regurgitant volumes are affected by definition of the dynamic 
regurgitation, valve orientation and shape of the pressure waveform. 
Experiments were carried out to determine the affect of these 
variables on the results (Appendix 1). From these tests the 
following standard set of test conditions were specified: 
i mean differential pressure and RMS flow measured during the 
pressure flow and pressure-pressure intervals. 
ii Upstream pressure measurements were made 25 mm from the mitral 
valve and 50 mm from the aortic valve, and the downstream 
measurements were made 50 mm from both valves. 
iii Pressure measurements were made in the minor orifice of tilting 
disc valves, the major orifice of bileaflet valves and adjacent 
to the stent in tissue valves. 
iv The end of dynamic regurgitation was defined as the lowest 
negative flow, prior to the constant leakage. 
v Mechanical valves were tested with the discs or leaflets opening 
in the horizontal plane in order that gravity had no effect. 
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vi The valves were tested without compliance in the ventricular 
chamber. 
The apparatus has been used to test the function of a range of 
prosthetic valves in both the mitral and aortic positions. ' The 
results of these studies have been published (117,118 - Appendix 2). 
2.6 Accelerated fatigue tests 
Accelerated fatigue testing remains the only way of assessing 
valve durability in a reasonable period of time prior to clinical 
implant. Valves have been tested at between 10 and 20 Hz which allow 
forty million cycles (equivalent of one year's lifetime) to be 
completed in 23 to 46 days. At these rates it is impossible to 
simulate physiological flows, volumes and pressure waveforms 
precisely. The cycle rate depends on the speed at which the valves 
can open and close. This is much lower in mechanical valves which 
have larger inertia in the moving parts (89). Although early fatigue 
studies were completed in 1964 (119,120) there has been little 
published data on valve durability. Recently, interest in the 
durability of bioprosthetic valves has increased (51) and four 
different test systems are currently being used. Test conditions 
have not been standardised and comparative studies of the durability 
of the same valves in different instruments have not been published. 
Two fundamentally different principles have been used in the 
design of these instruments. In three of the four instruments the 
fluid is pulsed through a stationary valve, whilst in the fourth the 
valve is nerved through a stationary column of fluid. In the 
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instrument developed by Swanson (48) and marketed by Dyrnatek, a 
rotating shaft with a small slot allows fluid from a high pressure 
reservoir to pulse through six valves simultaneously, whereas in the 
system developed by Haussinger (87,121) up to six valves are opened 
sequentially by a rotating slit disc. In the system manufactured by 
Shellhigh Co, fluid pulses are produced by a rotating cam acting on 
polyurethene bellows (46). 
In the most widely used test instrument (Rowan Ash accelerated 
fatigue tester 51,122) the valves are oscillated through stationary 
columns of fluid. The displacement of the valve determines the flow 
and the back pressure on the closed valve is adjusted independently. 
This instrument was selected for our fatigue studies. 
2.7 Fatigue test methods 
The Rowan Ash accelerated fatigue tester is shown in Figure 2.6. 
The machine cycled up to six valves at rates between 10 and 20 Hertz. 
The principle of operation is shown in Figure 2.7 Each valve was 
mounted on a hollow piston which oscillated through a stationary 
column of fluid (0.2% buffered glutaraldehyde). On the upward stroke 
of the piston the valve closed and pushed fluid around the 
recirculation tube and the variable resistance was used to adjust the 
closing pressure on the valve. On the downward stroke the valve 
leaflets opened fully. The displacement of the piston was adjusted 
to give maximum opening of the valve and full closure. Typically the 
amplitude was set to 3 to 4 mm which corresponded to peak flows of 20 
to 27 1 min -1 (330-450 ml s-1). The valve movements were viewed 
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using a synchronised strobe light and photographed using a 35 mm SLR 
camera. 
The pressure difference across the valve was measured with a 
Gaeltec 3CT special differential transducer, which was driven by a 
Gould (13 4615-85) pressure amplifier in a series 8000 recorder. The 
signal from the amplifier was linked to an oscilloscope and the 
pressure waveform photographed using a polaroid camera. The Gaeltec 
transducer had a volume displacement of 0.7 mm3/100 mmHg which when 
connected to a rigid tube (diameter 2 mm, 100 inn long) gave a resonant 
frequency of 125 Hz. This was measured with reference to a catheter 
tip transducer using a Siemens pressure generator. The pressure 
signal was filtered electronically to give a flat response (t 25%) up 
to 135 Hz. The peak closing pressure was set between 100 and 130 
mmHg. This was achieved by gradually increasing the pressure during 
the initial 2 million cycles of the test. The valves were cycled at 
12 Hz and viewed three times a week. Pressures were checked and 
adjusted every week (8 million cycles) and the machine stopped after 
every 160 million cycles or at valve failure and the valves taken out, 
inspected and photographed. 
Differential pressure waveforms for two 29 mm ISLP valves are 
shown in Figure 2.8. The differences in the shape of the waveforms 
were caused by interactions between the valves and the machine. The 
rapid rise in pressure as the valve closed was due to the inertia of 
the fluid which was recirculated around the chamber. This was 
highest for the first valve to shut (Figure 2.8a) and was lower for 
the valve which shut last (Figure 2.8b). In this case the second 
Peak was set to the maximum closing pressure by increasing the 
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resistance in the recirculation circuit. A catheter tip transducer 
placed in the chamber above the valve showed that there were 
high frequency pressure oscillations (greater than 100 Hz) which may 
cause localised pressure gradients greater than 130 mmHg. 
At these accelerated rates the leaflet movements differed from 
the movements recorded in the function tester at normal heart rates. 
At normal rates the leaflets nerved to the fully closed position in 
approximately 60 ms whilst in the fatigue tester closure occurred in 
about 10 to 20 ms. As the leaflet moved to the closed position in 
the fatigue tester the free edge of the leaflet lagged behind the 
belly causing a sharp bend or kink along the radial axis of the 
leaflet. This did not occur in the function tester. This is shown 
in Figure 2.9 for size 29 mm ISLP valves photographed just before full 
closure in the fatigue tester and function tester. 
It is not known whether this abnormal leaflet action affects the 
valve durability or whether the different pressure waveforms described 
previously affect the results of the test. 
2.8 Summary 
Apparatus and methods have been developed to perform mechanical 
function and durability tests on prosthetic heart valves. The 
function tests allowed the mean pressure difference during forward 
flow, regurgitant volumes, energy losses, valve dynamics and flow 
visualisation to be studied under standard conditions. Results of 
these tests on commercial valves have been published. A commercially 




EVALuAATION OF THREFd-TAE' PERICARDIAL VALVES 
3.1 Three leaflet pericardial valves 
Current designs of three-leaflet pericardial valves have evolved 
from valves fabricated from pieces of fresh tissue such as fascia lata 
sutured onto cloth-covered frames (25). Three leaflets have been 
used to mimic the geometry of the natural aortic valve where the width 
of each leaflet at its free edge is approximately equal to the 
diameter (d) of the orifice which allows the leaflets to open to the 
full circumference of the orifice. Clinical results with commercial 
pericardial valves were described in Section 1.4. The first valve 
manufactured, the Ionescu-Shiley Standard (ISU) valve has 13 years 
clinical follow-up (38) and has shown a significant incidence of 
tissue failure (46) with tears adjacent to the cloth-covered frame. 
Early clinical results have shown similar primary tissue failure with 
two low profile pericardial valves, the Hancock Pericardial (HP) and 
Ionescu-Shiley Low profile (ISLP) whilst two other pericardial 
valves, the Mitral Medical Mitroflow (MM) and Edwards pericardial (EP) 
have not shown tissue failures clinically. The MM valve has shown 
tissue failures in accelerated conditions in the laboratory (49). 
Various mechanisms for clinical tissue failure have been discussed but 
the precise reasons are not clear and correlations between clinical 
and laboratory studies are variable (46,47). 
In this chapter the design, construction function and durability 
of four pericardial valves which were commercially available in 1984 
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have been studied (ISU, ISLP, HP, MM). In addition, the design 
features of two newer three-leaflet valves, EP and Ionescu-Shiley III 
(ISIII) and two new bileaflet valves are discussed. The results of 
function and durability tests and clinical experience with explanted 
valves have been used to identify key areas of design and construction 
in these valves. 
3.2 Methods used to analyse valve designs and geaoetries 
A considerable number of studies have been made of the geometry, 
leaflet dynamics and stress analysis of both fresh and glutaraldehyde- 
treated aortic valves, but few studies have been made of fabricated 
leaflet valves. The geometry of natural valves has been extensively 
described (123,125) and the material properties of the leaflets have 
also been studied (126-129). Simple membrane and thin shell theories 
have been used to analyse the stress in closed valve leaflets 
described by two principal radii of curvature (130,131) and by 
ellipsoids of revolution (132). Finite element stress analysis has 
also been used for the closed aortic valve (133-136). Membrane and 
bending stresses in both the closed and open positions have also been 
studied by Thubrikar (137,138). The results of this stress analysis 
were highly dependent on the anisotropic, non-linear visco-elastic 
leaflet properties, the leaflet geometry, the boundary conditions 
applied, the leaflet thickness and the method of analysis used. 
These studies have revealed a number of important features of the 
natural and glutaraldehyde-treated aortic valves. 
i The leaflets grow in a complex shape with a variable radius of 
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curvature. The natural geometry is a prime determinant of the 
membrane stresses in the closed position. The leaflets coapt 
over a large area well below the top of the leaflets at the 
comnissures. 
ii The leaflets grow radially outwards from the aortic wall and are 
thickest at the points of attachment particularly close to the 
commissures where the membrane tension is highest, and thinnest 
in the belly of the leaflet where the tissue undergoes maximum 
bending. 
iii The leaflet material is anisotropic and is more extensible 
radially than circumferentially, but shows a higher ultimate 
tensile strength circumferentially than radially. This gives a 
more stable closed position with increased coaption caused by 
additional radial extension, whilst the high circumferential 
stresses at the comnissures act along the stiffer stronger axis. 
In transposing from the open to the closed position and vice 
versa, the increased radial extension allows the leaflet to 
buckle in aS shape along its radial axis as described by Swanson 
(124). 
iv The wall of the aorta expands during systole to create a larger 
orifice. This effectively straightens out some curvature in the 
leaflet giving a more stable open geometry. 
v The leaflet is not supported along its free edge and the radial 
stresses diminish rapidly towards the top of the leaflet, which 
produces high unidirectional stresses circumferentially towards 
the top of the conmissures or posts. The magnitude of these 
stresses is highly dependent on the geometry of the leaflet 
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close to the coaption area. 
vi Fixation of tissue under tension reduces its extensibility and 
flexibility. This may cause increased bending stresses and 
tissue failure (126). 
Designs of existing pericardial valves are considerably different 
to the natural valves and few detailed studies of their design 
have been published. An optimal geometry for a valve leaflet 
fabricated from synthetic material has been described using a 
shell defined by two principle radii of curvature (140-141) and 
the stresses in the leaflets of an ISU pericardial valve have 
been analysed by assuming a cylindrical geometry (53). These 
fixed geometries cannot account for changes in geometry caused by 
extension of the leaflet material under back pressure. 
Similarly, defining a fixed open geometry does not allow for 
changes in the geometry or strain caused by variable tissue 
properties. 
The studies of natural aortic valves would indicate the following 
areas to be particularly important for pericardial valves: 
i The geometry of the unloaded leaflet (its natural shape). This 
is determined by the shape formed during fixation with 
glutaraldehyde and/or the shape formed in the leaflet when 
mounting it on the frame. 
ii The geometry of the leaflet under back pressure in the closed 
position. In particular the area of coaption between the 
leaflets when closed as this not only seals the valve but also 
affects the leaflet stability and stresses in the closed 
position. 
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iii The geometry of the leaflet in the open position and the dynamics 
of moving between the open and closed, and closed and open 
positions. 
iv The mechanical properties of the leaflets (thickness and 
extensibility) which depend on selection of fresh tissue and 
fixation conditions. 
v The frame geometry and flexibility. 
vi The covering material used on the frame. 
vii The method of attachment of leaflet to frame. 
It is also important to define a number of parameters to describe 
the valve geometry. The size of the valve quoted as the tissue 
annulus diameter (TAD) cannot always be related to a particular 
dimension of the valve. Figure 3.1 shows some key dimensions. The 
external diameter of the frame, Do, should be defined at the base and 
the top of the posts for a tapered frame. The internal diameter of 
the frame, Di, is measured in the base of the valve. The overall 
height of the valve is H and and h is the height of the scallop over 
which the leaflets flex. W defines the width of the top of the posts 
and a radial view on post B indicates the shape of the post. The 
outline of the unloaded leaflet AOBC is shown with a dotted line, and 
a vertical section through OC defines the radial radius of curvature 
Rr. A vertical section through OB shows the area of coaption between 
the unloaded leaflets. The circumferential radii of curvature is 
defined by Rc. An additional parameter, Hi, is the implantation 
height for a mitral valve and is defined as the distance from the top 
of the sewing ring to the top of the posts. 
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A three dimensional plot of the leaflet can be generated by 
measuring vertical and horizontal sections every 2.5 ma through the 
unloaded leaflet. This is illustrated in Figure 3.2. 
3.3 Valve designs and descriptions 
1 
ii 
Ionescu-Shiley Standard Valve (ISU) 
A photograph of a size 29 mm ISU mitral valve is shown in Figure 
3.3 and has been described in (25,142-144). The three pronged 
frame was manufactured from rigid titanium and covered with a 
polyester cloth. The leaflets were manufactured from bovine 
pericardium, fixed in glutaraldehyde in its natural shape and 
stitched onto the outside of the cloth-covered frame. The key 
dimensions for a size 29 mm mitral valve are given in Table 3.1. 
The frame was slightly tapered and the outside diameter Do was 1 
mm greater at the top of the posts in the 29 mm valve. In the 
aortic valve the taper was greater with the outside diameter Do 
increased from 23 to 27 M in a 23 mm valve. The leaflets were 
sealed together with a coaption stitch inside the top of each 
post which also pulled the leaflets into the closed position. 
In addition, the valves were stored with spherical cotton balls 
restraining the leaflet in the closed position making the natural 
position of the unloaded leaflet closed. The tissue thickness 
was approximately 0.35 mm. 
Ionescu-Shiley Low Profile valve (ISLP) 
This valve is shown in Figure 3.3 and described in (52). It had 
an improved design compared to the ISU valve with a flexible 
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cylindrical stent manufactured from acetal. The heights H and h 
of the stent and leaf were reduced by approximately 1 mm (Table 
3.1) for the 29 mm valve, but the leaflets were no longer cut 
away towards the centre, so the height to the centre of the 
leaflet at the coaption depth remained similar to the ISU. As 
with the ISU valve, the tissue was fixed in its natural shape 
and then mounted on the frame. The main difference was in the 
design of the stent post and attachment of the leaflet at the top 
of the post. In the ISLP, the post projected into the orifice 
at the top of the post which allowed two coaption stitches to 
pass through the post and the leaflets. The new design was 
claimed to give improved durability over the ISU valve (38) and 
better hydrodynamic performance. The leaflet thickness varied 
from . 55 to . 35 mm. in the size 29 mn valves. 
iii Hancock Pericardial Valve (HP) 
The HP valve is shown in Figure 3.3. The valve had a flexible 
stent manufactured from polypropylene with a low overall height, 
H (Table 3.1). The stent post profile differed from the Shiley 
stents in that the posts were a triangular shape tapering away to 
a rounded point at the top, which eliminated the parallel portion 
found at the top of the Shiley posts. The tissue projected 
about 1 mm above the top of the posts where the leaflets were 
sealed with a coaption stitch. A small stitch was also used to 
attach the tissue to the edge of the stent post. The shape of 
the stent and posts gave a low coaption depth, hc, for the 
unloaded leaflets. Fresh tissue was sutured on to the 
cloth-covered stent and the leaflets fixed in the closed position 
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under a low pressure. This produced more curvature in' the 
leaflets (Rc Rr approximately 15 mm), a sharp V shape in the 
centre of the leaflet at the free edge and a sharp bend in the 
tissue as it passes over the edge of the frame. The leaflets 
were thin (approximately 0.35 nm) in the size 29 inn valve. 
iv Mitral Medical (Mitroflow) valve (MM) 
The valve shown in Figure 3.3 had a cloth-covered flexible acetal 
stent. The stent height was similar to the HP valve but the post 
had a small parallel section at its tip. A single stitch placed 
over the top of the post restrained the leaflets but did not 
bring the leaflets into apposition inside the post in the 
unloaded position. A small triangular hole was also seen 
between the free edges in the centre of the valve in the unloaded 
position. The leaflets were moulded on a jig during fixation 
with glutaraldehyde into a geanetry which nearly matched the 
closed position of the leaflet. This formed a natural curvature 
in the leaflet (Rc Rr approximately 15 mm) and fixed a sharp bend 
in the leaflet where it passes over the edge of the frame. The 
leaflet thickness, t, was approximately 0.5 mm in the size 29 mm 
valve. 
v other valves under development 
Other pericardial valves under development include the Edwards 
Pericardial valve (EP), the Ionescu-Shiley III pericardial valve, 
and the Sheffield and Cardiac Development Laboratories Bileaflet 
valves. The Shiley III valve was constructed similar to other 
Shiley valves but had a strip of pericardial tissue along the 
edge of the frame (54). The EP valve mounted the tissue under a 
52 
wire frame in a similar manner to that proposed by Reul (145) and 
Davis (146). In this configuration the leaflets came into 
apposition inside the frame at the top of the post without the 
need for a comnissure stitch (44). Effectively, the leaflets 
projected radially inwards from the frame taking a natural closed 
position without the need for moulding. A similar construction 
has been used in the Sheffield bileaflet valve (55,147) and a 
bileaflet valve has been developed with leaflets moulded in the 
closed position in the shape of a bubble surface (56). 
There were considerable differences in the detailed design and 
construction of these valves which were investigated during valve 
function and durability tests. All the valves are difficult to 
manufacture, with considerable skill and precision required to 
suture the leaflets in place. This resulted in a high 
proportion of rejected valves after final assembly. 
3.4 Valve function tests 
Four size 29 itm valves were tested in the mitral position of the 
pulse duplicator and four size 23 mm valves were tested in the aortic 
position. 
The mean pressure difference is plotted against RMS forward flow 
in Figure 3.4 for the 29 mit mitral valves and the 23 nm aortic 
valves. In the 29 mm mitral valves the ISU had the largest pressure 
difference whilst the MM had the lowest. In each case the valve 
orifice increased with flow rate and was determined by the free edge 
of the leaflets and not the internal diameter of the stent. The free 
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edges of the leaflets were restricted in opening to varying degrees by 
the coaption stitches at the top of the posts (Figure 3.3). This 
restriction was greatest in the ISU valve with the coaption stitch 
inside the post, and least in MM valve where the stitch was placed 
over the top and towards the outside of the post. The HP 23 mm 
aortic valve had the lowest gradient whilst the ISU and ISLP had 
similar gradients. The ISU valve was effectively a larger valve as 
dimension Do (Figure 3.1) at the top of the stent was 27 mm. 
The regurgitation was similar in all four valves (Figure 3.5). 
In the mitral position the closing volume was higher than the closed 
regurgitation, due to the large volume swept back by the leaflets, the 
flexibility of the stent and extension of the leaflets, and short 
systolic time period. In the aortic position the closing volumes 
were lower, but the static regurgitation higher, due to the longer 
diastolic time period. Energy loss results (Figure 3.6) show that 
the regurgitant fraction was dominant at low flows in both sizes of 
valve, but at higher flows energy losses during forward flow dominated 
(particularly in the aortic position) and valves with the lowest 
pressure differences also had the lowest total energy loss. 
The different valve designs also had a significant effect on 
leaflet dynamics. The closed position of the ISU and ISLP size 29 mm 
valves under 120 mm back pressure is shown in Figure 3.7. The 
flexible stent of the ISLP allowed the free edge of the leaflet to 
twist when closed indicating that the tissue was not under as much 
tension. This reduction in stress may improve durability (148). 
The effect of the tissue fixation method on the opening of the 
leaflets was shown by testing the 29 mm valves at low steady flows of 
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40,80,120,160 ml. s-1. All these leaflets opened at 40 ml. s-1 for 
the ISU and ISLP valves, at 80 ml. s-1 for the HP valve and 120 ml. s-1 
for the MM( valve. All leaflets opened at the lowest flow in the 
pulsatile test (stroke volume 60 ml, rate 60 BP min) with a peak flow 
of 150 ml. s-1, although the last leaf to open in the tVl was' slow 
taking an additional 50 ms to open. These tests confirmed that the 
fixation of the tissue could affect synchronous leaflet opening action 
and this was demonstrated more clearly in the valves with thicker 
leaflets. However, in all cases, the leaflets opened when the 
pressure difference across the valve was less than 1 mm Hg. The 
method in which the valves opened also differed. Synchronised 
photography at 10 ms intervals showed that the Shiley valves moved 
from the open to closed position by buckling across the leaflet 
forming an S shape in the circumferential direction whilst the HP and 
'? 1 valves reversed their curvature in the base of the leaflet first 
forming an S shape in the radial direction. The opening action was 
the reverse of the closure. The leaflets took 30 to 60 ms to open 
depending on the flow waveform and 50 to 70 ms to close. Synchronous 
closure was good in all valves with the leaflets coming together 
within 10 ms. Although it has been suggested that asynchronous 
closure may place extra load on the leaflets that close first, this 
may not be significant as the high back pressure was not generated 
until all three leaflets were almost closed. 
The geometry of the leaflet in the open position was also 
affected by the method of fixation. In the HP and MM valves fixed in 
the closed position the sharp curve fixed in the leaflet at the edge 
of the stent was not straightened out and when the leaflet opened this 
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produced an S profile at the edge of the stent on the base of the 
leaflet. In Shiley valves the leaflets opened up to a straight line 
(see Figure 3.8). This will affect bending stresses and perhaps 
tissue ingrowth in these areas. Alternatively, tissue ingrowth may 
change the open geometry of the Shiley valve over a'period of time. 
3.5 Fatigue studies 
Fatigue studies were carried out on one ISU, four ISLP, three HP 
and 2 MM, size 29 mm mitral valves. The results of the tests will 
be published (149,150). The lifetimes of the valves to failure are 
shown in Figure 3.9. Failure was defined as a tear 3 mm long in 
order that the start of a tear could be isolated before it propagated 
through the leaflet. In all valves, failure occurred due to tears 
originating close to the edge of the stent. These tears were caused 
by abrasion of the leaflet as it flexed over the edge of the 
cloth-covered frames. 
The four ISLP failed valves are shown in Figure 3.10. In three 
valves the tear started halfway up the post at the shoulder of the 
scallop and in one valve propagated to the free edge of the leaflet 
before the test was stopped. In the fourth valve the tear started 
after 315 million cycles at the top of the post where the post 
deepened and projected into the valve orifice. The tissue was intact 
around the coaption stitches in all four valves. All leaflets showed 
wear, abrasion and thinning along the edge of the cloth-covered frame 
(Figure 3.11). The one valve that failed after 20 million cycles had 
thinner leaflets. The ISU valve failed after 5 million cycles with a 
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tear in the leaflet which propagated from the shoulder of the stent 
scallop to the free edge (Figure 3.12) . The opposite. side of the 
same leaflet also had a short tear at the shoulder of the stent and 
the coaption stitches at two posts had pulled out through the tissue 
producing a small tear. As in the ISLP, all leaflets had abrasion 
and thinning around the edge of the frame. 
The HP valves all failed in under 10 million cycles with tears 
adjacent to the stent (Figure 3.13). In two valves the tears started 
two thirds up the post and propagated to the free edge while in the 
third the tear occurred at the top of the post. In each case the 
torn leaflet prolapsed and all leaflets showed abrasion and thinning 
along the edge of the cloth-covered frame (Figure 3.11). The tears 
did not appear to originate from the coaption stitches. 
The two MM valves failed at 15 and 54 million cycles with tears 
adjacent to the cloth-covered frames (Figure 3.14). As with all other 
valves, tears were caused by abrasion on the cloth-covered frames. 
Function tests were carried out on all the failed valves. These 
showed that where the tear had propagated to the free edge, the 
leaflet prolapsed below the other two leaflets giving a large 
regurgitation of between 25 and 45 ml for a stroke volume of 70 ml. 
The mode of failure abrasion on the cloth-covered stent was 
similar in all valves although the lifetimes varied considerably. 
The early failure of the ISU compared to the ISLP may have been due to 
thinner leaflets or a rigid stent and has been predicted by other 
workers (27,49). Our results showed earlier failure of the HP valve 
than other centres (49). The abrasion was caused by the leaflet 
being pulled over the edge of the frame in the closed position and was 
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greatest where the tension in the leaflet was highest. The position 
of maximum tension may have been affected by the abnormal closing 
action of the valve in the fatigue tester discussed in Chapter 2. 
The effects of different leaflet designs and dynamics discussed in 
Section 3.4 are clearly overtaken by the premature failure due to 
abrasion. 
These in vitro tests were artificially harsh for pericardial 
valves and did not predict clinical failure rates (typically 1% per 
patient year). In vivo blood deposits form rapidly on the cloth 
followed by host tissue ingrowth. These processes greatly reduce the 
abrasion of the leaflets on the cloth but do not eliminate it (46). 
Our clinical experience of six failed ISLP valves (Figure 1.11) and 
two explanted HP valves (Figure 1.12) show that clinically the tears 
appeared closer to the top of the posts than generally found in the 
fatigue tester. In the ISLP valve which failed in the fatigue tester 
after 315 million cycles, with a tear close to the top of the post, 
the mode of failure was more similar to the clinical valves. In both 
types of clinical valves endothelialisation and host tissue ingrowth 
reduced abrasion and reinforced the leaflets particularly in the base 
of the scallops. It is not clear whether the tears at the top of the 
stent posts were caused by abrasion or by the ooaption stitches which 
passed through the leaflet close to the point of the tears. However, 
stress concentrations around the stitches in an area which was thinned 
and weakened by abrasion probably contributed to the tissue failure. 
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3.6 Discussion 
Although pericardial valves have been used for over 13 years 
their clinical performance is not ideal and there is particular 
concern about longterm durability and calcification. Clinical 
experience with explanted valves has shown a characteristic failure 
mode with tears occurring close to the edge of the cloth-covered 
stent. Although extensive studies have been made of the function, 
design and dynamics of natural and glutaraldehyde-treated porcine 
valves few detailed studies have been made of the design, function and 
dynamics of pericardial valves. There was considerable variation in 
the detailed design of the four pericardial valves studied, in 
particular differing methods of tissue fixation, leaflet geometries, 
mechanical properties for the leaflets, methods of attachment to the 
stent and covering materials used. In all cases the methods of 
manufacture required skill and precision which resulted in a high 
rejection rate of finished valves. Standard hydrodynamic parameters 
were similar for all four valves although the pressure drop was 
dependent on the restricted opening of the free edges of the leaflet 
caused by coaption stitches. The leaflet dynamics were dependent on 
the method of fixation and the properties of the tissue used. 
Forming the leaflet in the closed position during fixation was seen to 
affect the synchronous opening of the leaflets, the method of buckling 
from the open to closed position, and the geometry of the open 
position. It is clear that the method of fixation, the changes 
induced in the material properties (126) and the varying geometries 
can affect the stresses in the leaflet (53). 
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The in vitro fatigue studies were not able to show differences in 
valve durability due to these differences in valve design, as abrasion 
of the leaflets on the cloth-covering at the edge of the stent caused 
premature tissue failure and tears in all but one of the valves. 
This confirms studies made in other centres (44,49). In these in 
vitro tests, tissue failure was not caused by flexion (145), tears 
from sutures (30) or by Dacron buttresses on the outside of the post 
(51) although in the ISU valve, coaption stitches did pull through 
the leaflets producing small tears, but these did not extend or cause 
leaflet prolapse. However, if the abrasion problem was overcome, 
alternative failure modes would be identified which could perhaps be 
attributed to differences in valve design, tissue fixation, etc. 
Clinical results with two valves, HP and ISLP, showed that 
abrasion of the leaflets was greatly reduced by biological processes, 
such as endothelialisation and tissue ingrowth, but did occur 
especially close to the top of the posts where coaption stitches may 
also have contributed to the tears. It is clear that tissue abrasion 
on the cloth-covered stent and coaption stitches at the top of the 
post are the main factors affecting valve durability. only after 
these failure modes have been eliminated will the effect of different 
leaflet designs and function on valve durability becane apparent. 
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, CHAPTER 4 
BOVINE PERICARDIAL TISSUE 
4.1 Introduction 
Bovine pericardium is a complex biological material. Variations 
in the mechanical properties and structure of the tissue within sacs 
and between sacs from different animals, and changes induced in the 
tissue following treatment with glutaraldehyde pose considerable 
problems when studying the properties of tissue used in valve 
leaflets. A better understanding of these material properties is 
essential if current valve designs are to be improved. 
There is considerable knowledge of the mechanical properties of 
biological materials such as skin and tendon (151-153) and also 
natural valve leaflets (154). Uni-axial testing of fresh aortic 
leaflets has shown them to be anisotropic and non-linear with an 
initial low modulus of elasticity followed by an abrupt transition to 
a much stiffer material. They are more extensible and have a lower 
ultimate tensile strength (UTS) radially than circumferentially 
(155). The anisotropy is caused by fibre orientation and the low 
initial modulus of the stress-strain curve (often described as the 
soft incubation period) has been attributed to the "waviness" or 
"crimp" in the collagen fibres (156). Fixation of the valve leaflets 
in a stressed condition can reduce or eliminate this "crimp" (157,158) 
and cause a less extensible material by modification of the soft 
incubation period on the stress-strain curve. These variations in 
the mechanical properties have been related to changes in function and 
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durability of glutaraldehyde-treated porcine aortic heart valves 
(159-163). The visco-elastic properties of fresh porcine leaflets 
have been illustrated using uni-axial testing (129) and have been 
attributed to movement of the collagen fibres through the viscous 
ground matrix. In this study, fixation with glutaraldehyde in a 
stressed condition produced a less extensible material (as above), but 
fixation at zero stress produced a more extensible material (164). 
This additional extensibility was associated with break-up of the 
ground substance matrix. 
The structure of both human and bovine pericardium has been 
described by Ishihara (165,166). Three distinct layers were 
identified, the inner serosal surface of mesothelial cells, the middle 
fibrosa containing variously orientated layers of type 1 collagen 
fibrils and elastin fibres, and the epipericardial connective tissue 
layer containing random orientated collagen bundles up to 15 pM in 
diameter, blood vessels, nerves and adipose tissue cells. The 
collagen fibrils in the fibrosa are formed in bundles or layers 
approximately 5 pM thick, with the fibrils within each bundle or layer 
having similar orientation. The orientation of the fibrils may vary 
from layer to layer. The fibrils themselves are between 50 and 150 
nM in diameter and are formed from aggregates of collagen pentafibrils 
(diameter 3.5 nM). A cross section through each pentafibril reveals 
five staggered tropocollagen molecules (each molecule being 290 nM 
long). This produces a characteristic banding every 67 nM in the 
tropocollagen molecules (167). 
The layers or bundles of collagen fibrils in the fibrosa have a 
wavy appearance (period typically 20 um) which is often referred to as 
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"crimp". The layers of fibrils are birefringent and the pattern of 
the "crimp" can be readily seen using polarised light microscopy. 
This is a simple way of identifying the orientation of the fibrils are 
running. The fibrils themselves are quite inelastic and extensibility 
of the tissue is due to the "crimp" of the fibrils, realignment of the 
fibrils in the ground substance, and the elastin fibres. It has been 
shown that the "crimp" disappears when the tissue is stretched. 
Mechanical testing of canine pericardium (168) has shown a non-linear 
visco-elastic material with an initial low modulus of elasticity and a 
much stiffer modulus at high strains. Shifts in the stress-strain 
curve were found after preconditioning. The viscous properties are 
related to rearrangement of the collagen fibres in the viscous ground 
substance (169). Although the tissue has been described as nearly 
isotropic, the ultimate tensile strength and tissue modulus were 
greater in the direction of the long axis of the heart than the 
circumferential direction. Bi-axial stress-strain testing of fresh 
canine pericardium has also indicated anisotropic properties 
(170,176). Van Noort has shown that fixation of bovine pericardium 
with glutaraldehyde modifies the stress curve with stiffening of the 
soft incubation period (171). The stress-strain curve is further 
modified and moves towards the origin if stress or strain is applied 
to the tissue during fixation (172). This correlates with loss of 
waviness in the collagen bundles. Trowbridge has shown that the 
abrupt stiffening of stress-strain curve found in fresh samples occurs 
more gradually in fixed tissue (174) and that the response to load in 
the unstrained state suggests fixed tissue is isotropic (174). There 
is however considerable difference in the stress-strain curves and 
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maximum extensibility for tissue taken from different areas of the sac 
and this has been attributed to the elastin content of the tissue 
(175). Stress-strain curves can also be affected by choice of gauge 
length (177). 
The anatomy of the human pericardial sac has been described in 
detail (178) and compared to the bovine sac. The mechanical 
properties of the tissue, its thickness and ultimate strength, vary 
throughout the sac and are associated with the orientation of the 
layers of fibrils in the fibrosa. To select the best tissue for 
valve leaflets it is important to define more precisely the mechanical 
properties of both the fresh and fixed bovine tissue in different 
areas of the sac. 
The properties of bovine pericardium taken from beef cattle aged 
12 to 36 months have been studied. The gross structure and geometry 
of the sacs have been defined and I have established a frame of 
reference using the ligaments (sterno pericardiaca) and the tissue 
surrounding the inferior vena cava. The tissue thickness has been 
measured throughout the sac and the fibril orientation studied using 
polarised light microscopy. In one area of the sac with more uniform 
thickness, uni-axial and bi-axial tensile testing have been carried 
out. The mechanical properties of this area have also been studied 
after glutaraldehyde fixation. 
In addition I have investigated the chemistry of glutaraldehyde 
fixation and have monitored the degree of crosslinking in the tissue 
by measuring the thermal denaturation temperature. 
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4.2 Pericardial sac 
Pericardial sacs obtained from beef cattle aged 12 to 36 months 
have been studied as part of this thesis work. Sacs were harvested 
from animals by circumferential dissection around the top of the heart 
adjacent to the major vessels. Sacs were stored in physiological 
saline and transported to the laboratory. Fat was carefully removed 
from the epipericardial surface and the tissue washed thoroughly in 
saline. The approximate shape of one sac was determined by taking a 
plaster cast of the heart and is shown in Figure 4.1. The shape can 
be considered a truncated cone with the apex of the heart forming a 
spherical tip. Each sac was dissected down the posterior surface 
along the line of attachment to the pleural membrane. This line 
overlies the posterior descending coronary artery. This dissection 
line was continued around the apex to the two ligaments (stern 
pericardiaca) on the lower anterior surface. This allowed the sac to 
be laid out as a flat membrane. Figure 4.2 shows a sac trans- 
illuminated on a light box and Figure 4.3 shows a diagram of a 
membrane. The circumferential dissection line made to remove the sac 
from the heart is shown as ACBEFA1, and AB, A1B1 shows the dissection 
down the posterior surface to the ligaments BB1. C shows the flap of 
tissue from around the inferior vena cava. Transillumination of the 
sac (Figure 4.2) showed two bands of thicker tissue extending over the 
anterior surface of the sac from the two ligaments. These were 
defined by lines BD and B1E. The curvature of the sac did not allow 
it to lie smoothly on a single plane without some wrinkling. This 
occurred in areas of most curvature. Lines BC, BD and B1E were used 
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as a frame of reference. The angle CBD was between 800 and 90" and 
the angle between BD and B1E was approximately 300. Ten sacs were 
studied and the tissue thickness measured at 26 points radiating fran 
ligaments B and Bl (see Figure 4.3). The dimensions BB1, BC, BD, BE, 
BF were also measured. The tissue thickness was measured with a 
Mitutoyo thickness gauge with 1 an diameter pads and five seconds was 
allowed for tissue relaxation before each measurement was taken. The 
mean value and standard deviation for the thickness is given in Table 
4.1. The tissue was significantly thicker at points 10 to 15, which 
lie on the bands originating from the ligaments, and also at points 3 
close to the inferior vena cava (point C). It was marginally thicker 
at points 2,3 and 23. In between the thick bands, points 24 and 25, 
the tissue was much thinner. Areas defined by points 4 to 9 and 16 
to 22 had more uniform thickness. 
The radii of curvature varied over the mould (see Figure 4.1). 
Circumferentially it was almost flat on the posterior surface, but had 
a much snaller radius of curvature over each ventricle (r v 40 cm) . 
The radius of curvature was smaller close to the apex. In the 
direction parallel to the long axis of the heart there was little 
curvature over the midline of the ventricles, but there was 
significant curvature at the apex A and also in the area overlying the 
atrium producing a spherical surface. 
Polarised light transmission microscopy was used to identify 
crimp or waviness in the collagen fibrils in the tissue, which can be 
used to define the orientation of the fibrils. An example of a 
micrograph of the epipericardial surface is shown in Figure 4.4 it 
was not clear whether the pattern relates to the top surface of the 
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tissue or was an averaging effect of the light passing. through the 
tissue. 
The pattern was difficult to identify in all areas of the sac, 
and in other areas the orientation of the fibrils was different from 
the two surfaces. Figure 4.5 shows the general direction of the 
fibrils on one sac studied. The fibrils ran along the long axis of 
the heart in thick bands BD, B'E, but elsewhere they tended to run 
circumferentially around the heart. 
Three areas shown in Figure 4.5 which were considered to have. 
uniform thickness were possible sites for leaflet manufacture. Area 1 
in the centre of the sac overlying the right ventricle was selected 
for further investigation using tensile testing and histological 
techniques. This area close to reference points 5 and 8 (Figure 4.3) 
also had uniform fibril orientation. 
These investigations have been carried out as a joint research 
project with the BioEngineering Unit at Strathclyde University. 
4.3 Mechanical properties of fresh pericardial tissue 
Initial studies of the properties of fresh pericardial tissue 
have been carried out in area 1 of the sac (Figure 4.5) using biaxial 
inflation and uniaxial tensile tests. Biaxial inflation tests (179) 
have shown that the tissue was more extensible in the circumferential 
direction than along the long axis of the sac (axial direction). 
This anisotropy could have been due to geometrical or material 
properties. In the circumferential direction the sac had more 
natural curvature, R 40 mn, but this would only account for the 
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difference in extensibility of 4%. Microscopic examination of the 
tissue stowed that in this area the fibrils predominantly ran 
circumferentially around the sac, so the additional extensibility 
could have been caused by the crimp or waviness seen in collagen 
fibrils, as suggested by other workers (172). 
Initial uniaxial tensile tests have been carried out with tissue 
taken from area 1 of three sacs. The sacs were prepared as described 
previously and the predominant direction of the fibril orientation in 
area 1 identified with polarised light (Figure 4.4). Three parallel 
strips of tissue 70 mm x3 mm were cut in the direction of the fibrils 
(circumferentially) and three parallel strips cut perpendicular to the 
fibrils (axially) in aT configuration. The strips were cut to allow 
a final gauge length of 15 mm to be used. This was selected so that 
the same size of strips could be cut from fabricated leaflets. In 
order to set the gauge length for the tissue, the tissue was floated 
onto a piece of glass under water and, when totally relaxed, a piece 
of paper was placed onto the tissue so that the tissue adhered to the 
paper. A 15 mm steel gauge was used to set the jaws of the Instron 
tester, and the paper and tissue set betweem the jaws at this length. 
The paper kept the tissue in an unstrained state and allowed the gauge 
length to be set. The specimen was bonded in position in the jaws 
of the test instrument using sandpaper and cyanoacrylate adhesive. 
The tissue was then mounted at its gauge length, the supporting paper 
removed by cutting and the initial gauge length recorded on the 
instrument. The tests were carried out in physiological saline with 
a cross head speed of 5 mm/min. 
As well as defining the original gauge length, the first load 
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. point was also 
determined at a force of 0.001 N (0.1 g) by increasing 
the sensitivity of the machine ten times. This was similar to the 
reference point defined by Trowbridge (174) where the specimen was 
extended to register a load of 1 grain, and then the tester reversed 
until no load was detected. In our case it was considered easier to 
define a very small first load 0.1 g. 
Specimens were cycled five times to a load of 0.8N to condition 
the tissue. This corresponds to a stress of 0.8 N mm-2 induced by a 
pressure of 150 nmHg in a leaflet with a curvature R of 13 mm. The 
load-unload extension curves for the first and fifth pulls were 
recorded along with the first load point at 0.001N. After the fifth 
extension the tissue was extended to its ultimate breaking point and 
the extension curve recorded. 
All the specimens showed typical non-linear force extension 
curves as described by other workers (172,174,175,177) with a soft 
incubation period and a greater modulus at higher extension ratios. 
The visco-elastic nature of the tissue was seen with the hysteresis in 
the load-unload curves as energy was dissipated and a reduction in the 
force at each extension point on the second to fifth pulls as the 
tissue was conditioned. The first load point (0.001 N) was within a 
few percent of the gauge length on the first extension for all the 
specimens. However, the first load point occurred at greater 
extension ratios on the conditioned specimens due to the creep caused 
by the visco-elastic nature of the tissue. 
The graphs of the load extension curves for the fifth cycle and 
the final extension to the breaking point for six specimens from each 
sac tested are shown in Figures 4.6 a, b, c. Details of the tissue 
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thickness and the extension ratio for the first load points on the 
conditioned curves are shown in Table 4.2. Both force extension 
curves are plotted for the original gauge length and the first load 
point on the condition curves are also shown. The graphs are plotted 
for strips 1,2,3, cut in the direction of the long axis of the heart 
and strips 4,5,6, cut in the circumferential direction. 
For each sac specimen 4,5,6 and 1,2,3 showed similar loading 
curves to 0.8 N, which confirms the uniformity of the tissue and the 
repeatability of the technique. For strips 1,2 and 3 the slope of 
the initial portion of the loading curve was less, the extension ratio 
of the first load point greater, and the transition to the higher 
modulus region more abrupt than for strips 4,5 and 6. The extension 
ratio at 0.8 N was similar for all the strips from any one sac but 
varied between 1.3 to 1.5 for different sacs. These loading 
extension curves did not correlate with the biaxial tests which showed 
greater extensibilities in the circumferential direction parallel to 
the fibrils than in the axial direction. 
The ultimate tensile strength was much greater for strips 4,5,6 
than strips 1,2,3 in each sac (17 to 20 N compared with 1.5 to 5 
N). In strips 4,5 and 6 the breaking point was more abrupt which 
would be consistent with the breaking of the fibrils, while strips 1, 
2 and 3 had a low ultimate tensile strength and more gradual 
transition which would be consistent with pulling the fibrils apart in 
the matrix. 
In tissue where the fibrils tend to run in one direction 
(circumferentially in this case) cutting the tissue in thin strips 
across the direction of the fibrils, as in strips 1,2 and 3, could 
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reduce the ultimate strength of the tissue compared to a larger piece 
of tissue where fibrils orientated at shall angles to the average 
direction can give a much greater contribution to the strength in the 
normal direction. Similarly, this could have increased the 
extensibility of strips 1,2 and 3 in uniaxial test which could 
explain the difference between the results of the uniaxial and biaxial 
test. It is also worth noting that if the extension curves were 
plotted from the first load point on the conditioned curves, the 
tissue would appear less extensible in the axial direction. 
These initial studies suggest that the average orientation of the 
fibres in the circumferential direction in area 1 can cause different 
mechanical properties between the circumferential and axial directions 
in the fresh tissue. 
4.4 Mechanical properties of glutaraldehyde treated tissue 
The mechanical properties of tissue taken from area 1 of three 
sacs and treated with 0.25% glutaraldehyde has been investigated with 
uniaxial tensile tests. The sacs were prepared as described 
previously and dissected down the line BD. The tissue surrounding 
the right ventricle including area 1 was fixed in 0.25% buffered 
glutaraldehyde for seven days. The tissue was freely floated in the 
fixation bath so it was fixed in its unstrained state. Uniaxial 
tests were carried out as with the fresh tissue. The average 
orientation of the fibrils was identified optically and strips 4,5 
and 6 cut circumferentially in the direction of the fibrils and strips 
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1,2 and 3 cut axially normal to the fibrils. The tissue was mounted 
in the Instron tester and cycled five times to 1. ON before being 
extended to its breaking point. 
The force extension curves for the conditioned tissue on the 
fifth cycle are shown in Figures 4.7 a, b, c for the three sacs and 
the sixth cycle to determine the UTS is also plotted. The, tissue 
thickness and first load point for the fifth cycle is shown in Table 
4.3. As with the fresh tissue the specimen showed typical non-linear 
visco-elastic properties of soft tissues. The graphs were similar 
for specimens 1,2,3 and 4,5,6 in each sac showing the uniformity 
of the tissue on a localised area and the repeatability of the 
technique. There was sane variation between sacs with an extension 
ratio at 1.0N varying between 1.20 and 1.35. All the loading curves 
showed a greater modulus in the initial incubation period than the 
fresh tissue and this had the effect of reducing the extension ratio 
of the first load point of the conditioned cycles to between 1.02 and 
1.07. This also gave a more gradual transition to the fixed, tissue 
curve which was probably caused by the crosslinks formed between or 
within fibrils during fixation. It was difficult to detect any 
difference in the loading curves to 1.0N between the circumferential 
and axial directions. The extension ratios for the fixed strips at 
0.8 N were slightly less than for the fresh strips when taken fran the 
gauge length, but were slightly greater when taken from the first load 
point. This confirms that the definition of the original gauge 
length can be a critical factor in interpreting the results (173). 
As with the fresh tissue the UTS was much greater in the 
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circumferential direction (strips 4,5,6) than the axial direction 
(15 to 20 N compared with 1 to 5 N) and was primarily caused by the 
orientation of the fibrils. However, the loading curves to 1N 
stowed little difference between the circumferential and axial 
direction for the fixed tissue. This agreed with the findings of 
Trowbridge et al (173). 
The structure and mechanical properties of both fixed and fresh 
tissue are complex. The conditioned force extension curves to 1 N, 
the first load point on the conditioned cycle which is the point to 
which the tissue returns to during cycling, and the variation found 
between specimens and between the different orientations, are 
particularly important in valve leaflet design. 
4.5 Fixation of tissue with glutaraldehyde 
Glutaraldehyde has been used for over 15 years to stabilise and 
crosslink tissue in bioprosthetic heart valves (180). The crosslinks 
reduce the biodegradability and antigenicity of the tissue (181), 
modify the mechanical properties (171) and may reduce its 
thrombogenicity (182,183). The complex reactions which occur between 
the glutaraldehyde and the primary amine groups (lysine, 
hydroxylisine and N terminal amino acid groups) which are all present 
in the protein molecule, are not fully understood (184). The 
complexity is due to the mixture of free aldehyde, mono and dihydrated 
monomeric glutaraldehyde, monomeric and polymeric cyclic hemiacetals 
and alpha and beta unsaturated polymers found in aqueous solution of 
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glutaraldehyde (185-187). The nature of the crosslinks has caused 
considerable controversy in the literature (188,189) but more recently 
a fuller description of the possible reactions has been given 
(190-193) with up to 12 different compounds being proposed. Under 
certain conditions fixation of the tissue may not be uniform or 
complete (191-193). Polymerisation of the glutaraldehyde during 
formation of the crosslinks may prevent penetration of the free 
monomer into the whole matrix of the tissue. Alternatively, 
polymerisation may occur on the outer surface of the fibrils 
themselves which would prevent penetration into the structure of the 
pentafibrils. These effects depend on fixation conditions, 
glutaraldehyde purity, concentration, pH, temperature and time. If 
the tissue is not crosslinked completely, repeated cycling of the 
tissue in vivo, which gives rise to structural changes, may well 
expose areas of tissue which are not fully crosslinked. These would 
be sites for biological degradation, immunological reactions and 
possible calcification. 
It is difficult to determine the sites in the microscopic 
structure onto which the crosslinks form or indeed the nature of the 
crosslinks. I have carried out two studies (described in the next two 
sections) in an attempt to ensure that the tissue is adequately and 
consistently fixed. 
Firstly, ultraviolet spectroscopy has been used to monitor the 
purity and concentrations of commercially available aqueous 
glutaraldehyde solutions. Secondly, the shrinkage temperature 
(collagen denaturation temperature) of the fixed tissue has been 
measured to assess the amount of crosslinking. A stratographic 
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analysis of the shrinkage temperature of 25 In layers of tissue cut 
sequentially parallel to the surface of the tissue has been made to 
investigate any variation due to penetration of the glutaraldehyde. 
4.6 Chemistry of aqueous glutaraldehyde solutions 
Commercial glutaraldehyde is normally supplied in 25 percent 
aqueous solution at acidic pH. Upon dilution the camposition of the 
monomer is 4% free aldehyde, 16% monohydrate, 9% dihydrate, 74% cyclic 
hemi-acetal (194). In concentrated solutions the heni-acetal forms 
dieters and trimers which readily revert back to the monaner upon 
dilution. Alpha and beta unsaturated polymers are also present in 
small amounts. The rate of formation of the alpha-beta unsaturates 
increases with pH, temperature and concentration (186). The monaner 
can be separated by distillation and/or multiple extraction with 
charcoal. The alpha-beta unsaturates absorb light strongly at 235 nM 
whereas the monomer absorbs light weakly at 280 nM, the extinction 
ratio of absorbance being 160: 1. Hydrated aldehydes absorb W very 
weakly. The ratio of the free monaner to the alpha-beta unsaturates 
can be monitored using W spectroscopy. For purified glutaraldehyde 
a ratio of 2: 1 in the absorbance peaks at 235 and 280 nM can be 
obtained. Several grades of commercial glutaraldehyde are available 
and the purity and effect of storage conditions for the 25% solutions 
has been reported by Gillet and Gull (187). 
The purity of three different commercial solutions has been 
studied and the effects of distillation and filtration have been 
investigated. The rate of formation of the alpha-beta unsaturates has 
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been monitored after the solutions have been diluted and buffered to 
pH 7.4. In addition, the effect of adding pericardial tissue to 
to glutaraldehyde has been monitored. 
Three commercial solutions of glutaraldehyde were studied; 
technical glutaraldehyde (supplied by the University Chemistry 
Department), Agar Aids glutaraldehyde (vacuum distilled) and Sigma 
Chemical Co glutaraldehyde. All three were supplied as 25% 
solutions. In addition, technical glutaraldehyde was distilled and 
also filtered with activated charcoal. The commercial solutions were 
diluted to 0.25% with sodium phosphate buffer pH 7.4 assuming a stock 
concentration of 25%. The technical glutaraldehyde was purified by 
distillation and also by charcoal filtration and diluted so that the 
absorbance at 280 nM peaks was 0.24. The W spectrum of all five 
solutions at 0.25% concentration was measured on a Beckman DU-7 
spectrophotaneter. The sodium phosphate buffer was used as a 
reference solution. 
The two solutions, Sigma and distilled technical, were diluted to 
a concentration of 0.5,0.25,0.125,0.06 percent, with the buffer. 
They were stored at roan temperature and the W spectrum measured at 
1,3,7,10,17 and 32 days to assess the rate of formation of the 
alpha-beta unsaturates. Two solutions of Sigma and distilled 
technical were diluted to 0.25% and a piece of pericardial tissue 
(approximately 4 an2) was added to 200 ml of each solution. The W 
spectrum was measured after 2,4,7,24 and 60 hours for solutions 
with and without tissue. 
Examples of the W spectrum for 0.25% solutions of Sigma and Agar 
Aids are shown in Figure 4.8. The peaks at 280 and 235 nM were 
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well-defined and a small peak at 200 nM was also detected. 
Table 4.4 shows the absorbance measured for five solutions at 235 and 
280 nM. The Sigma, Agar Aids and the filtered and distilled 
technical were very pure whilst the technical was less pure. The 
absorbance at 280 nM for the diluted Sigma and distilled technical 
solutions is shown in Table 4.5 for concentrations of 0.5% to 0.06%. 
As expected, reduction in absorbance is directly proportional to 
concentration. In this range of concentration the absorbance can be 
used to monitor concentration of the monomer. 
The rate of formation of the alpha-beta unsaturates is shown in 
Figure 4.9 for the Sigma and distilled solutions as a graph of 
absorbance at 235 nM against time. The rate of formation of 
alpha-beta unsaturates was greater for higher concentrations and 
slightly higher for Sigma than distilled technical. Figure 4.10 
shows the effect of adding tissue to the 0.25 percent solutions. The 
rate of formation of alpha-beta unsaturates was greatly increased when 
tissue was added to the solutions (approximately ten times greater). 
This was not surprising as the formation of crosslinks in the tissue 
acted as a catalyst for polymerisation (190-192). Although the free 
monomer was used to form the alpha-beta unsaturates there was little 
reduction in the amount of free monomer in solution as monohydrate and 
dihydrate revert back to free monomer to maintain the balance. 
There are various conditions which can affect the purity of 
aqueous glutaraldehyde solutions. Gillet and Gull (187) have shown 
storage of 25% solutions at acid pH of 4°C has little effect on the 
solutions. Our results showed that there were considerable 
differences in the commercial solutions and, more importantly, the 
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solutions changed rapidly when buffered and diluted to pH 7.4. Even 
more rapid polymerisation of the alpha-beta unsaturates was found when 
tissue was added to the glutaraldehyde. 
The effects of increased amounts of alpha-beta unsaturates on the 
crosslinks formed in the tissue are not known. However, to 
standardise fixation conditions, a pure commercial solution has to be 
used, the solutions have to be freshly diluted and buffered, and 
solutions should only be used once for fixing tissue. 
4.7 Thenaal denaturation temperature of fixed pericardium 
Measurement of the thermal denaturation temperature of fixed 
pericardium has been used as a simple physical test to assess the 
degree of crosslinking in fixed tissue. The rate of fixation and the 
structure of the crosslinks is dependent upon the pH, temperature and 
glutaraldehyde concentration (186-188). The variation in the thermal 
denaturation temperature (shrinkage temperature), with time and 
glutaraldehyde concentration, has been determined by heating tissue 
slowly in a water bath and determining the temperature at which the 
tissue contracts (185,196). A higher shrinkage temperature indicated 
a greater number of crosslinks. This did not indicate, however, 
whether the crosslinking was uniform throughout the tissue. In the 
leather industry shrinkage temperature measurements have been made on 
fresh skin using differential scanning calorimetry (DSC) (197). In 
DSC the heating rate of the specimen was controlled and the energy 
input to specimen monitored. A sharp increase in energy input was 
recorded at the transition temperature of the collagen, corresponding 
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to the collapse of the triple helical structure. This work used only 
very shall samples of tissue. In this study this technique has. been 
adapted to perform a stratographic analysis of . 
the degree of 
glutaraldehyde tanning on the tissue by measuring individual shrinkagfi 
temperatures on a number of layers cut parallel to the surface of the 
pericardium. DSC has also been used to assess the effect'of fixation 
time and glutaraldehyde concentration on shrinkage temperature. 
Bovine pericardial sacs were collected and prepared as in Section 
4.3. Fixation of the tissue was carried out with Agar Aids 
glutaraldehyde which was diluted and buffered (sodium phosphate) to pH 
7.4. Tissue was placed in fixation baths of 0.25% and 0.5% 
glutaraldehyde and removed after 15 and 30 minutes; one and four 
hours; one, two, five, eight and 28 days. Samples were washed 
thoroughly in saline after fixation for 20 minutes and the shrinkage 
temperature measured on a Dupont (model 990/910) DSC. A heating rate 
of 10C per minute was used and the energy scale was set to 400 uW per 
an. 
The penetration of the glutaraldehyde into the pericardium was 
assessed for fixation times of 28 days in 0.25% glutaraldehyde. 
Tissue was removed from the fixation baths, washed thoroughly, and cut 
into layers 25 }IM thick using a cryogenic knife starting from the 
mesothelial surface. Frozen sections were referenced and stored in 
saline and shrinkage temperature was measured every fourth slice (100 
FM). 
The variation in shrinkage temperature with time and 
concentration is shown in Figure 4.11. There was no detectable 
difference in the rate of increase of shrinkage temperature at 0.5% or 
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0.25% concentration; in both cases the temperature appeared to reach a 
maximum after two hours fixation time. The tissue in the lower 
concentration showed a slightly higher value between two days and 28 
days. This has also been shown by other workers (193,185). 
The results of the shrinkage temperature measurements on the thin 
sections of tissue are shown in Figure 4.12. There was no 
significant difference between the layers in any pieces of tissue 
which suggests uniform penetration and fixation throughout the tissue. 
Shrinkage temperature measurements are a simple physical method 
of monitoring the degree of crosslinking and the shrinkage temperature 
of small tissue samples can be determined accurately using DSC. It 
is not known however how sensitive the shrinkage temperature 
measurements are to variations in the different types of crosslinks 
proposed by Cheung (190-192). The results showed that the shrinkage 
temperature was stable beyond two days whilst it is known that the 
solution continued to polymerise after two days. Although the 
shrinkage temperature measurements indicated uniform penetration of 
the fixative, we cannot say whether crosslinking took place at the 
surface of the fibrils or whether it penetrated further into the 
molecular structure. Formation of glutaraldehyde polymers on the 
surface of fibrils may have restricted further penetration. 
4.8 Discussion 
Both the structure and material properties of bovine pericardium 
and the chemistry of glutaraldehyde fixation are complex and not fully 
understood. In this chapter I have described initial tests to 
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investigate the mechanical properties and structure of the tissue in 
one area of the sac and have described two simple studies in an 
attempt to produce standard uniform conditions for fixation of the 
tissue. 
The ultraviolet spectroscopy showed that there were some 
differences in the purity of commercial glutaraldehyde solutions but, 
more importantly, the solutions polymerised rapidly when diluted and 
buffered to PH 7.4, and when tissue was added to the solution. The 
polymerisation of the glutaraldehyde will affect the types of 
crosslink forms and may also affect the penetration into the molecular 
structure of the tissue (192). 
Thermal denaturation temperature measurements of fixed tissue 
indicated that the degree of crosslinking was constant after two days 
fixation time and uniform through different layers. We have shown 
that polymerisation of the glutaraldehyde solution increased with time 
and this may alter the chemical nature of the crosslinks for longer 
fixation times. 
The standard method used for fixation in the rest of this study 
was to dilute Agar Aids (25% vacuum distilled glutaraldehyde) and 
buffer to 0.25% PH 7.4. The solution was used 24 hours after 
dilution and tissue was fixed in the same glutaraldehyde solution for 
a minimum of seven days and maximum of 30 days. 
General investigation of the pericadial sacs showed that they 
were not homogeneous membranes and showed systematic variation in both 
tissue thickness and fibril orientation. Three areas with uniform 
properties were identified as possible areas for leaflet manufacture 
and initial mechanical tests have been completed in one of these 
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areas. Uniaxial tensile tests showed characteristic properties of 
non-linear visco-elastic force extension curves typical of most soft 
tissues. There did not appear to be any major differences between 
the properties of the tissue taken from cattle aged between 18 and 30 
months and the properties of pericardium taken from calves aged 16 
weeks in other studies (173). Our results showed some variation in 
the force extension curves between sacs and also between the two 
orientations of the same sac in the fresh tissue. Biaxial inflation 
tests showed that the fresh tissue was more extensible in the 
circumferential direction along the predominant direction of the 
fibrils than in the axial direction, but this was not confirmed in the 
uniaxial tests. There was, however, a large difference in the UTS of 
both the fixed and fresh tissue between the two orientations. 
Fixation increased the modulus of the initial soft incubation period 
causing a more gradual transition to the high modulus region of the 
force extension curve. This made the shape of the curve similar in 
both orientations. This increase in modulus will affect the 
flexibility of the fixed tissue at small extension ratios which could 
in turn affect the opening and closing action of the valve leaflets. 
The visco-elastic nature of the tissue was also important as the creep 
found in the first load points of the cycled fixed tissue of 1.02 and 
1.07 determined the unloaded length to which the tissue returns during 
cycling. This extension may not be permanent (172) but will remain 
as long as the tissue is being cycled and this therefore has to be 
considered in the leaflet design. 
The tissue in area 1 had an anisotropic structure which produced 
variation in some mechanical properties with orientation. The 
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uniaxial strips were cut parallel and normal to the optical pattern 
produced by the fibrils in an attempt to maximise these differences. 
It is not clear how to orientate the leaflets in the light of these 
initial results. Natural valve leaflets have strong fibres running 
circumferentially which would be consistent with making the 
circumferential direction of the leaflet the circumferential direction 
of the sac. However, the structure of the two materials are 
canpletely different and other factors have to be considered when 
selecting the orientation of the leaflet. These include the 
deformation of the fresh tissue, differential extension of the loaded 
leaflets, the flexibility of the tissue, and variations in tissue 
thickness. 
The initial tests on the properties of the pericardium will be 
extended to other areas of the sac in further studies being carried 
out in the BioEngineering Unit at Strathclyde University. 
The studies I have canpleted on the properties of the pericardial 
tissue and the fixation conditions allowed me to select one area of 
the sac for the manufacture of valve leaflets and establish a standard 





A major concern with the clinical performance of existing 
pericardial valves has been early tissue failure seen as tears in the 
leaflets adjacent to the cloth-covered stent. The laboratory tests 
described in Chapter 3 showed that these tears were primarily caused 
by abrasion and wear to the leaflets as they were pulled over the edge 
of the frame under tension in the closed position. Coaption stitches 
placed through the leaflet at the top of the posts may also have 
contributed to the tears in implanted valves. Two other valves under 
development (45,55) have used a different method of mounting the 
tissue in an attempt to improve valve durability. In one of these 
valves, however, the method of suturing the tissue to the frame has 
been modified following tears from sutures (55). The long-term 
durability of these valves is not known. Other areas of valve design 
investigated in Chapter 3 which affected valve function, and perhaps 
durability, were the method of fixation of leaflets, leaflet geanetry 
and method of attaching the leaflet to the frames. In addition, all 
valves required considerable skill and precision to suture the 
leaflets to the frames, which can cause high rejection rates during 
manufacture. 
The following design ideas were produced to give an improved 
pericardial heart valve. 
Leaflets were mounted mechanically between two frames which were 
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clamped together. The leaflets and frames were precisely located to 
one another by radial pins and studs. This allowed a consistent 
method of manufacture and allowed leaflets to be interchanged and 
matched easily. It also allowed different covering materials to be 
used on the valve frames in order to reduce abrasion to the leaflets. 
one potential drawback of this more complex frame structure was the 
possibility of the frame becoming bulky, so restricting the orifice 
area of the valve. 
This chapter describes five different design options for the 
frames and possible alternative covering materials. Different 
leaflet designs, geometries and methods of leaflet fixation are 
also described which were tested during the valve development. 
5.2 Frame design 
Five different options for the twin frame designs were produced. 
In the first two options leaflets were mounted over and outside a 
strong inner support frame. In the third option the tissue was 
mounted under the support frame and projected radially inwards. The 
fourth and fifth options were hybrids of these two configurations. 
Each option is illustrated with vertical sections through the frame at 
the base of a scallop and at a post. A radial view of the outside of 
the posts showing the frames without the leaflets and a horizontal 
section through a post. The diagrans are simplified by not showing 
the covering material for the frames. 
i The leaflets were mounted over the outside of a strong inner 
acetal support frame with pins and studs projecting radially to 
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locate the leaflets (Figure 5.1). A cloth-covered wire frame 
was placed over the inner frame to restrain the leaflets and an 
additional plastic ring clamped the leaflets in place in the base 
of the valve. The position of the wire frame could be adjusted 
to deflect the leaflets radially inwards. 
ii A similar inner support frame was used as above, but the outer 
sleeve was manufactured from a thin acetal cylinder profiled to 
the sane shape as the inner frame (Figure 5.2). The outer 
sleeve was slotted at the base of each post to allow assembly 
over the inner frame and radial pins and studs. The outer frame 
projected about 1.5 mm above the top of the inner frame which 
allowed a thin rib to be incorporated along the top edge to 
deflect the leaflets radially inwards, if required. A locking 
ring was used in the base to secure the two frames together. 
iii The leaflets were mounted underneath an inner support frame and 
located on the outside surface with securing pins. The inner 
frame had an inverted U shape at each post through which the 
leaflets passed, which allowed them to close campletely together 
with no post in between (Figure 5.3). The inner frame was a 
complex shape profiled on both its upper and lower surfaces and 
an outer sleeve was similarly profiled to retain the leaflets in 
position. The leaflets projected radially inwards from the frame 
to take up a natural closed position. 
iv The inner support frame had three slots located along the edge of 
each scallop through which the leaflets projected (Figure 5.4). 
At each post only a thin vertical rib separated the slots 
allowing adjacent leaflets to come together. A thin outer ring 
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was used to retain the leaflets in position in the base. The 
slot orientated the leaflets radially inwards so the natural 
unloaded position of the leaflets was closed. 
v Both inner and outer frames were used to support the leaflets 
(Figure 5.5). The inner frame with truncated posts supported 
the leaflets in the base of the scallop whilst the outer frame 
supported the leaflets at the top of the posts. The leaflets 
passed through vertical slots in the outer frame which gave them 
a radial orientation and allowed them to seal together 
completely. 
options 1 and 2 had similar disadvantages to the conventional 
valve designs such as wear of the leaflets where they were pulled 
over the edge of the inner support frame. Both required a smooth 
covering material on the inner frame to reduce abrasion of the 
leaflet. In addition the posts projected between adjacent leaflets 
so an additional restraint or stitch was needed to seal the leaflets 
together at the top of the posts. However, fastening the leaflet in 
the base of the frame ensured that the stress concentration around the 
fastenings were away from areas of dynamic stress in the flexing 
portion of the leaflet, and away from the area of abrasion at the edge 
of the frame. In option 2, the more rigid outer sleeve gave a secure 
clamping action to locate the leaflets. 
Options 3 and 4 allowed the leaflets to be mounted radially 
inwards, take a natural closed position and seal together at the 
posts. In option 3, however, the points of attachment to the frame 
were close to the flexing portion of the leaflets. The frame in 
option 4 was more difficult to manufacture and very difficult to 
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cover. Option 5 combined the advantage of the radial mounting at the 
posts with the fastenings in the base on the outside of the inner 
frame. Differential deflection between the two frames could cause 
distortion to the leaflets. 
Frame configuration 2 was selected for the initial development 
work and particular attention was paid to the covering material used 
on the inner frame to reduce abrasion and the method used to seal the 
leaflets around the top of the posts. This configuration allowed the 
thin outer sleeve to project above the leaflets in the base of the 
scallops and at the posts which had the following advantages for 
valves in the mitral position. The leaflets were protected from the 
surgeons needle during implantation; rounded posts were less likely 
to cause damage to the myocardium, and the sewing ring was positioned 
away fran the inflow edge of the valve so reducing the length 
projecting into the ventricle. In addition a protective thread could 
be placed around the top of the posts to prevent surgical sutures 
snaring around the posts during insertion. 
5.3 O vering materials for the frans 
The twin frame design allowed different materials to be used to 
cover the inner and outer support frames. The outer frame was 
covered with polyester cloth as in porcine and existing pericardial 
valves and the sewing ring was fabricated from the sane cloth. The 
cloth was intended to act as a lattice or support framework for host 
tissue ingrowth and endothelialisation over the sewing ring and 
outside of the outer frame. This would allow the valve to be 
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incorporated readily into the natural orifice. 
The requirements for the covering material for the internal frame 
were different. primarily, it had to be smooth to eliminate abrasion 
to the leaflets at the edge of the frame. It also had to have good 
blood canpatability and preferably had to be fabricated over the frame 
without any seams on the internal surface, as this surface contacts 
the blood on the inflow aspect of the valve. The material had to be 
thin in order that the radial wall thickness of the assembled valve 
was kept to a minimum. It would also be an advantage if the material 
did not encourage host tissue ingrowth to avoid the valve orifice 
becoming restricted (Figure 1.6). 
Several materials were considered suitable for covering the inner 
frame. These included bovine pericardium treated with glutaraldehyde, 
porcine pericardium treated with glutaraldehyde, expanded PTFE, and 
polyester cloth coated with polyurethane. These different materials 
were considered during the valve development. 
5.4 Leaflet design and configurations 
The studies of pericardial valves in Chapter 3 showed how the 
different leaflet designs affected valve function. It proved 
difficult to describe the leaflet geometries theoretically in either 
the open position, closed position under load, or natural unloaded 
position, due to the complexity of the gantries and non-linear 
extension of the fixed tissue. Indeed, no theoretical basis has been 
given for the leaflet design in any of the valves studied. Other 
workers have defined leaflet geometries in the closed position 
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(56,140). In only one case was the open position or method of 
opening described (55). Optimal leaflet geometries are more readily 
derived empirically in a function tester rather than by attempting to 
predict the complex extension and shape of the leaflets 
theoretically. In this section four basic leaflet designs and 
geometries that were studied in the function tester during valve 
development are described. 
Two basic methods were considered for the fabrication of the 
leaflets. Firstly, the tissue was fixed with glutaraldehyde in its 
natural shape and, secondly, the leaflets were moulded during fixation 
into a complex shape with curvature in two planes into a geometry that 
closely related to the closed position of the leaflets. Fixation in 
a semi-open position was not considered feasible for pericardial 
leaflets (200) as any geanetry which was not fully open or closed 
required complex reversals in the radii of curvature of the unloaded 
leaflets. It has been shown with porcine valve leaflets (126) and 
pericardium (172) that tissue extensibility was greatly reduced when 
stress or strain was placed on the tissue during fixation. 
Considerable emphasis has been placed on controlling the strain placed 
on the tissue during fixation. The frame configuration selected for 
development with the leaflets mounted over the outside of the inner 
support frame caused the leaflets to project upwards in a vertical 
cylinder when unloaded (open position). This was changed to the 
closed position by using the outer frame to deflect the tissue 
radially inwards at the top of the posts, by using coaption stitches 
at the top of the posts or by the shape formed in the leaflet during 
fixation. 
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The simplest geometry (A) for the tissue which was fixed in a 
flat sheet was a cylindrical or conical shell which was produced by 
bending the tissue in one plane. Leaflets formed into a cylindrical 
shell equal to the external radius ro of the stent allowed a full 
orifice for the open leaflet. Figure 5.6a shows a vertical section 
through the centre line of a leaflet with cylindrical geometries. 
C01B shows the open position for the leaf. The leaflet flexed into 
the unloaded closed position COB by reversing the curvature of the 
cylinder. The shape of the scallop in the stent CB defined the angle 
through which the leaflet flexed. In the example shown h the height 
of the post B equals ro and o(: TAW1 O "5 = 26.5', so the leaflet 
flexed through an angle äo4 = 53'. The scallop in the frame ACB was 
in a plane inclined at an angle cc to the vertical defined by the 
intersection of two cylindrical surfaces. If the angle of was 
increased, the height of the frame h was increased. The vertical 
sections through the closed leaflets taken at 2.5 mm intervals from 
the centre line of the leaf are shown in Figure 5.6b. As the 
leaflets met in the plane OB there was a sharp change in the leaflet 
direction as the leaflets coapt. The area of coaption is shown in a 
projection of the leaflet in Figure 5.6d. The free edge of the leaf 
was defined 1 nm above the post B and the centre point 0. Figures 
5.6c shows the radial view on the post which had a triangular shape 
defined by the intersecting planes of the scallops. 
most of the coaption in this leaflet was above the line AEB 
joining the top of the posts (Figure 5.6d). The loaded closed 
position for the leaflet cannot be predicted but an extension of 20 
percent under a load would cause a significant increase in the angle 
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2 C(. The leaflet was not constrained in the vertical plane along its 
free edge whereas its position was precisely constrained by the edge 
of the scallop. These different boundary conditions will produce 
anisotropic strains and significant changes in leaflet geometries in 
the loaded position. The outer frame was used to deflect the 
leaflets radially inwards at the top of the posts so that it took up 
the closed position CEOB when unloaded. This geometry was used with 
different heights to the posts and angleso(, with small changes in the 
radius of curvature of the cylindrical shell and with a variable width 
in the leaflet at the top which produced a slightly conical shell. 
An alternative geometry for the leaflet in the closed position 
was produced by changing the shape of the scallop in the frame. An 
example of this geometry is shown in Figure 5.7. The open position 
of the leaflet C01B remained unchanged as a cylindrical shell, but 
the scallop in the frame was defined by a plane at an angle c( +ß to 
the vertical with a short parallel vertical portion 318 at the top of 
the post. The leaflet can be deflected by the outer frame at the top 
of the posts to take up an unloaded closed position defined by 
CEOBBI (OEC being the vertical section through the centre line of 
the leaflet) in Figure 5.7a. In the base of the leaflet the tissue 
was cylindrically shaped, inclined at an angle 2 (a( + ß) to the 
vertical. This shape changed towards the free edge of the leaflet 
where the vertical section CEO became curved. The position of point 
0 remained unchanged from the previous geometry, but cutting away the 
scallop deeper in the frame at Bl (Figure 5.7c) allowed the leaflets 
to cone together in a deeper coaption (Figure 5.7b). Effectively, a 
wider portion of the leaflet was able to flex inwards. The increased 
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area of coaption on the leaflets (shown in Figure 5.7d) was below the 
line joining the top of the posts AEB. In the example shown, angle ß 
was 3.5' and 2 (o( + ß) was 60' . The change in the unloaded closed 
position caused by the change in the scallop shape introduced greater 
anisotropic strains in the loaded closed position as the leaflet 
geometry deviated further from the cylindrical geometry. The angles 
o(and ß and radius ro and width of the leaflet were varied as in the 
previous example. 
Figure 5.7b showed that radially the leaflet closed shape was 
curved producing a spherical shape. This curvature could be more 
easily produced and controlled by forming the spherical shape in the 
leaflet during the fixation. This was achieved simply by laying the 
tissue on a mould shaped to form the outside surface of the stent, the 
shape of the scallop and the geometry of the closed unloaded leaflet. 
In this method anisotropic strains were fixed in the tissue when 
forming the shape of the leaflet as opposed to them being induced by 
the loading of the leaflet in the closed position. Inducing this 
strain during fixation could affect the mechanical properties of the 
tissue and this had to be considered when forming the leaflets. 
Two simple geometries were considered for the closed position, a 
spherical surface and a combination of cylindrical and spherical 
surfaces. Figure 5.8 shows an example of the spherical geometry. 
In Figure 5.8a the vertical section through the centre line of the 
leaflet OC shows radial curvature Rr moulded in the leaflet which was 
equal to 0.96ro. The open position 01C was also spherical in 
shape having the reverse curvature of the closed surface. View b 
shows the vertical sections through the closed leaflet at 2.5 mm 
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intervals from the centre line and the line CB which was the line of 
intersection of the spherical shell with the cylindrical frame. This 
produced a narrower post as seen in view C. The radial curvature in 
the leaf allowed the leaflets to come together tangentially as two 
parallel surfaces in the area of coaption. This is illustrated in 
the horizontal section through the leaflet in view d. The radii of 
Curvature for the spherical shell Rc was varied as was the position of 
the centre of the shell (D). The height of the leaf h (equal to ro in 
the example) was also varied. This geometry produced a small 
triangular hole in the centre of the valve between the three spherical 
leaflets. This was designed to close up as a small load was applied 
to the leaflets. The moulded shape also formed the cylindrical 
surface to the leaflet which was mounted around the outside of the 
frame. At the edge of the frame a small radii Re was generated to 
give a smooth transition from the vertical cylinder to the spherical 
flexing portion of the leaflet (view a). 
Figure 5.9 shows an example of the second moulded geometry. The 
closed shape of the leaflet shown as a vertical section CD (in view a) 
was a cylindrical surface in the base of the leaflet inclined at an 
angle ö to the horizontal, followed by a spherical surface in the 
centre of the leaflet with a small cylindrical surface at the top of 
the leaflet. As in the previous example Rr = 1äc = 0.96ro and h= 
1.12ro. The vertical sections through the leaflet are shown in view 
b, the horizontal sections view d and the post in view c. This 
configuration differs from the previous geometry in the base of the 
leaflet where the leaflet had to flex through a smaller angle between 
the open and closed positions. As before, the open geometry was the 
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reverse curvature of the closed geometry. In the example shown 
'equalled 30°. As before, a radius Re was formed where the flexing 
portion of the leaflet intersects the cylindrical frame. 
One possible disadvantage of the last two geometries was that 
fixation of the tissue in the spherical shape could alter its 
mechanical properties. A flat sheet of tissue formed into a 
cylindrical surface has little bending strain. For a radius ro and 
thickness t, bending strain Fb = t/2ro. For the examples shown where 
ro = 12.5 mm and t=0.5 mm 
Fb =f 2%. However, to form the tissue 
into a spherical surface greater strains were induced which were more 
difficult to predict. A cylindrical piece of tissue (Figure 5.10) 
required an additional 9% extension in the length OC to form a 
spherical surface, if points 0 and C remained fixed. However, if 
tissue at 0 was displaced to 0", approximately 1 mm, then the 
extension required radially was only a few percent. Similarly, the 
additional extension required circumferentially was also only a few 
percent. It did, however, introduce complex shear strains in the 
tissue. Ideally, the tissue should be positioned in the mould to 
minimise the strain placed on the tissue during fixation, so reducing 
the changes induced in the mechanical properties. At the edge of the 
mould a much smaller radius was fixed in the leaflet Re (approximately 
2 mm). This small portion of the leaflet was not expected to flex as 
the leaflet opened or closed, so the curvature fixed into the leaflet 




The unique design philosophy which uses twin cylindrical frames 
to support the leaflets, and radial pins to locate them, has been 
described in several forms. In each case the leaflets were 
mechanically mounted on pins and studs and could be interchanged 
easily to allow matching for synchronous movement. The frame design 
option selected for the valve development (option 2) allowed easier 
construction of the valve and more readily lent itself to the use of 
radial locating pins. The problem found in other coamercial 
pericardial valves of abrasion of the leaflets against a cloth-covered 
inner frame, was reduced by selection of a smooth material to cover 
the inner frame. The abrasion and wear to the leaflets caused by 
different covering materials was assessed during the valve 
development. In addition, the problem of sealing the leaflets 
together around the top of the posts was also considered during the 
valve development described in the next chapter. The advantages of 
using an outer frame had to be offset against the overall increase in 
the radial width of the valve wall which reduced its potential orifice 
area. It was most important in the frame design that the leaflets 
opened up fully to utilize the internal diameter of the frame. 
Although a valve construction using concentric frames has 
recently been described (202,203) for use in the operating theatre, it 
did not indicate the method of positioning or restraining the 
leaflets, or whether the leaflets could be readily interchanged. 
The frame design described only the method of mounting and 
restraining the leaflets. Several different leaflet designs and 
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geometries have also been described. Previous work has only described 
a cylindrical or conical shaped leaflet for a bileaflet valve (55) and 
a spherical geometry for synthetic leaflet valves (140). I have 
attempted to describe a wider range of different leaflet geometries 
and methods of fixation combining both spherical and cylindrical 
geometries with fixation of the tissue both as a flat sheet and in 
curved shape. Function tests on other pericardial valves (Chapter 3) 
showed that the method of fixation and leaflet geometry significantly 
affected valve function, while methods of fixation also affect the 
material properties (Chapter 4). The leaflet designs proposed in this 
chapter were assessed by manufacturing a range of prototype valves 
with different leaflet geometries, and analysing the leaflet dynamics 
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6.1 Introduction 
An improved valve frame design and four different leaflet designs 
were described in Chapter 5. The frame design offered several 
advantages, such as precise location of the leaflets and 
interchangeability of the leaflets during manufacture, but potential 
problem areas, such as abrasion of the leaflets on the inner frame and 
the method of sealing the leaflets at the top of the posts, had to be 
investigated during the valve development. The frame design enabled 
easy assembly of the leaflets which allowed a wide range of prototype 
valves with the different leaflet geometries described in Chapter 5 to 
be manufactured and tested. 
This chapter describes the development of the frames and 
fastenings, and the development of an optimal leaflet geometry. Four 
different leaflet geometries were tested in the pulsatile flow test 
apparatus. Different configurations were tested for each geometry 
corresponding to changes in the detailed sizes, and several prototype 
valves were tested for each configuration in order to reproduce any 
variations in function detected. This also helped to reduce the 
effect of any variations in the tissue properties. 
The development work was carried out on size 27 mm mitral valves 
and the final design was scaled up and down for the other sizes of 
valves. 
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6.2 Frame development 
A photograph of the two frames for a size 27 nm prototype valve 
is shown in Figure 6.1. The frames were machined out of solid acetal 
rod. The small pins and studs, which were injection-moulded, were 
pressed into the radial holes. The detailed shape and position of 
the pin and stud fastenings are described in Figure 6.2. Seven pins 
(3 to 9) were used to locate the leaflets in the base of each scallop 
and two studs were used to locate the tissue at each post. Each 
leaflet was manufactured with predetermined holes made with 0.5 mm 
tapercut needles which were located over the pins and studs. The 
outer sleeves were slotted at each post to allow the base of the 
sleeve to splay out and clip over the radial pins thus retaining the 
leaflet in position. These slots were wider at the top of the posts 
to allow the two studs to project through. shall washers were 
pressed over the ends of the studs to retain the leaflets in position 
(Figure 6.2). A thin locking ring was positioned over the base of 
the sleeve to clamp the two frames together. For the prototype valves 
made with tissue treated as a flat sheet (geometries A and B) the 
outer sleeve was manufactured with a deeper flange at the top of the 
posts so it projected over and around the inner frame, deflecting the 
leaflets towards the closed position when unloaded. 
The four leaflet geometries were tested on frames without 
covering materials. To canpensate for the covering materials, the 
internal and external diameter of the valve frame were increased. 
For the size 27 mm valve the outside diameter of the inner frame (the 
surface over which the leaflets flexed) was defined as 25 nm, while 
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the outside diameter of the outer sleeve was 26.5 mn. The internal 
diameter of the uncovered inner frame was 22.8 mn. 
6.3 Leaflet geometries A and B 
For leaflet geanetries A and B the tissue was fixed ' with 
glutaraldehyde in the natural shape of the pericardial sac. This was 
achieved by placing tissue over 4" diameter perspex rings in a bath of 
glutaraldehyde, and placing a second ring over the tissue to restrain 
it at the edges. The tissue was allowed to take up its natural shape 
within the ring so it was relaxed, but as the fixation occurred the 
tissue appeared to tighten and shrink a little. Supporting the 
tissue on a ring avoided the wrinkles that could occur if the tissue 
was fixed as a flat sheet. The larger area of tissue covering the 
right ventricle (zones 1 and 3) was used and leaflets were cut from 
the centre of the mounting ring to avoid areas close to the edge where 
strain could have been placed on the tissue. Tissue thickness of 0.4 
to 0.45 mm was selected with the epipericardial surface as the inflow 
surface of the leaflet. Typical uniaxial load extension curves for 
the tissue fixed in this manner are shown in Figure 6.3. The tissue 
showed similar characteristics to the tissue fixed as a flat sheet 
(Section 4.3). No specific orientation was taken when cutting these 
leaflets fran the membrane. After fixation the tissue was floated on 
a flat template and five holes cut in the tissue corresponding to the 
mounting points, 1,2,6,10,11, in the frame. A second template 
was used to cut the edges of the leaflets (Figure 6.4). The key 
dimensions were the width of the leaflet between the fastening points 
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(1,11) q, the height of the post supporting the flexing portion of 
the leaflet hh, the height to the top fastenings he and the height 
to the centre of the free edge 1. The approximate area of the 
flexing portion is also shown in Figure 6.4. 
The basic cylindrical geometry of configuration A was described 
in Figure 5.6. The frame cut-outs or scallops were produced by the 
cylindrical surface of a 25 mm end mill inclined at an angle (24C = 
53') to the axis of the cylindrical frame. This produced a plane of 
intersection at an angle of (26.5') to the axis of the frame. The 
detailed shape of the frame is shown in Figure 6.5 by a radial view of 
the post and a radial view on the centre of the scallop. The leaflet 
was cut with a width q of 26 mm, an overall height 1 of 17 mm and a 
height h of 13 mm. Two valve prototypes tested in the function 
tester showed this leaflet configuration was not stable in the closed 
position under a high back pressure. A photograph of one valve in 
the tester in the fully open position (test conditions: stroke volume 
70 ml, rate 70 per minute - sine wave - peak flow 280 ml s-1), and 
in the fully closed position (back pressure approximately 100 mmHg) is 
shown in Figure 6.6. In the fully open position the leaflets took up 
a full cylindrical shape providing a large orifice. However, in the 
closed position the valve was not competent as all three leaflets 
folded under themselves at the free edge creating a triangular orifice 
in the centre of the valve. The reason for this is explained in 
Figure 5.6. A significant portion of the leaflet above the line AEB 
was not in the area of coaption between adjacent leaflets. This 
triangular portion of the leaflet ADBE could not support the back 
pressure and folded along the line AEB creating the hole in the centre 
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of the valve. 
The second geanetry B was designed to overcame this problem. A 
greater portion of the stent frame was cut away to produce a deeper 
coaption between the leaflets when loaded (Figure 5.7), so a larger 
portion of the area RUBE was supported by the other leaflets. Three 
different frames were manufactured for this configuration Bl, B2 and 
B3 (Figure 6.5). In two frames, Bi and B2, the scallops in the 
frames were produced by a cylindrical cutter inclined at an angle 
a(d +B) = 60° to the axis of the cylindrical frame. The cut-out was 
restricted in depth to allow a short parallel post 2 mm wide. The 
overall height of the flexing portion of the leaflet h was 13 and 14 
mm, with a leaflet width q of 26 mm and an overall length 1 of 17 
and 18 mm for configurations Bi and B2, respectively. Several 
prototype valves of these configurations were tested. Figure 6.7 
illustrates the function of a valve with configuration Bl. In the 
unloaded position the leaflets were deflected inwards into the closed 
position by the outer frame, so they touched at their free edges but 
left small holes around the top of the posts and a small triangular 
hole in the centre. As in the previous configuration the leaflets 
opened to a full cylindrical orifice. In the closed position under 
pressure, the leaflets sealed together to form a competent valve. 
There was however a significant mismatch in the heights of the free 
edges of the leaflets with the least extensible leaflet sitting higher 
than the other two leaflets. The area of coaption under load shown 
in a side view on one leaflet was quite small. The maximum coaption 
depth he was approximately 3 mm and the reference point E, was not 
in coaption with the other leaflets. A small portion of the leaflet 
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above the line AEB was not in coaption with the other leaflets. A 
vertical section through the leaflet on the centre line OEC showed how 
the leaflet was displaced downwards as the pressure extended the 
tissue (Figure 6.8). The displacement was greatest towards the free 
edge of the leaflet where the leaflet was not restrained in the 
vertical direction. This explains why the less extensible leaflet 
was higher than the other two leaflets. If taken to an extreme this 
could allow the most extensible leaflet to prolapse below the other 
leaflets. The area of coaption between the leaflets not only sealed 
the leaflets together but prevented one leaflet prolapsing below the 
other two leaflets. 
Configuration B2 was used to try and improve the depth of 
coaption beteween the leaflets and the stability of the closed 
position. The extra 1 mm in leaflet and post height improved the 
coaption depth slightly but mismatches in leaflet height occurred due 
to small variations in tissue extensibility. In Figures 6.8 and 5.7 
the loaded closed leaflet took up a curved shape radially as well as 
circumferentially, which improved the coaption depth. 
In the configuration 33 the frame scallop was cut away further by 
using a 25 mm spherical ball cutter (Figure 6.5). This effectively 
smoothed the profile of the scallop at the top of the post and allowed 
a greater portion of the leaflet to flex inwards. This was intended 
to provide a deeper coaption between the leaflets. several 
prototypes were tested and their function is illustrated in Figure 
6.9. Although the valve showed greater coaption than B2 and B1, hc 
approximately 5 mm, there was still a mismatch in the heights of the 
three leaflets when closed under pressure. As before, the open 
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leaflets gave a large cylindrical orifice. At flow conditions of 
stroke volume 70 ml, rate 70 per minute (sine wave) the mean pressure 
difference across the valve was 1.6 mmHg at an RMS flow of 194 ml 
s'1. This gave an effective orifice area of 3.0 ant. The 
closing regurgitant volume was 6.5 ml and the closed regurgitant 
volume 2.1 ml. In all these prototype valves made with tissue fixed 
flat, the leaflets transposed easily from the closed to the open 
positions with all leaflets opening up fully at low flows of under 50 
mis-1. 
The fundamental geometry of all these leaflet configurations 
meant that the area of coaption between the leaflets was not defined 
by the cylindrical surfaces which met at an acute angle. There was 
excess material in the coaption area of leaflets causing the free 
edges to twist and wrinkle and consequently the closed position of the 
leaflets was not the sane on every cycle. The more stable spherical 
shape of the leaflet with a deeper coaption was only produced when the 
tissue was extended under load and was partially due to the geometry 
of the scallop in the frame. It was felt that if this spherical 
shape was produced in the tissue during fixation it would give a more 
stable closed position. In particular, as the leaflets came together 
they would meet as two parallel surfaces in the area of coaption. 
6.4 Leaflet configurations C and D 
The basic geanetries of the moulded leaflets C and D were 
described in Figures 5.8 to 5.9. Leaflets were manufactured on 
single leaflet moulds so only a small area of uniform tissue was 
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required. A photograph of a size 27 mm mould is shown in Figure 
6.10. The mould not only defined the shape of the flexing portion of 
the leaflet, but also the stationary cylindrical portion positioned 
around the support frame. The edge of the mould was rounded where 
the flexing portion of the leaflet intersected the cylindrical surface 
of the frame defined by radius Re (Figure 5.7). The moulded shape 
formed the leaflet towards the closed position. Therefore, the outer 
sleeve was made a uniform thickness at the top of the posts as there 
was no need to deflect the tissue inwards. The mould was also used 
to position the array of holes 1 to 11 corresponding to the fastening 
points for the pins and struts (Figure 6.3). 
The fresh tissue was placed on the moulds precisely, by initially 
floating it on a flat template as in Figure 6.4, and picking up five 
reference holes, 1,2,6,10 and 11. As with the fixed tissue the 
critical dimensions were the width q and height h. The fresh tissue 
was placed on the mould and the five reference holes aligned to the 
appropriate holes on the mould. The mould and tissue were then 
submerged in a saline bath to allow the tissue to take up its position 
on the mould and the other six reference holes marked. The tissue 
and mould were placed in a glutaraldehyde bath for 24 hours and the 
tissue was removed from the mould and fixed for a minimum of six days 
in glutaraldehyde. The tissue on the mould extended beyond the free 
edge of the leaflet and this was cut using a further template once the 
shape of the leaflet was formed. 
The fresh tissue was orientated so the radial direction of the 
leaflet OC was along the circumferential direction of the pericardial 
sac. Tissue was taken from zones 1 and 3 overlaying the right 
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ventricle. The orientation was selected so the most extensible axis 
of the fresh pericardium in the biaxial inflation tests 
(circumferentially) was in the radial axis of the leaflet OC, where 
the deformation was greatest. A fixed tissue thickness of 0.4 to 
0.45 mm was used. The load extension curves for uni-axial tests of 
fixed tissue taken from the leaflets (Figure 6.11) showed that the 
loading part of the curves were similar in both directions and were 
also similar to the tissue fixed flat (Figure 6.3). As expected, 
strips taken radially in the leaflets had greater UTS. There was an 
increased variation in the extensibilities of the tissue taken from 
the moulds which suggested that the restraint placed on the tissue 
during fixation could have produced some change in the mechanical 
properties of the fixed tissue. 
For the spherical geometry, two configurations, Cl and C2, 
corresponding to radii of curvature 11 and 12 mm were tested. The 
differences between the two geometries is shown in Figure 6.12. In 
the horizontal section Cl, the smaller radii of curvature, allowed a 
wider post w, whilst in the vertical section the larger curvature, 
R12, was inclined at less than 90' to the axis of the cylinder in the 
base of the cusp, due to the position of D2 being outwith the 
cylindrical frame. The position of D and D2 and hence the depth of 
the spherical surface d was calculated from the arc length Sab where 
the spherical surface intersected the cylindrical shell of the frame. 
A depth d of 11 nm gave Sab equal to 24.5 mm for both 
configurations. The width q for the fresh tissue template (26.5 mm) 
was calculated from ( Sab+w ) with a small correction for the radius 
Re at each post. The height of the scallop h was 14 mu. Several 
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prototype valves of both configuration were tested. Non-synchronous 
opening of the leaflets was a major problem with both'configurations. 
In particular, at low flows the pressure gradient was not sufficient 
to reverse the curvature of all the leaflets causing them to buckle 
into the fully open position. This was a particular problem in the 
base of the leaflet where the tissue had to flex through an angle of 
over 90 degrees. Figure 16.13 illustrates the function of one of the 
worst prototype valves tested at flow conditions B (stroke volume 70 
ml, rate 70min-1). The valve had a symmetrical unloaded position 
defined by the geometry of the mould, with a small triangular hole at 
each post and a small triangular hole in the centre. These closed up 
under a small back pressure (less 5 mHg) to give a stable closed 
position with deep coaption between the leaflets. However, one 
leaflet in the open position did not reverse its curvature fully at a 
peak flow of 200 ml s1 and a peak pressure difference of 2.8 mmHg. 
This was an effect seen in the other prototype valves at lower flows. 
It appeared that the best leaflet opening action was achieved if the 
leaflet reversed its curvature in the base first. if the free edge 
of the leaflet moved out towards the open position first, this could 
produce a tighter radius of curvature in the base of the leaflet, 
making it more difficult to reverse its curvature and open fully. 
Leaflet geometry D (Figure 5.8) was used to obtain leaflets that 
transposed fran the closed to the open position at lower flows and 
pressure differences. A cylindrical surface was used in the base of 
the leaflet inclined at an angle (90 - ýf) to the axis of the 
cylindrical stent. The angle X was varied between 20 to 30 degrees 
for radii of curvature of 11 and 12 mn. Prototype valves were made 
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to configuration Dl with a radius of curvature R 12 mm and an angle 
30° and configuration D2, a radius of curvature R 11 and angle Ö 
25°. In all cases the leaflets opened up more readily at lower flows 
and pressures and also maintained a stable closed position. 
The function of a prototype valve manufactured to configuration 
Dl is shown in Figure 6.14 for flow condition B. In the unloaded 
position the leaflets did not sit symmetrically, but this did not 
affect the leaflet function. The leaflets moved synchronously to the 
fully open position at 70 BPM, S. V. 70, with a peak flow of 200 ml 
s-1 and had a stable open position with the leaflets taking a convex 
spherical shape as described in Figure 5.8. The portion of the 
leaflet fixed in a radius Re at the edge of the frame moved very 
little. Consequently, a small portion of the leaflet around the edge 
of the frame formed an S shape when the leaflet reversed its curvature 
in the open position (Figure 3.6). The leaflets moved from the 
closed to the open position at low flows typically 80 ml s-1 
corresponding to a pressure difference of 0.8 to 1 mmHg. The closed 
position of the valve was stable with an even height to the leaflets 
and a coapt ion depth he equal to 5 mm. The valve had an effective 
orifice area of 2.7 cm2 with a mean pressure difference of 1.2 na fig 
at an RMS flow of 150 ml s-1, a closing regurgitant volume of 6 ml 
and a closed regurgitant volume of 0.5 ml. 
The prototype valve manufactured to configuration D2 had similar 
function at flow conditions B (Figure 6.15). The unloaded position 
of the leaflets was more symmetrical. This was attributed to the 
slightly greater distance w at the top of the post, which allowed the 
tissue to bend uniformly around the top of the posts. As before the 
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leaflets opened at flows of approximately 80 ml s-1 corresponding to 
pressure differences of 0.8 to 1 mmHg and at a peak flow of 200 ml 
-1 all leaflets opened up synchronously. As before the closed 
position was stable (coaption depth he equal to 5 nmHg). The valve 
had an effective orifice area of 3.0 ant corresponding to a mean 
pressure gradient of 0.95 mmHg at an RMS flow of 149 ml s'1, a 
closing regurgitant volume of 5.3 ml, and a closed regurgitant volume 
of 1.7 ml. Configuration D2 was considered the better option for the 
moulded leaflets due to the better unloaded position. 
6.5 Discussion 
The frames and fastenings developed, allowed the precise 
positioning of the leaflets on the frames, and when used with the flat 
tissue templates to locate the holes in the tissue, gave a highly 
reproducible method to producing the valves. Any variation in 
function seen between leaflets on the sane prototype valve was more 
likely to be caused by variation in the tissue properties. It was 
estimated that critical dimensions on the leaflets could be reproduced 
to f 0.5 nm which was equivalent to changes in the leaflet 
extensibilities of f 2%. Figure 6.3 showed that variation in the 
leaflet properties were greater than this. 
Configurations A and B showed that the geometry of the closed 
leaflet under back pressure was an important factor in determining the 
stability of the closed valve. In particular, the area of coaption 
between the leaflets not only sealed the valve to prevent leakage, but 
gave mutual support to the leaflets. The shape of the cut-out or 
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scallop in the frames determined the geometry of the closed leaflet 
under pressure. The cylindrical geometry in configration A was not 
stable as a portion of the leaflet close to the free edge was not 
fully supported. This was significantly improved in configuration Bl 
to B3 by cutting away more of the frame which allowed a greater 
portion of the leaflet to flex inwards giving a deeper coaption hc. 
This produced a more spherical shape to the closed loaded leaflet 
which was optimised when the frame cut-out was defined by a spherical 
surface in configuration B3. This spherical geometry and deeper 
coaption was only produced when the back pressure was applied on the 
leaflets. Consequently the geometry, position and height of the 
loaded leaflets was dependent on the extensibility of the tissue. 
This was illustrated by the mismatch in the heights of the closed 
leaf lets. The coaption depth hc was an important parameter in 
leaflet design, as it affected the stability of the closed position. 
This was a function of the closed leaflet geometry rather than the 
overall height h of the flexing portion of the leaflet. In all 
these prototype valves the leaflets were deflected towards the closed 
position when unloaded by the outer sleeve, but moved easily to the 
open position at low flows and pressure differences. 
The leaflets moulded with a spherical geometry (configuration C 
and D) had a well-defined stable closed position under load. The 
spherical geometry gave a deeper coaption he and the leaflets met as 
parallel surfaces in the area of ooaption. Consequently, any small 
variation in the tissue extensibility did not cause significant 
differences in the heights of the loaded leaflets. The main 
disadvantage of these moulded leaflets was that a significant pressure 
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difference was required to buckle or reverse the curvature of the 
leaflets from the closed to the open position. All the leaflets in 
configuration C did not open fully at low flows. . Theoretical 
considerations for the least resistance to opening have given a 
minimum peak pressure difference of 0.4 to 0.95 mmHg for a natural 
aortic valve and 1 to 4 mmHg for synthetic leaflet valves (76). For 
bovine pericardial leaflets treated with glutaraldehyde the minimum 
pressure differences have been estimated as 1.3 to 2.2 mmHG (203). 
The minimum pressure difference required to open the valve leaflets 
increased with leaflet thickness and stiffness, and reduced with 
increased radius of curvature. These calculations made a number of 
approximations about the bending, canpression and extension stresses, 
derived from uni-axial load extension curves (53). Leaflet 
flexibility may also be dependent on the microscopic structure of the 
tissue (173). In the worst prototype valve made from configuration C 
one leaflet did not open at a peak pressure difference of 2.8 mmHg. 
The leaflet was measured as being thicker in its base but its 
extensibility was not determined. overall, the pure spherical 
geometry of configuration C did not give acceptable opening 
characteristics. 
Geometry D with the cylindrical surface in the base of the 
leaflet gave better opening characteristics, with typical minimum 
opening pressure differences of 0.8 to 1 mmHg. The minimum opening 
pressures and flows were determined for both steady and pulsatile 
flows as the flow was being increased. The minimum opening pressure 
differences and flows (steady and peak) were measured just prior to 
the opening of the third leaflet, as when the leaflet opened the 
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pressure difference reduced due to the increase in the valve orifice. 
The minimum opening pressure differences 0.8 to 1 mmHg occurred at 
peak flows of 80 ml sl which are approximately 40% of the peak 
flows for a resting cardiac output in the mitral position, and 30% of 
the peak flows for a resting cardiac output in the aortic position. 
In addition, the time interval for the leaflet to move from the closed 
to the open position was also monitored using still frames on the 
video camera to ensure synchronous leaflet action at normal flow 
rates. To achieve uniform opening of the leaflets in configuration D 
the tissue thickness and extensibility had to be controlled during 
manufacture. The spherical shape of the open leaflet did not affect 
the hydrodynamic function of the valves as the effective orifice areas 
and regurgitation were similar to the valves with geometries A and B. 
O nfiguration D2 was considered to give the best leaflet function 
with both a reproducible stable closed position and symmetrical 
unloaded position with acceptable opening characteristics. This 
leaflet configuration was used for further development of the valve. 
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CEiAPIER 7 
VALVE DEVE[DPMERr II AND FINAL SPECIFICATION 
7.1 Introduction 
The development of a leaflet geometry which gave optimal function 
was described in the previous chapter. The leaflet was moulded in a 
geometry defined by cylindrical and spherical surfaces which closely 
approximated the closed position of the leaflet. Several areas of the 
valve design required further consideration. In particular, the 
materials used to cover the frames, and the abrasion caused to the 
leaflets at edge of the frames, the methods used to close the leaflets 
together at the top of the posts to prevent leakage, and whether the 
flexural durability of the tissue had been affected by forming the 
tissue in a spherical shape during fixation. 
This chapter describes the evaluation of different materials to 
cover the frames and the accelerated fatigue tests carried out to 
assess the abrasion to the leaflets caused by the covering materials. 
In addition, several methods of closing the leaflets together at the 
top of the posts were investigated. The unloaded position of the 
leaflets shown in Figure 6.15 showed small triangular holes between 
the leaflets at the top of each post. These did not always seal up 
completely when the valve was fully closed. Several different 
prototype valves were manufactured with a different design at the top 
of each post. The function and leakage was assessed in the column 
tester and pulsatile flow test apparatus, and the durability assessed 
in the accelerated fatigue tester. The final specification for the 
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valve is also described for the range of aortic and mitral sizes and 
the importance of the valve manufacture discussed briefly. 
7.2 Covering materials for the frames 
Several knitted polyester cloths were considered for covering the 
outer sleeve and fabricating the sewing ring for the valve. These 
were manufactured by the School of Knitwear Technology at Leicester 
Polytechnic. The outer sleeve was covered by producing a cylindrical 
tube of cloth which was folded over the top of the frame. The excess 
material in each of the three scallops was pulled down so the cloth 
was stretched until it conformed to the profile of the upper edge of 
the sleeve. It was then sewn in a single seam along the base of the 
sleeve. The important characteristics for the cloth were: 
i Thickness - approximately 0.2 to 0.4 mm was required. 
ii Extensibility - sufficient stretch to conform to the shape of 
the frame. 
iii Coverage - adequate coverage of the acetal frame when 
stretched. 
iv Stability - to be sewn without running or snaring. 
A 50 dtex/22 filament bulked polyester yarn was used on a warp 
knitting machine. For early development valves a Tricot structure 
was used which was very thin and extensible but did not give adequate 
coverage or stability for sewing. Other structures were assessed 
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and, finally, a locknit was selected as it gave greater stability and 
ease of sewing. It was slightly thicker (0.3 nm when stretched) due 
to its more complex structure. The extensibility was varied by 
adjusting the number of courses in the cloth, and the tension in the 
yarn, to allow the cloth to be stretched over the frame, but 
controlled to give an adequate coverage at the top of the posts. The 
coverage of the frames was monitored by photography at thirty times 
magnification. Figure 7.1 shows a photograph of the covered outer 
frame. 
The covering materials for the inner frame were more critical as 
they had to eliminate abrasion to the leaflets at the edge of the 
frames. The important properties of this material were: 
i Smoothness - to reduce abrasion to the lealflets. 
ii Thickness - approximately 0.25 mn to minimise the overall 
bulk of the valve. 
iii Extensibility - to stretch and deform to the shape of the 
frames. 
iv Stability - to be able to suture the material without 
tearing. 
The four materials considered were bovine and porcine 
pericardium, both treated with glutaraldehyde, PTFE (Gortex), and 
polyester cloth coated with polyurethane. The polyurethane coating 
on the cloth gave a smooth surface but was unacceptably thick adding 
over 1 mm to the overall thickness of the valve frame. The Gortex 
PFTE membrane was very thin, typically (0.1 nm), but was highly 
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extensible in only one direction, and so it would not conform to the 
frame. It was also very difficult to sew without tearing. 
Both the porcine pericardium (thickness approximately 0.15 nm) 
and the bovine pericardium (thickness approximately 0.3 mm) were 
extensible enough to cover the frames. In both cases the 
tissue was stretched over the inner frame when fresh, and fixed with 
glutaraldehyde whilst in position. The porcine pericardium tended to 
wrinkle as it was stretched over the edge of the frame but this did 
not happen with the bovine pericardium which was slightly thicker. 
Bovine pericardium selected from an area 2 overlaying the left 
ventricle was used with a thickness of between 0.25 and 0.3 mm when 
fresh. A single piece of tissue was used to cover each frame with no 
seams on the inside surface of the frame (Figure 7.2). The tissue 
was overlapped in vertical seams down the outside of each post and 
sewn around the base of the valve. This cover added approximately 
0.5 mm to the wall thickness of the inner frame. Consequently, for a 
size 27 mm valve the outside diameter of the inner frame, when 
covered, was 25 mm, and the internal diameter 21.8 mm. The width of 
the post when covered increased to approximately 2.5 mm. 
The amount of abrasion to the leaflets at the edge of the frame 
was assessed by cycling two valves covered with bovine pericardium, 
two valves covered with Tricot knitted polyester cloth, and one valve 
with a naked acetal inner frame, in an accelerated fatigue tester. 
The bovine pericardium and acetal gave a relatively smooth surface for 
the leaflets to flex over at the edge of the frame while the open knit 
of the cloth gave a rough surface. 
The results of the fatigue tests are shown in Figure 7.3. 
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Valves 27.1 and 27.2 with the cloth-covered frames failed after 42 and 
78 million cycles (approximately equivalent to 1 and 2 years) with 
tears in the leaflets on the shoulder of the scallop at the edge of 
the frame caused by the abrasion of the leaflets on the cloth (Figure 
7.4). The tear on the leaflet of valve 27.1 extended to the free 
edge causing the leaflet to prolapse while the test was stopped for 
valve 27.2 before the tear could extend to the free edge. All the 
leaflets showed the abrasion caused by the cloth on the edge of the 
inner frame. This is illustrated clearly in Figure 7.5a, the 
photograph of the inflow aspect of a leaflet taken from valve 27.1. 
In all leaflets the abrasion was greatest at the shoulder of the 
scallop, about 3 mm from the top of the post. Valve 27.3 with the 
uncovered inner frame was tested to 160 million cycles without failure 
while valves 27.4 and 27.5 with the pericardial-covered frames were 
tested to 430 million cycles without failure. A photograph of the 
inflow aspect of a leaflet from valve 27.4, after 430 million cycles, 
showed that there was some wear to the leaflet at the edge of the 
frame, but this was greatly reduced compared to the leaflets from 
valves 27.1 and 27.2 with cloth-covered frames. 
Figure 7.6 shows photographs of valves 27.4 and 27.5 after 430 
million cycles. There appeared little damage or fatigue to the 
flexing portion of the leaflet with only small marks in the centre of 
the free edge of the leaflet where there is a small radius of 
curvature in the closed leaflets as they come together. This 
extensive cycling indicated that moulding the leaflets in a spherical 
configuration during fixation had not significantly affected the 
flexural durability of the tissue. There was a slight tendency for 
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the free edges of the leaflets to remain apart at the top of the 
posts, both when unloaded and loaded. This gave an increase in the 
closed regurgitant volume when the valves were cycled in the function 
tester at the end of the fatigue test. Otherwise the hydrodynamic 
function of these valves was unchanged. 
These tests showed conclusively that the bovine pericardial 
covering caused the least abrasion to the leaflets and significantly 
improved the valve durability. This is illustrated in a vertical 
section through the frames in the base of the scallop at point C 
(Figure 7.7). 
7.3 Closure of the leaflets at the posts 
In the prototype valves described previously, the leaflets had 
not been brought together in apposition at the top of the posts. This 
is seen in the unloaded valves and some closed valves where the 
leaflets did not seal together fully allowing a small closed 
regurgitation of 1 to 3 ml per stroke in the mitral position. After 
valves 27.4 and 27.5 were cycled in the fatigue tester this leakage 
increased. The leakage was variable from valve to valve and may have 
been dependent on how the leaflets were positioned on the fastening at 
the back of the post. The pericardial cover on the frame may also 
have affected the leakage as it increased the effective width of the 
post w. Other commercial valves have coaption stitches to close the 
leaflets together at the posts (Chapter 3) but they have been 
indicated as possible sources for tears in the leaflet. Any suture 
placed through the tissue in the flexing position of the leaflet, or 
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at the edge of the frame, will produce a stress concentration. 
Therefore, any method of closing the leaflets together has to be 
assessed in the fatigue tester as well as the function tester. 
Four options were considered for sealing the leaflets together, 
two of which involved the use of sutures. The leakage occurred due 
to the small gap between the leaflets on the inside of the post 
(Figure 7.8). The gap closed up as the leaflets moved together under 
back presure but did not seal completely. In the prototype valves 
manufactured previously, the leaflets projected 1 mm above the top of 
the posts in an attempt to prevent leakage. As an alternative to 
this, valves were made where the top of the post projected inwards to 
fill the space between the leaflets, and the leaflets were cut level 
with the top of the posts. Two stitch configurations were also used 
to seal the leaflets together (Figure 7.9). In both cases the 
leaflet was extended 2 mm above the top of the post (h=16mm) and a 
small stitch hole made 1 mm from the free edge of the leaflets. The 
leaflets were brought into apposition with a stitch above the post, 
but were not stitched to the post. When the valve was closed under 
pressure the stitch did not restrain the inward movement of the 
leaflets, so a stress concentration was avoided. In stitch A the 
suture looped over the free edge of the leaflets, around the back of 
the leaflets, and knotted at the back of the post. In stitch B the 
suture was looped around the back of the post twice and knotted at the 
back of the post. In both cases, the ends of the suture were sewn 
into the cloth-covered outer sleeve. 
Prototype valves manufactured to the four different options were 
assessed in the function tester and column tester. In valves without 
119 
the stitch, but with the leaflets above the posts, a small variable 
leakage was measured in the column tester (3 to 5 ml s-1) and a 
closed regurgitant volume of 1 to 2 ml. In valves without the 
stitch, with the inward projecting posts and the leaflets cut at the 
top of the posts, the leakage was greater (6 to 10 ml s-1 in the 
column tester and 2.5 to 4 ml closed regurgitant volume). In this 
second case the gap at each post in the closed valve under pressure 
could be seen in the function tester (Figure 7.10a). In the previous 
prototypes the leaflets were probably sealed together above the top of 
the posts. Both stitch configurations sealed the valves completely at 
the top of the posts which reduced the leakage to 1 to 2 ml s-1 in 
the column tester and less than 1 ml closed regurgitant volume (Figure 
7.10b). However, the stitches did restrict the fully open position 
of the free edge of the leaflet (Figure 7.11) which slightly reduced 
the effective orifice area of the valve. For stitch configuration At 
flow conditions B, this gave an effective orifice area of 2.7 cm2 
compared to 3.0 cm2 for the valves without the stitch. The 
stitches constrained the leaflets in the fully open position causing a 
sharp bend in the leaflet close to the stitch which could cause 
increased stress levels. These would be greater at high flows and in 
smaller valves when the pressure difference across the open valves was 
larger. 
The durability of the valves which were stitched at the top of 
the posts was assessed in the accelerated fatigue testers (Figure 
7.12). Four size 27 mm valves, 27.6 to 27.9, with stitch A, were 
cycled and compared to 27.4 and 27.5 without stitches. In addition, 
six size 31 mm valves, 31.1 to 31.6, with stitch B, were cycled. 
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Valves 27.6 to 27.9 were tested to 440 million cycles without failure 
or damage to the leaflets around the stitch, which confirmed similar 
durability to valves 27.4 and 27.5 without the stitch. These valves 
are shown in Figure 7.13 after 440 million cycles. The performance 
of valves 31.1 to 31.6, with stitch B, was not as good. One stitch 
hole elongated after 150 million cycles in valve 31.1, and after 200 
to 300 million cycles in other valves. The elongations occurred 
towards the back or outside of the leaflets (Figure 7.14). This was 
caused by the leaflet moving against the suture as it opened fully 
which gradually eroded a slot in the tissue. It probably occurred 
more rapidly in sutures that were not as tight. The elongated stitch 
holes eventually tore to the free edge of the leaflet. At this stage 
the damaged leaflets had good hydrodynamic function but tended to be 
displaced lower down under pressure than the leaflet with intact 
stitches. They also had abnormal opening and closing action. This 
seemed to contribute to the ultimate failure of the valves which will 
be discussed later. 
These tests showed that stitch A did not cause tissue failure and 
gave an adequate seal between the leaflets at the top of the posts. 
It also gave a more symmetrical unloaded valve. 
7.4 Final specification 
The development work allowed a final specification for the size 
27 mm mitral valves to be reached which was scaled up for the larger 
mitral valves and down for the smaller aortic valves. The final 
specification incorporated leaflet configuration D2, a pericardial 
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covering for the frame, and stitch configuration A. 
The leaflet geometry D2 was defined by two cylindrical surfaces 
which intersected in the centre of the leaflet in a spherical 
surface. This was shown in Figure 5.9 and is illustrated in three 
dimensions in Figure 7.15. The cylindrical surface in the base of 
the leaflet formed the lower third of the leaflet, and was inclined at 
angle Ö =25'. For the size 27 mm valves the , radii of curvature of 
the cylindrical and spherical surfaces, Rc, Rr, were each 11 mm 
while the depth of cut d was 11 mm. The height of the frame scallop 
hf was 14 mm, the height of the flexing portion of the valve leaflet 
was 16 mm which gave an overall height for the valve H of 20 mm. The 
arc length Sab was 24.5 mm and the uncovered post width W was 2 mm. 
The critical dimensions for implantation are shown in Figure 7.16. 
The outside diameter of the covered outer frame Dbut was 27.5 mit and 
the internal diameter of the covered inner frame was 21.8 mm. The 
implant height in the mitral position Himp was 15 run while the 
implant height in the aortic position was 19 mm. The implant diameter 
for the mitral position Gout was 27.5 mm, while the implant diameter 
for the aortic supra-annular position was taken as a nominal 27.5 mn, 
which is the outside diameter of the outflow aspect of the valve. 
The valve was developed in sizes 19 to 27 mm for the aortic 
position and sizes 25 to 31 mm for the mitral position. The valves 
were similar in both positions except for the design of sewing ring 
and the shape of the base of the valve. In the mitral position the 
sewing ring was placed away from the inflow aspect of the valve so 
reducing the implantation height Himp, and the outside diameter of 
the sewing ring Ds was larger. In the aortic position the base of 
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the valve was scalloped and a smaller sewing ring was positioned 
towards the inflow edge of the valve to give a supra-annular 
configuation with no projection into the aortic orifice. The 
diameter of the aortic sewing ring Ds was smaller. The sizes of 
the key dimensions are given in Table 7.1. All the dimensions are 
scaled up or down in accordance with the diameter of the valve. In 
the aortic position overall height H was reduced by 0.5 mm in the 
base, and a scallop depth of 1.5 mm used to shape the base. Average 
leaflet thicknesses of 0.45 mm and 0.4 mm were used for the mitral and 
aortic valves, respectively. A photograph of the inflow and outflow 
aspect of a size 27 mm mitral valve and size 25 mm aortic valve are 
shown in Figures 17.17 and 17.18. These illustrate the differences 
in the sewing ring configurations. 
7.5 Manufacture 
The frames, sleeves and locking rings were manufactured out of 
solid acetal bars with general tolerances of t 0.025 mm and t 0.01 
mm on critical dimensions. The injection moulded pins and studs were 
pressed into the frames with interference fits (* 0.05 mm). The 
inner frame was covered with a single piece of bovine pericardium 
(Figure 7.1) which was sutured around the base of the valve. A tube 
of polyester cloth was sewn to the tails of the pericardium projecting 
from the base of the valve. The outer sleeve was covered in 
polyester cloth as shown in Figure 7.2. Leaflets were formed on the 
moulds as described in Section 6.4 and fixed in glutaraldehyde for a 
minimum of seven days. The leaflets were selected and matched for 
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thickness and uniformity. A variation of 0.03 un in thickness of the 
leaflets (t) in one valve was acceptable. Variation in thickness of 
up to . 03 mm was accepted in any one leaflet but, if a gradient was 
measured, it had to be thinner in the base than the top of the 
leaflet. The leaflets were placed on an inner frame jig whose 
dimensions matched the covered inner frame and were retained in place 
with an outer jig. The function of the three leaflets was tested 
under a range of pulsatile and steady flow conditions for synchronous 
and uniform leaflet action. Any malfunctioning leaflets were 
replaced until a matched set was obtained. 
The three leaflets were taken off the test jig and assembled onto 
a covered inner frame for the final assembly of the valve. The 
washers were pressed over the studs to secure the leaflets to the 
posts, a single stitch placed through the leaflets above the top of 
each post, the outer frame clipped over the projecting pins, and a 
locking ring slid into position in the base of the valve. At this 
stage in the valve assembly the functional parts of the valve had been 
secured in position and only the tails of cloth and pericardium 
extending from the base of the valve required to be sewn into place 
and a sewing ring fabricated fram the cloth. The details of these 
final sewing procedures differed for the aortic and mitral sewing ring 
configurations. Essentially, each tail of cloth or pericardium was 
turned onto the outside of the cloth-covered sleeve and sewn in place, 
and two cloth tails were rolled together to form the sewing ring or 
cuff which was held in place with a final circumferential seam. This 
sewing added additional security to the valve construction as the 
pericardium from the cover of the inner frame was sewn to the cloth 
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covering of the outer frame. After the final assembly each valve was 
tested under pulsatile flow and steady flow conditions, before being 
placed in its final sterilisation and storage solution of 4% buffered 
formaldehyde. 
7.6 Discussion 
Fatigue test results for the prototype valves, with different 
covering materials on the inner frame, showed that the pericardial 
covering on valves 27.4 and 27.5 reduced the abrasion to the leaflets 
caused by the cloth on valves 27.1 and 27.2. The failure mode in 
valves 27.1 and 27.2 was similar to that described for commercial 
valves with cloth-covered frames in Chapter 3. The lifetime of 430 
million cycles (the equivalent of 11 years) without failure confirmed 
that, with a smooth covering material such as pericardium, it was not 
necessary to rely on biological processes such as tissue ingrowth 
to maintain the integrity of the tissue at the edge of the frame 
(149,150). There was some wear to the leaflets along the edge of the 
pericardial-covered frames which may have been caused by the leaflets 
being compressed against the edge of the frame when the leaflets were 
in the closed position. 
The tests also confirmed that the pericardial leaflets had good 
flexural fatigue properties and that fixation of the leaflets in the 
spherical shape did not affect the flexural durability of the tissue 
(55). The only sign of wear or damage was in the centre of some 
leaflets close to the free edge where the three leaflets net at a 
point. In this area striation and markings were found on the smooth 
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outflow mesothelial surface of some leaflets. The closed leaflets 
had high bending strains at this point particularly in the 
circumferential direction. It may well be that markings were the 
start of tissue disruption due to compressive bending stresses on the 
outflow surface of the tissue (53). Membrane stresses in this area 
were quite small (135,136). 
The leaflets were sealed together at the top of the posts to 
prevent leakage. This was achieved with stitch configuration A which 
closed the leaflets together but did not restrain them to the post, so 
avoiding stress concentrations around the stitch when the valve was 
closed under pressure. The stitch did constrain the leaflet movement 
in the fully open position and this could induce stress in the tissue 
around the stitch. The fatigue tests on valves 27.6 to 27.9 tested 
to 400 million cycles showed that the stitch did not cause tissue 
damage. It was important to control precisely the position of the 
stitch holes and the tension in the suture. It was not easy to 
measure the flow through the valve or' the forward flow pressure 
difference in the fatigue testers but, in the test conditions used, 
the peak flow through the valve was calculated at between 330 and 460 
ml s'1 for an amplitude of 3 to 4 mm at 12 Hz. Stitch 
configuration B in size 31 mm valves was not as good and movement of 
the leaflet against the thread elongated the hole in the tissue and 
eventually caused a small tear in some leaflets. This may have 
contributed to the eventual failure of some leaflets which will be 
discussed fully in the next chapter. 
The final specification reached for the size 27 mm valve was 
scaled up or down to manufacture the other sizes of mitral and aortic 
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valves. Quality control was an important factor in the manufacture 
of all the valves. The unique design of haunting the leaflets on 
pins and studs allowed the leaflets to be matched and function-tested 
on a jig prior to final assembly. To a great extent this eliminated 
the need to reject valves for poor leaflet function after final 
assembly. The quality control function tests allowed the leaflets to 
be matched for symmetrical opening and closing, even ooaption between 
the leaflets when closed, and a symmetrical open postion. These 
tests often revealed small variations in leaflet properties which were 
not detected prior to the test. Synchronous opening was assessed 
under steady and pulsatile flows and a minimum opening flow of 51 
min-1,80 ml s-1, was taken as an acceptable limit. This 
corresponded to minimal opening pressure difference of less than 1 
mmHg for the size 27 to 31 mn valves, increasing to approximately 2 
nmHg for the 19 mm valves. This increase was due to the smaller 
radii of curvature in the smaller valves (141). 
The development work described in the last two chapters has 
produced a valve with optimal leaflet function and good durability in 
initial accelerated fatigue tests for the size 27 min valve. 
Prototype valves were manufactured in all sizes to this final 





Prototype valves have been manufactured to the final 
specification given in Chapter 7 for sizes 25 to 31 mm in the mitral 
position, and sizes 19 to 27 mm in the aortic position. Photographs 
of a size 27 nm mitral and 21 mm aortic valve were shown in Figures 
7.17 and 7.18. A number of prototype valves have been made in each 
size. one valve of each size has undergone a full evaluation in the 
pulsatile flow test rig and ten size 25 nm mitral valves have 
undergone limited tests to assess the reproducibility of the 
manufacturing process. Size 27,29 and 31 mm valves were 
manufactured for fatigue tests and size 25 and 21 nm valves were 
manufactured for animal trials. 
The sizes of valves are usually taken as a nominal implant 
diameter (Figure 17.16) but this can vary between different 
manufacturers. Table 8.1 shows how the key dimensions and implant 
sizes of the Glasgow Valve compare with other pericardial valves for 
size 29 mm mitral and size 23 mm aortic valves. 
In this chapter the results of the laboratory function and 
fatigue tests on the prototype valves are described and the results 
compared with similar studies on commercial pericardial valves 
described in Chapter 3. 
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8.2 Hydrodynamic function tests 
The function of the prototype valves was assessed under steady 
and pulsatile flows as described in Chapter 2, and leaflet notion 
studied by video camera and synchronised still frame photography. 
The leaflet function of the prototype valves was similar in all sizes 
with little variation due to the scaling of the leaflet geometries. 
Figure 8.1 shows sequential photographs at 10 ms intervals of the 
opening and closing of a size 27 mm valve in the mitral position with 
the test apparatus under flow conditions B (rate 70 min-1, stroke 70 
ml, cardiac output approximately 41 min-1). The leaflets took 
approximately 70 ms to move from the open to the closed position and 
approximately 40 ms to move from the closed to the open position. 
The time to open was dependent on the shape of the flow waveform 
whilst the time to close was dependent on the size of the valve and 
the volume of fluid swept back by the leaflets. The leaflets moved 
synchronously and uniformly under these flow conditions (the peak flow 
was 200 ml s-1). The leaflets opened in the base or belly of the 
leaflets first with the free edges moving outwards after the curvature 
on the base of the leaflet had been reversed. This was similar to 
the action described for the MM and HP valves in Chapter 3, and 
proposed for natural aortic valves (124). During closure the leaflet 
tended to move inwards at the edge of the frame and the base first 
with the area of the leaflet at the free edge and in the centre being 
the last to reverse its curvature. 
At much lower flows and pressure differences it was always 
possible to detect slight differences between the opening 
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characteristics of the leaflets due to the inherent variation in their 
mechanical properties. The most sensitive test to detect this was to 
slowly increase a steady flow through the valve and view the 
sequential opening of the leaflets as the flow and differential 
pressure across the valve increased. Figure 8.2 showed two size 25 
mm mitral valves at a steady flow of 40 ml s-1 (2.4 1 min-1). In 
Figure 8.2a one leaflet had not transposed from the open to the closed 
position, while in Figure 8.2b the free edge of one leaflet had opened 
but the belly remained in the closed position producing a shelf. In 
the first case the leaflet was less extensible so required a larger 
gradient to transpose it to the open position, while in the second 
valve the leaflet material was slightly thicker in the base. In both 
these valves the leaflets opened up fully at steady flows of less than 
80 ml s1 (4.8 1 min-1) and functioned normally under minimal 
pulsatile flow conditions specified in the quality control tests for 
manufacture. 
The precise positioning of the leaflets on the radial pins and 
studs and the precise manufacture of the leflets allowed the 
dimensions of the flexing portion of the leaflets to be defined 
precisely. This gave uniform open and closed positions for the 
leaflets. Variations in the opening and closing actions described 
above was attributed to inherent variation in the mechanical 
properties of the tissue (extensibility and thickness). Figure 8.3 
shows a size 25 um mitral valve in the function tester (flow 
conditions B) showing the valve unloaded, closed under pressure and 
fully open. In each case the position and geometry of all three 
leaflets was uniform. There was deep ooaption between the closed 
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leaflets he 4 to 5 mm which gives a stable closed position. This is 
an improvement over some low profile valves described in Chapter 3 
which had less coaption between the closed leaflets. 
Figure 8.4 shows the mean pressure difference across the valves 
plotted against RMS forward flow for sizes 25 to 31 mm in the mitral 
position, and sizes 19 to 27 in the aortic position. The pressure 
difference was measured 25 mm upstream and 50 mm downstream of the 
mitral valve and 50 mm upstream and 50 mm downstream of the aortic 
valve (see Chapter 3). At the upstream pressure measurement point 
the diameter of the test sections was 57 mm so the fluid had 
negligible kinetic energy. The downstream measurements were made 50 
mm from the valve sewing ring in the area where the jet of fluid 
passing through the open valve had contracted to a minimum. 
Consequently the maximum pressure difference across the valve was 
measured. The pressure recovery in the aortic position was not 
measured. The mean pressure difference plotted in Figure 8.4 is for 
the time interval defined by the zero pressure point at the start of 
forward flow and the zero flow point at the end. 
As expected the mean pressure difference increased with reducing 
valve size. For the mitral position at flow conditions B (RMS flow 
150 ml s-1) pressure differences varied from 1.0 to 2.5 mmHg for the 
size 31 to 25 mm valves, whilst at the highest flows (corresponding to 
a cardiac output of approximately 8.5 1 min-1) the mean pressure 
difference varied from 3.5 to 8 mmHg. In the aortic positions, the 
RMS flows were greater than the mitral position due to the shorter 
systolic time period. However, the graph of mean pressure difference 
against R4S flow was similar in both positions for the size 25 ma 
131 
valve. The size 27 mm valve had a greater pressure difference in the 
aortic position due to the aortic diameter (28mm) affecting the full 
opening of the leaflets. At flow conditions B (RMS flow 250 ml 
s-1 the mean pressure gradient varied from 3 to 14 nmHg for the size 
27 to 19 mm valves. At the highest flows (Cardiac output 8.5 1 
min-1) the mean pressure difference varied from 7 to 22 mnHg for the 
size 27 to 21 mm valves. The size 19 mm valve was not tested at the 
highest flow. 
In both the mitral and aortic positions the effective orifice 
area EZ of the valves increased with flow as shown in Table 8.2. At 
higher flows the larger pressure difference opened the leaflets 
wider. Table 8.3 compares the calculated EXaA for the valve at the 
highest flows with the actual maximum orifice area defined by the 
internal diameter of the frame. The EX)A is the calculated area of 
contraction of the jet downstream of the valve (assuming no viscous 
losses). This is less than the actual area of the orifice by the 
discharge coefficient ratio. A discharge coefficient of 0.8 is not 
unreasonable for an orifice which suggests that free edges of the 
valve leaflets opened up approximately to the full orifice of the 
valve. 
The mean pressure difference measured across ten size 25 mm 
mitral valves, at flow condition C, to assess the repeatability of the 
valves manufactured are given in Table 8.4. The variation * 2SD t 
0.62 mmHg was greater than the variation found on a single valve, and 
was attributed to variations in the properties of the leaflets in 
different valves. This variation would not be detected clinically. 
The mean pressure differences of the size 29 mm mitral and size 
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23 mm aortic valves was compared to the pressure differences found 
with other pericardial valves in Figure 8.5. The size 29 mit Glasgow 
Valve (GHV) had the same pressure difference as the MM valve. The 
other valves had higher gradients which were caused by restriction to 
the opening of the leaflets at their free edges (Chapter 3). The 
Glasgow Valve had the smallest frame internal diameter Di (Table 8.1) 
so it made the greatest use of the orifice available. In the aortic 
position the size 23 min Glasgow Valve had a slightly greater pressure 
difference than the HP and MM valves and similar pressure difference 
to the ISU and ISLP valves. The latter two used flared stents which 
gave a comparatively larger orifice at the top of the stent posts 
(Table 8.1). The HP valve also increased its overall diameter it 
from the nominal 23 mm size, which gave it similar characteristics to 
the *1 valve. The slightly increased gradient in the Glasgow valve 
compared to the HP and MR valves was basically due to the bulkier 
frame and smaller internal diameter Di. In comparison with other 
bioprosthetic valves, the size 25 mm mitral Glasgow Valve had a lower 
pressure difference than the 29 mm porcine valves (118) while the size 
23 mm aortic valve had a similar pressure difference to the size 25 mm 
Carpentier-Edwards porcine valve. 
The regurgitant volumes passing back through the valves are 
plotted in Figure 8.6. The regurgitation was measured while the 
valve was closing and while it was closed, and each volume was 
averaged over the five waveforms tested. The closing regurgitation 
was greatest in the size 31 mm valve and lowest in the size 19 mm 
valve. This was due to the larger volume of fluid swept back by the 
leaflets and the longer time period to close in the larger valves. 
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There was also additional displacement of fluid due to the extension 
of the leaflets under the back pressure as the leaflets moved to the 
closed position. The closing regurgitation was similar in both the 
mitral and aortic positions for the size 25 and 27 ma valves. The 
closed regurgitation was similar in all sizes of mitral valves and all 
sizes of aortic valve, but was greater in the aortic valves. The 
closed regurgitation (leakage) mainly occurred through the cloth- 
covering on the outer frame and the sewing ring. The sewing rings 
were sealed to the valve mounting ring with silicon rubber, but the 
sewing ring and cloth-covering were not coated with silicone rubber to 
simulate tissue ingrowth. The construction of the sewing ring in the 
aortic positon may have allowed a greater leakage through the closed 
valve. In addition, the longer diastolic time period when the aortic 
valve was closed also increased the closed volume. 
Figure 8.7 shows the regurgitation of the Glasgow Valve with 
other pericardial valves for the size 29 mm mitral and size 23 mm 
aortic. The regurgitant volumes were similar for all the size 29 mit 
mitral valves. In the aortic valves (size 23 mm) the closing volumes 
were similar but the closed volumes were slightly higher in the ISU 
and ISLP, due to the slightly different construction of the sewing 
ring. In clinical use we would expect that the closed leakage would 
reduce as the host tissue grew into the sewing ring and cloth. 
The energy losses across the Glasgow Valve during forward flow, 
closing, and closed regurgitation are compared to other size 29 mn 
mitral and size 23 mm aortic valves in Figure 8.8. These results 
confirmed that the overall hydrodynamic function of the Glasgow Valve 
was similar to existing conwrcial pericardial valves. For all the 
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valves in the mitral position the energy losses during regurgitation 
were greater than the energy losses during forward flow, even at the 
highest flow rates (waveform E). The ISU 29 nm valve which was the 
most obstructive valve (Figure 8.4) also had the greatest total energy 
loss. In the aortic valves, the forward flow pressure differences 
and consequently the forward flow energy losses are greater. The MM 
23 and HP 23 had slightly lower forward flow energy losses than the 
Glasgow valves, while the regurgitant energy losses were similar in 
all valves. 
8.3 Fatigue test results 
Accelerated fatigue tests have already been described in Chapter 
7 in which valves of different specifications were cycled to over 400 
million cycles at 12 Hz. This took approximately one year. Before 
these tests to determine the final specification were completed 
additional tests were started. The results of all the fatigue tests 
completed are summarised in Figure 8.9. In total, nine valves 
manufactured to the final specification have been tested (four size 27 
mm and five size 29 mm). In addition, seven valves with the 
different stitch configuration were also tested (six size 31 mm and 
one size 29 nm). The results of these extra seven valves were 
discussed as they gave additioinal explanations of failure moles. 
Each valve was tested in the function analyser before and after the 
fatigue tests. 
The four size 27 mit valves completed 440 million cycles 
(equivalent of 11 years) without failure and have already been 
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illustrated in Figure 7.13. On some of the leaflets there were 
markings on the mesothelial surface at the centre of the leaflet close 
to the free edge. Table 8.5 shows that there was little change in 
the hydrodynamic function of the valves before and after the test. 
There was slight reduction in the mean pressure difference across the 
valves and a slight increase in the closing regurgitant volume. This 
may have been caused by the leaflets being stretched a little by the 
repeated cycling in the fatigue tests. 
Four of the size 29 mm valves were tested to 400 million cycles 
without failure while one valve 29.1 failed after 156 million cycles 
with a hole in the centre of the free edge of the leaflet (Figure 
8.10). This failure was probably caused by bending stresses in the 
closed leaflet at the point where the three leaflets came together in 
the centre of the valve. The valve had a large regurgitation 23.8 ml 
per stroke when tested after the fatigue test, due to the leakage 
through the tear. When valves with large regurgitant volumes were 
tested the mean aortic pressure was set to 70 mmHg instead of 95 mmHg 
in an attempt to simulate the loss of pressure that would occur 
clinically. 
In the other four size 29 m valves, valve 29.2 showed a small 
tear in the tissue above the stitch above the top of one post after 
330 million cycles while valve 29.5 showed a similar tear in one 
leaflet after 380 million cycles. Valves 29.3 and 29.4 were cycled 
to 400 million cycles without damage (Figure 8.11). Some leaflets 
however showed marks in the centre close to the free edge in the same 
position as the hole in the failed 29.1 valve. Both valves 29.2 and 
29.4 were cycled to 400 million cycles without further damage after a 
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small tear was detected above the stitches. Function tests after 
completion of the fatigue test showed that these small tears did not 
affect the hydrodynamic function of the valves which remained 
unchanged. Similarly, there was little change in the hydrodynamic 
function of valves 29.3 and 29.5 after the fatigue test (Table 8.5). 
In valves 31.1 to 31.6, and valve 29.6, with stitch configuration 
B, small tears were detected in leaflets of all valves at the stitch 
between 160 and 400 million cycles. In all cases the stitch hole 
elongated as described in Section 7.4. The test was continued after 
the damage was detected and in four valves further damage and ultimate 
failure was found in the same leaflets. In two of the valves 31.2 
and 31.5, elongation of the stitch hole was also associated with 
lamination of the tissue at the top of the same post. The failure 
time for these valves is shown in Figure 8.9 and photograph of the 
damaged leaflet shown in Figure 8.12. In two of the valves, 31.1 and 
31.3, the leaflet with the tear dropped lower than the other two 
leaflets when closed under pressure. In both cases a small hole 
appeared in the leaflet at the edge of the frame on the shoulder of 
the scallop. This occurred at 210 and 290 million cycles, 50 and 20 
million cycles after the initial tear was detected. At this point 
the tests were stopped. One possible reason for the holes occurring 
was that as the leaflet dropped the tissue was deformed over the 
inside edge of the frame producing excessive bending stresses at this 
point. Function tests of the two valves after the failure, showed 
that there was little difference in the regurgitant volumes going back 
through the closed valves (Table 8.5). However, both failed leaflets 
had an abnormal opening and closing action on the side where the hole 
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occurred. 1. 
In valves 31.2 lamination of the leaflet, close to the torn 
stitch hole, increased as the test was continued until eventually at 
300 million cycles a small hole appeared in the leaflet 3 mm away fran 
the top of the post. The lamination of the tissue appeared to give 
permanent extension to the tissue and this caused an abnormal opening 
action to the leaflet. The leaflet appeared to open and close by 
bending at the point where the hole occurred. It is likely that 
bending stresses caused the hole in the tissue. This small hole did 
give a small increase in the closed regurgitant volume (4.9 ml) in the 
function test (Table 8.5). 
In valves 31.5 and 29.6 the leaflets with the torn stitch hole 
eventually tore at the top of the posts at the edge of the frame 
(Figure 8.11). This was most severe in valve 31.5 which failed after 
318 million cycles with a large regurgitation while in valve 29.6 the 
valve was still competent after 400 million cycles. Function tests 
on these two valves after the fatigue test, showed a large regurgitant 
volume for valve 31.5 as the tear allowed the leaflet to prolapse 
below the other two leaflets, but only a small increase in the 
regurgitation in valve 29.6 (2.6 ml) where the tear did not extend 
very far down the post. In the other two valves, the leaflets with 
the tear at the stitch hole were tested to 400 million cycles without 
further damage. 
These valves, although not to the final specification, showed 
that small holes can occur in the leaflets either at the edge of the 
frame or in the roving position of the leaflet. These appeared to 
occur if the leaflet motion was abnormal and may have been caused by 
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excessive kinking or bending. The tears occurring at the top of the 
posts in valves 31.5 and 29.6 were probably due to high tensile 
stresses in an area of the leaflet which was weakened by some wear. 
Comparison with the lifetimes for the commercial valves in Figure 
3.9 confirm the improved durability of all the Glasgow valves with a 
significant reduction in wear and abrasion at the edge of the frames. 
8.4 Discussion 
Extensive function tests carried out on the full range of 
prototype valves have shown that the hydrodynamic function of the 
valve developed was very similar to existing camwrcial pericardial 
valves. Small variations in pressure differences compared to the 
commercial valves tested were due to the differing restrictions placed 
on the opening of the free edges of the leaflets and the overall 
orifice area of the valve frames. Closing regurgitation was similar 
in all valves while closed regurgitation was dependent on the 
construction of the cloth covers and sewing rings. The opening 
characteristics of the Glasgow valve were similar to the HP and MM 
valves, the leaflets of which were also moulded in the closed 
position. 
There was some variation in the mechanical properties of the 
leaflets which affected both the leaflet dynamics at low flows and to 
a lesser degree the pressure difference across the valve. it is 
important to reduce this variation to a minimum during the manufacture 
of the valve. Although inspection of, and thickness measurements of, 
the leaflets were made before assembly, testing the leaflets on a jig 
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under pulsatile and steady flows proved to be the most sensitive test 
to detect variation in the leaflet properties. The extensibility of 
the leaflet proved to be the most critical parameter as a stiff 
leaflet gave a slow or lazy opening action while a very extensible 
leaflet dropped below the heights of the other two leaflets when 
closed under pressure. The provision to test the leaflets on a jig 
prior to final assembly proved an important design feature, and should 
improve the overall consistency of manufacture and reduce the 
percentage of valves rejected after final test. The variation found 
in this type of valve makes it imperative to test every valve 
manufactured. 
Fatigue test results on the Glasgow Valve confirm its superior 
durability and the elimination of premature failure of other 
commercial valves due to abrasion of the leaflets on the edge of the 
cloth-covered frames (Figure 3). Only one major failure (valve 29.1) 
was found in the fatigue tests on the nine valves manufactured to the 
final specification which were cycled to over 400 million cycles. 
Slight damage was seen at the cortmissure stitch on two valves after 
330 and 380 million cycles, but this did not affect the valve 
function. These tests confirmed the resilient nature of fixed 
pericardial tissue. 
The failure of valve 29.1 and some of the size 31 mm valves 
occurred where the bending stresses in the leaflets were very high, at 
the centre of the free edge, when abnormal leaflet action and kinking 
occurred or where the leaflet stretched and kinked over the inside 
edge of the support frame (Figure 8.12). In these areas the radii 
of curvature were typically 1 to 2 mm, which gave much greater bending 
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strains than the normal curvature found in the leaflet. All the 
leaflets were cut with the fibrils in the pericardium predominantly 
running in the radial direction. The effect of rotating the axis by 
90°, so that the fibrils ran ciricunferentially, was not 
investigated. However, further studies of the durability of 
pericardial valves will be made to investigate the effect of the 
orientation of the leaflets in the sac on valve durability. This 
rotation would have made the leaflets similar to the natural leaflets 
with the direction of highest ultimate tensile strength in the 
direction of maximum tensile stress (circunferentially). Bending 
stresses were also greatest in the circumferential direction and it is 
not known whether the tissue is more resistant to bending along or 
across the fibrils. 
Some damage was detected at one of the stitches above the posts 
in two size 29 mm valves. This was seen as a tear in the tissue 
above the stitch hole, approximately 1 mm long to the free edge, 
adjacent to the loop of thread which passed over the free edge. This 
was caused by the bending stresses which occurred at this point when 
the leaflet was fully open. The stitch was important in sealing the 
free edges of the leaflets above the post and the stitch configuration 
used was clearly superior to the configuration used in the size 31 mm 
valves. 
It is difficult to assess the significance of defects found in 
the valves after long periods in the fatigue tests as, clinically, 
biological affects such as tissue ingrowth and calcification are 
likely to have a greater effect on valve function and durability. 
Indeed, experience of function testing explanted clinical valves after 
141 
two to four years implantation time shows that leaflet mechancis are 
dramatically changed after implantation due to tissue overgrowth, 
calcification and blood deposits on the leaflets. Although 
accelerated fatigue tests gave quite accurate prediction of the 
mechanics of early failure in commercial pericardial valves they will 
be a less accurate indication of failure modes after eight to ten 
years when biological affects will be more dominant. Nevertheless, 
these fatigue tests provided a very harsh test on the mechanical 





Although the valve has undergone extensive laboratory tests for 
both function and durability, these tests did not give information 
about biological effects such as calcification, thrombogenicity or 
tissue ingrowth. Our experience with explanted clinical valves 
described in Chapter 1 showed that these biological effects can cause 
significant changes in the valve appearance and function. A Hancock 
pericardial valve (size 23 mn), which was considered to be functioning 
normally in vivo, was explanted after 20 months. The appearance of 
the valve tissue was good although there was excessive host tissue 
ingrowth over the sewing ring and edge of the leaflets. Assessment 
of the explanted valve function in the pulsatile flow test apparatus 
gave a mean pressure difference of 6 mmHg (DOA 1.4 am2) at an RMS 
forward flow of 185 ml s-1, compared to 3.2 mmHg (FAA 2.0 an2) at 
the same flow for an identical valve prior to implant. The 
restricted opening of the leaflets and pressure drop was caused by 
adherence of the leaflets to the cloth-covered frames and tissue 
ingrowth over the edge of the outflow surface of the leaflets. 
Calcification has also caused dramatic changes to the function of 
tissue valves. An Ionescu-Shiley size 31 mm pericardial valve 
explanted after four years with severe calcification had a mean 
pressure difference of 26 mmHg compared to 2.0 mmHg for an identical 
valve prior to implant for an RMS flow of 150 ml s-1. The only way 
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to assess the effect of these biological processes prior to clinical 
implantation is to carry out implants in animals. 
No ideal animal model is available for bioprosthetic valves. 
Mitral valve replacements have been carried out in dogs (36), but this 
requires small sizes of valves (21 to 25 mm). Young calves have also 
been used but they grow very rapidly and are not suitable for longer 
term studies. Sheep have also been used successfully for mitral 
valve replacement (203) but they have been reported to cause 
accelerated calcification (204). 
Sheep aged approximately 18 months have been selected for initial 
animal studies with this valve. They are readily available and are 
relatively easy to operate on and manage postoperatively. Their size, 
although smaller than humans, is generally larger than dogs, and a 25 
mm mitral valve can easily be implanted in the mitral position. The 
range of cardiac outputs in sheep is typically 2 to 4 imin-1. At 18 
months they are almost fully developed and they do not outgrow the 
prosthesis. 
9.2 Methods 
Valves were implanted in the mitral position of 10 'grey-faced' 
sheep aged 18 to 21 months. The operative procedure involved left 
thoracotomy through the fifth intercostal space, and cardiopuln nmary 
bypass by cannulation of the descending aorta and the right ventricle 
through the pulmonary artery. The heart was maintained in 
fibrillation throughout the procedure and bypass carried out at normal 
temperatures. Bypass times were between 40 to 70 minutes and pump 
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flows between 2 to 3.5 1 min-1. The left atrium was opened through 
a vertical incision in its appendage and the native mitral valve was 
not removed. Size 25 mm valves were implanted using 12 2/0 Tycron 
sutures with pledgets. The sheep were given a five day course of 
Penicillin and Streptomycin as prophylaxis against infection. No 
anticoagulants were given. Seven sheep survived the planned implant 
period of three months and valves were explanted at beteween 13 and 16 
weeks. Two other sheep died within 24 hours of the operation with 
respiratory failure. These deaths were not valve-related. One 
sheep died after eighteen days with infective endocarditis around the 
valve annulus and vegetation and thrombus on the inflow aspect of the 
valve. The animal had been infected since the operation and 
Streptococcus faecalis was isolated in the blood tests. 
Cardiac output and pressure difference measurements were 
attempted in six of the seven survivors prior to sacrifice. After 
sacrifice, the heart and valves were examined in situ and the lungs 
examined for macroscopic abnormalities. Other major organs were 
removed for histological examination. The valve was removed from the 
heart and a macroscopic examination carried out in the laboratory. 
The valves were then washed in sterile saline and their function 
assessed in the pulsatile flow test apparatus. The valve was then 
fixed in glutaraldehyde and x-ray films taken in an attempt to 
identify areas of calcification on the leaflets. The valve was then 
taken apart and an x-ray film taken of the individual leaflets. The 
leaflets and frame were then sent for histological studies. 
Two of the valves implanted (1 and 2) were not manufactured to 
the final specification and configuration B (Chapter 7) was used for 
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the suture above the posts. The other five valves (3 to 7) were 
manufactured to the final specification. 
9.3 General description and testing of the explanted valves 
The explanted valves are shown in Figures 9.1 to 9.7 and the 
x-ray films are shown in Figures 9.8 and 9.9. All the explanted 
valves showed good tissue ingrowth over the sewing rings and outer 
cloth-covered frames, and this extended about 1 mm over the edge of 
the outflow surface of the leaflets. Tissue ingrowth stopped at the 
edge of the pericardial covering on the inflow aspect of the valve. 
All the valves were free from thrombus and the pericadial tissue was 
in good condition. There were small deposits of calcium visible on 
some leaflets in some of the valves and these were also detected on 
x-ray films. 
Valve 1 shown in Figure 9.1 had a surgical suture looped over the 
post between leaflets 3 and 1 which caused some distortion to the 
leaflets and prevented them from closing together when unloaded. 
There was also some calcification and stiffening of the leaflets at 
this comnissure (Figures 9.8 and 9.9). The gap between the unloaded 
leaflets sealed under back pressure in the function test to give a 
competent valve with normal regurgitation as shown in Table 9.1. The 
forward flow pressure differences listed in Table 9.1 was increased by 
approximately 30 percent in the explanted valve due to the restricted 
leaflet opening caused by the calcification. The minimal opening 
flow for leaflet 3 was increased fran less than 80 ml s-1 before 
implant to 110 ml s-1 after explant due to the stiffening caused by 
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the calcification at the left hand comnissure. This valve had suture 
configuration B at the commissure. 
Valve 2 shown in Figure 9.2 also had a small gap between leaflets 
3 and 1 in the unloaded valve. As with valve 1 these leaflets had 
suture configuration B at the top of the posts. Leaflet 1 was 
stiffened with calcification on the right hand commissure (Figures 9.8 
and 9.9). A pledget and surgical suture was looped over the post 
between leaflets 2 and 3 but this did not affect the leaflet 
function. The function tests showed that the gap between leaflets 3 
and 1 closed under pressure to give a canpetent valve with little 
difference in the regurgitation before implant and after explant. 
The mean pressure difference across the explanted valves was increased 
by approximately 30% (Table 9.1) and the in vivo peak pressure 
gradient was 4 mmHg for a cardiac output of 2.4 1 min just prior to 
sacrifice. 
Valve 3 shown in Figure 9.3 was manufactured to the final 
specification (as were valves 4 to 7) and had a better unloaded 
position for the leaflets. A surgical suture was looped over one 
post but this did not appear to affect the leaflets. Small calcium 
deposits were detected on the inflow aspect in the base of leaflet 1, 
which distorted the unloaded leaflets, and also at the right hand 
comnissure of leaflet 1, and both conmissures of leaflet 2 (Figures 
9.8 and 9.9). There was extensive tissue ingrowth over the base of 
leaflet 3. The calcification greatly increased the pressure 
difference across the explanted valve (Table 9.1). Leaflet 1 opened 
at a minimal flow of 120 ml s-1, while the calcification at the 
comnissure of leaflet 2 restricted its opening at the free edge. In 
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vivo measurements prior to explant showed a peak pressure drop of 
4 mmHg. 
Valve 4 shown in Figure 9.4 also had sane visible calcium 
deposits on the outflow surface at the edge of leaflets 2 and 3 about 
one third of the way up the right hand posts. This was confirmed on 
the x-ray films. The calcium deposits stiffened the leaflets and the 
mean pressure difference across the explanted valve was doubled due to 
the restricted opening of the leaflets. However, all leaflets opened 
at a minimal flow of 80 ml s-1. Peak pressure gradient in vivo was 
3 mmHg at 2.2 1 min-1 cardiac output. 
Valve 5 in Figure 9.5 appeared good with no visible calcification 
or wrinkling of the leaflets. The inflow view showed a small dimple 
in the base of leaflet 3 which was also slightly higher than the other 
two leaflets at the free edge. Tissue ingrowth was also quite 
extensive on the outflow aspect in the base of leaflet 2. The 
function test results (Table 9.1) showed that the mean pressure 
difference was increased by 20% in the explanted valve due to tissue 
ingrowth and the regurgitation was unchanged. In vivo pressure 
measurements showed a peak pressure difference of 3 mmHg. 
The leaflet of valve 6 shown in Figure 9.6 also appeared good 
with no visible calcification or distortion in the unloaded leaflets. 
The x-ray films confirmed that the valve was free from calcification. 
Tissue ingrowth was quite extensive in the base of leaflet 1. The 
function tests showed that the pressure difference across the 
explanted valve increased by between 25 to 30%. This was probably 
due to the tissue ingrowth restricting the opening of the leaflets. 
In vivo pressure measurements were not completed in this animal. 
148 
Valve 7 also appeared free from calcification and distortion of 
the leaflets (Figure 9.7). X-ray films detected a small deposit of 
calcium on the right hand oommissure of leaflet 2 (Figures 9.8 and 
9.9). In the function test, leaflet 3 did not open fully in the base 
even at the highest flows tested, and the leaflet appeared to be 
stiffened in this area. This may have been associated with tissue 
ingrowth. As a consequence the mean pressure difference of the 
explanted valve was increased by over 50%. 
9.4 Pathology of explanted valves 
The explanted sheep valves are currently being studied in the 
Pathology Department at Glasgow Royal Infirmary, using optical 
microscopy, scanning and transmission electron microscopy, and x-ray 
element analysis. Initial results show little change in the 
structure of the tissue before implant and after explant shown in 
sections of the leaflets in Figure 9.10. The areas of calcification 
seen visually and on x-ray film were confirmed with electron 
microscopy element analysis. Extensive studies are planned for the 
leaflets and the results will be compared with specimens of other 
explanted clinical pericardial valves such as ISLP. 
Initial results have confirmed the macroscopic findings that the 
valves have performed satisfactorily in vivo. 
9.5 Discussion 
The function of the valves implanted for three months in the 
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mitral position in sheep, without anticoagulation therapy, has been 
satisfactory. Explanted valves were free from thrombus and showed 
good tissue ingrowth over the sewing ring and outer frame-covering 
with the valve being well-incorporated into the native orifice. 
Although some valves showed same calcification which stiffened the 
leaflets and affected valve function, it has been recognised that 
sheep do provide an accelerated model for calcification of 
bioprosthetic valves (204). The calcification appeared at varying 
places on the leaflets although it always tended to be towards the 
edge of the support frame where bending stresses were greatest. This 
is consistent with findings from other workers (205). In our case 
the calcification appeared on both the inflow and outflow surfaces of 
the leaflets. There is no clear explanation for the varying amounts 
of calcification between valves or between leaflets on the same 
valves. The looped surgical suture on valve 1 which distorted the 
leaflet probably also caused the calcification at the top of the post 
in this valve. It is likely that calcification will be dependent on 
the variable structural and mechanical properties inherent in the 
leaflets and this should be investigated further. 
The pulsatile flow tests showed that there were changes in the 
valve function caused by tissue ingrowth over the edge of the leaflets 
as well as calcification. The tissue ingrowth restricted the portion 
of the leaflet that could flex to the open position which caused a 
significant increase in the pressure difference measured in the in 
vitro tests. This was consistent with our limited experience of 
function testing explanted clinical pericardial valves. It is clear 
that biological processes in vivo do affect leaflet dynamics and the 
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pressure differences, and it is important to be able to study the 
function of explanted valves in the laboratory and canpare valve 
function at explant to the function prior to implant. At present, 
valve designs and improvements are based primarily on valve function 
prior to implant. In vivo pressure measurements confirmed the 
satisfactory function of the valves, but the accuracy of these 
measurements was limited and it is inappropriate to base a detailed 
analysis of valve function on these measurements. 
The sheep implants have shown satisfactory function over a period 
of three months and, currently, further tests are being carried out 
with five size 21 mm mitral valves implanted in dogs without 
anticoagulation therapy. A randomised clinical trial is planned 
comparing a standard porcine valve with the Glasgow pericardial valve. 
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CHAPTER 10 
DISCUSSION AND FURLMü. R bK 
The overall long-term clinical performance of the Ionescu-Shiley 
Standard pericardial valve has been good. However, a significant 
number of valves have been explanted due to leaflet prolapse and 
regurgitation caused by leaflet tears (up to 4% per patient year). 
Limited clinical experience in Glasgow with the more recently 
developed low profile pericardial valves has sham similar tissue 
failure in some of these valves. In same follow-up studies, rates of 
primary tissue failure are higher than valve failures due to 
calcification or thrcmboembolic events. A characteristic failure 
mode has been described in most of the explanted pericardial valves 
with tears in the leaflets occurring close to the edge of the 
cloth-covered frames. A number of different causes have been 
suggested for these failures but it is not clear from the clinical 
studies which is the major factor contributing to these tissue 
failures. Although there have been large numbers of follow-up 
studies of valve implants, including multi-centre trials, the number 
of detailed studies of explanted valves is few (206). 
My experience of explanted porcine and pericardial valves in 
Glasgow has shown significant changes in valve function and leaflet 
dynamics after explant compared to valve function for canparable 
valves prior to implant. As well as tears in the leaflets and 
calcification which have been widely reported, tissue ingrowth also 
affected leaflet function and caused an increase in the pressure 
difference across some valves of between 25 to 50%. In the 
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pericardial valves tissue ingrowth was found up to 2 mit over the edge 
of the leaflet which changed the geometry of the open leaflet and in 
some cases caused leaflet flutter. In one porcine valve the tissue 
ingrowth restricted the valve orifice but did not grow over the 
flexing portion of the leaflets. The advantage of lower pressure 
differences across pericardial valves compared to porcine valves, 
found in hydrodynamic tests, may not be fully realised clinically due 
to tissue ingrowth affecting valve function in vivo. This could 
explain the similar pressure difference measurements found for porcine 
and pericardial valves using Doppler ultrasound measurements in vivo 
(118). More detailed analysis of both the function and pathology of 
explanted prosthetic valves is required to assess how biological 
processes affect long-term valve function. 
Hydrodynamic studies on four pericardial valves showed that 
different leaflet designs and construction methods affected valve and 
leaflet function. In particular, leaflet geometry, method of 
fixation, and position of coaption stitches, affected leaflet dynamics 
and transvalvular pressure differences. Our studies of bovine 
pericardium have confirmed that it is a complex material with 
variation in the mechanical properties between sacs, between different 
sites on the same sac and before and after fixation. They have also 
shown anisotropic properties at one site. Both differing material 
properties and valve designs can have an effect on long-term valve 
durability. However, accelerated fatigue tests completed on four 
different types of valves have shown that in all valves, abrasion of 
the leaflets against the edge of the cloth-covered frames caused 
leaflet tears and premature valve failure. These accelerated fatigue 
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tests are artificially harsh for pericardial valves as biological 
effects, such as blood deposits on the cloth and tissue ingrowth which 
can reduce abrasion and reinforce the leaflets at the edge of the 
frame, are not simulated. Care must be taken when extrapolating 
failure rates from fatigue tests to the clinical situation. 
Nevertheless, the fatigue tests did predict the mechanism 'Of failure 
which caused the tissue tears in the explanted valves I have studied. 
In both the laboratory tests and with explanted valves, abrasion of 
the leaflets on the cloth-covered frame was the major cause of leaflet 
tears. In the fatigue tests the tears started lower down the posts 
at the shoulder of the scallop as opposed to the top of the post in 
the clinical valves. This may be due to an abnormal closing action 
of the leaflets seen in the fatigue tester or due to greater tissue 
ingrowth lower down the posts in the clinical valves. In the ISU 
valve the coaption stitches pulled through the tissue producing small 
tears in both the fatigue tests and in explanted valves, but they did 
not appear to cause the major tears. If the abrasion to the leaflets 
is eliminated, greatly improved durability is expected, and the 
influence of other factors such as leaflet geometry and material 
properties can be determined. 
In this improved valve design which utilises twin frames, the 
pericardial covering on the inner frame greatly reduced wear and 
abrasion of the leaflet in accelerated fatigue tests when compared to 
other valves made with cloth-covered frames. Valves were cycled to 
over 400 million cycles without failure, the equivalent of ten years. 
One valve failed with a hole in the centre of the leaflet at the free 
edge which was probably caused by bending stresses. All the leaflets 
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were cut so that the fibrils in the tissue were predominantly 
orientated radially, so at the point of failure the bending strains 
were across the fibrils. It is not known if the tisssue has better 
flexural durability across or along the fibrils. This will be 
assessed in the future by manufacturing leaflets with alternative 
orientations but this can only be carried out once the mechanical 
properties of the tissue at other areas of the sac have been 
determined, and the anisotropic nature of the tissue is more fully 
understood. Although the leaflets were orientated with the direction 
of lowest ultimate tensile strength (determined in the uniaxial tests) 
in the circumferential direction, none of the leaflets showed 
excessive extension or failure in tension circumferentially. These 
tests showed that fixed pericardium is a higbly durable material and 
can support repeated flexion and high tensile stresses. Lower values 
of ultimate tensile strength found in one direction in uniaxial tests 
may be a consequence of cutting the tissue in thin 3 min strips across 
the direction of the fibrils. 
Coaption stitches caused a all tear in a leaflet in two valves 
in the fatigue testers after 320 million cycles, and these were 
probably caused by the restriction and bending strain placed on the 
leaflets in the fully open position. Closure of the leaflets at the 
posts is essential to prevent leakage and also to prevent the 
separation of the leaflets at the free edge as seen in animal valves 1 
and 2 which had stitch configuration B. The stitch configuration 
used brings the two leaflets together, without constraining the 
leaflets in the closed position and having a minimum of restraint in 
the fully open position. 
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The fatigue tests and animal tests have confirmed the stability 
of the closed leaflet geometry. This is achieved with fixation of the 
leaf let on a mould in the closed position with a geometry which gives 
deep coaption between the leaflets. Although in other low profile 
pericardial valves the coaption between the leaflets has been reduced, 
experience with explanted valves of this type shows mismatch in the 
heights between the closed leaflets under pressure, which can easily 
lead to prolapsed leaflets, and central regurgitation. Fixation of 
the leaflets in the closed position can cause problems with 
synchronous leaflet opening. The geometry of the leaflets that I 
have described, the ability to mould the shape in the leaflet without 
introducing large changes in its mechanical properties, and being able 
to match, test and replace leaflets on a jig prior to final assembly, 
allow the valve to be manufactured with synchronous leaflet action. 
The precise location of the leaflets on the pins and studs also helps 
to achieve synchronous leaflet action. The inherent variations in 
the properties of biological materials make it essential to test the 
function of every valve manufactured. 
The valves explanted from sheep showed some small calcium 
deposits which were expected as it had been reported by other 
workers. More significant was the variation in leaflet function 
caused by tissue ingrowth over the edge of the leaflets. Tissue 
ingrowth over the sewing ring and cloth covering of the outer frame is 
desirable but ideally this should stop at the edge of the flexing 
portion of the leaflets. Tissue ingrowth over the leaflet at the 
edge of the frame, typically between one and two millimetres, 
restricted the portion of the leaflet that could flex to the open 
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position and influenced the synchronous opening, uniformity of the 
open position of the leaflets, and the transvalvular pressure 
difference. This was seen in other explanted clinical valves where 
tissue ingrowth over the outflow surface of the leaflet and adherence 
of the inflow surface of the leaflet to the cloth-covered frames, 
restricted the opening portion of the leaflet, increased the pressure 
difference, and produced abnormal leaflet dynamics and flutter. These 
changes in leafet function are clearly undesirable and should be 
studied further and related to the detailed design of each valve. It 
is essential to test the hydrodynamic function of explanted valves to 
compare this to the function prior to implant and relate the changes 
to valve histology and pathology. 
This improved design of the Glasgow valve has shown good function 
and durability in the laboratory tests and satisfactory results in 
initial animal trials. Material properties of pericardium and valve 
durability will be studied further, and further implant studies in 
animals are planned. A randomised clinical trial is planned to 
compare a porcine valve to the Glasgow pericardial valve. 
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APPENDIX I 
S. rANOARD OONIDITIOI+TS FOR VALVE F(NCTICN TESTS 
The following tests have been carried out to assess the effect of 
a number of conditions and parameters on the results of the function 
test. 
i Forward flow time intervals 
Four reference points were defined during the forward flow time 
interval (Figure Al. l). Point 1: start of forward flow, Point 
2: the start of positive differential pressure; Point 3: end of 
positive differential pressure; and Point 4: end of forward 
flow. For mechanical valves, Points 1 and 2 coincide, whereas 
for tissue valves a small forward flow was detected before a 
positive differential pressure. This was due to relaxation of 
the valve and leaflets as the negative back pressure reduced. 
The differential pressure was always negative (Point 3) before 
the end of forward flow due to deceleration of the fluid. Four 
time intervals were used to average the differential pressure and 
flow signals. These were: Points 1 to 4: flow to flow, FF; 
Points 1 to 3: flow to pressure FP; Points 2 to 4: pressure to 
flow PF; and Points 2 to 3: pressure to pressure PP. The 
effect of the different time intervals on the mean differential 
pressure, RMS flow graphs is shown in Figure A1.2 for the 
Bjork-Shiley spherical disc valve BSS and the Ionescu Shiley Low 
Profile (ISLP) valve. For the BSS valve, Points 1 and 2 
coincide so the intervals shown, PF and PP, were equivalent to 
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intervals FF and FP. In both valves the PP interval gave 
slightly higher pressure readings than the PF interval. In the 
tissue valves the FF and FP intervals were much lower. ' The 
start of the interval includes a short period of time when the 
differential pressure has a high negative value which produces an 
artificially low result. The signals should be averaged between 
the zero flow points FF to eliminate the inertia term from 
equation 4. In practice the start of forward flow was 
difficult to define due to relaxation of the valve so the 
pressure flow PF interval was used as the standard measurement. 
The results of the pressure interval were also recorded as it has 
been used by other centres and is used clinically. 
ii Position of pressure measurements 
The upstream measurement was made 25 mm from the mitral valve and 
50 mm from the aortic valve where the test sections had maximal 
cross-sectional area. The downstream measurements were taken 
25,50 and 75 mm from the mitral valve and 25,50,100 and 150 mn 
from the aortic valve. The variation in the mean pressure 
difference graphs with the position of the pressure measurements 
is shown in Figure A1.3 for the BSS 23 mm aortic valve and BSS 29 
mm mitral valve. The mitral position showed a slight reduction 
in the pressure difference 75 mm downstream of the valve whilst 
in the aortic position there was between 20 and 25% pressure 
recovery 150 mm downstream of the valve. Close to the valve the 
differential pressure signal was quite noisy due to turbulence 
and recirculation, so Point B, 50 mm downstream of either valve, 
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was selected as the standard measurement 'point. Further away 
from the valve it is not known how a physiological geometry, 
i. e., ventricular cavity or curved aorta would affect the 
pressure recovery. 
iii Valve position 
Valves were tested in different positions in both the mitral and 
aortic positions. The mean pressure difference was reduced by 
about ten percent when the pressure was measured in the major 
orifice of the BSS 29 nm mitral valve. This was due to the 
downstream jet impinging on the pressure tapping. The minor 
orifice was taken as the standard position for the pressure 
measurement. In all other valves no significant variation was 
found in pressure measurement with valve position. 
iv Reverse flow time interval 
The reverse flow period was defined by Points 4 and 1 (Figure 
A1.4). Point 5 determined the end of dynamic or closing 
regurgitation and the beginning of static or closed 
regurgitation. It was defined as the lowest negative value for 
reverse flow prior to the constant leakage. Position of this 
point affects the ratio of the two regurgitant volumes but not 
the total regurgitaiton. The energy loss calculations were more 
sensitive to the position of this point as the pressure 
difference is changing very rapidly at this point in the cycle. 
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Valve orientation 
The dynamic (closing) regurgitation was dependent on the 
orientation of tilting disc valves. When valves opened in the 
vertical plane with gravity assisting closure, regurgitation was 
lower than when the valve opened on the horizontal plane. This 
is shown in Figure Al. 5 for the BSS 29 mit mitral valve. All 
mechanical valves were positioned so the leaflets or discs opened 
in the horizontal plane. 
vi Shape of the ventricular pressure waveform 
The dynamic (closing regurgitation of the mitral valve was 
dependent on the shape of the ventricular pressure waveform. In 
the rigid test section the rate of rise of ventricular pressure 
was high (dp/dt). This was reduced by introducing a compliance 
into the pump chamber. This in turn reduced the dynamic 
regurgitation by 0.5 ml (Figure A1.6). It also produced 
variable lower frequency oscillation in the pressure waveform 
which were difficult to control. For this reason rigid chambers 
without compliance were used as standard conditions. 
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Abstract. A lea rig has been developed to investigate the function of prosthetic heart 
sakes under pulsatile flow conditions. The rig uses a semo-contralled pump to produce 
a physutlugtcal flow waveform through the sake. The pressure ddlerence across the sake 
and flow through the sakes are measured to assess the salve function The mean pressure 
Jttlerence. root mean square ittsºsv forward 11ow and regurguant volumes are calculated 
on a : omputer In the initial study. sewn popular mc: hanº: al prostheses 'sties : 't and 
:' mm' were evaluated in the mural position under use dttterent tlow conditions The 
mean pressure dttleren a was dependent on the position of the downstream pressure 
lapping. the orientation of the salve and the time interval used to average the signals. Rte 
ortcntatton of some +al+c . tlso atlcaed the regurgrtant volumes These sarratums t lu.. st 
were similar in sue to the Jittcrences measured hetwcen indtstdual salves Tesº sonduums 
hose to he spe, ilied scrs . irefutls 
for .i uratc : omp. trtson of +alsc funsuon to he made 
1. Introduction 
The methods used to test the function of prosthetic heart Res under pulsatile to'. 
conditions have become increasingly sophisticated since the work described by Welting 
1969) and Wright and Temple ( 19711. The complex function of the left heart and 
arterial system have been simulated in several ways. producing varying test conditions 
for the valves. Most test rigs that have been developed can he divided into four discrete 
sections: 
(i) the pump used to generate pulsatile flows; 
(ii) the chambers for testing the valves; 
1 iii t the afterload and peripheral circulation; and 
(iv) the measuring instruments and data analysis. 
Two types of pumps have been used. A pneumatic actuator controls the ventricular 
pressure precisely but the flows produced vary with load (Yoganathan et at 1979). A 
servo-controlled positive displacement pump can reproduce the complex physiological 
flow waveforms precisely (Martin er at 1981), but may also produce abrupt changes 
in the ventricular pressure waveform at the beginning and end of systole when the 
valves are opening and closing (Scotten et at 1983). 
Two different configurations have been used for the valve test chambers. Straight 
test sections have been used to produce uniform flow patterns upstream of the valve 
(Martin et at 1981). Alternatively, the complex geometry of the left ventricle has been 
simulated (Kohler et al 1981, Scotten et at 1983, Reul 1984) in an attempt to produce 
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more realistic flow patterns. A standard afterload has been used in most rigs (Westerholl 
et at 1971). 
The measuring techniques and data analysis have improved with the introduction 
of mini- and microcomputers (Walker er at 1934). The measurements most commonly 
used to assess valve function are the mean pressure difference across the valve as a 
function of root mean square (Rsts) forward flow and the reverse flow through the 
valve. The flow has been measured directly with an electromagnetic flowmeter 
(Yoganathan et at 1979) or can be derived from the velocity signal of the pump (Tindale 
and Trowbridge 1983). It has already been shown that the pressure difference is 
dependent on the position of the downstream pressure tapping in the aortic position 
(Tindale et at 1982) but it may also be dependent on the orientation of the valve and 
the time interval used to average the signal. In some studies an orifice area equation 
has been used to express the ratio of the is flow to the square root of the pressure 
difference. This can he misleading if the ratio is dependent on the flow ITindale et at 
1982) or if different empirical constants are used (Gabhay et at 1971). The reverse 
flow through the valve is usually expressed as two regurgitant volumes per cycle, during 
the period that the valve is closing and during the period that it is closed. 
The ditliculties involved in modelling the left ventricle and arterial system are 
reflected in the variety of -system. which have been used to test cakes. Particular 
problems occur when trying to match the inertia, compliance and geometry of the 
system whilst trying to measure accurately the instantaneous 11oss through the salve 
under test. An electromagnetic Host meter has to he used in a cylindrical tube several 
diameter% long to ensure uniform flow patterns through the transducer and should he 
connected by rigid chambers to the sake under test tGahhav er at 07S. Yoganathan 
er u! 1'4'96. This column of fluid introduces significant inertia into the system which 
can cause distortion of the flow and or Pressure wasctorms. Vshen the 114iw meter is 
used in a much shorter tube iScotten et et! )vý+i with a non-compliant %entricle, the 
pressure in the sentricle is still distorted during the closure of the mitral sake. Systems 
have been described with a flexible sentricle. with variable source impedance i Reul 
l9.43 and stick a rigid ventricular chamber and flexible aorta tTnndale and Trost bridge 
19831 but in neither case uas the flow through the valve measured. A modular test 
system has been developed using rigid chambers which allow the flow through. and 
pressure across, the valves under test to he measured directly in both position.. The 
modular construction will allow the addition of different test sections at a later stage. 
Seven popular mechanical prostheses have been tested under varying floss conditions 
in the mitral position. The effects of varying the position of the pressure tappings. the 
orientation of the valve, and the time interval for averaging the signal have been 
investigated and the results compared with data from other centres. 
2. Description of the test apparatus 
A positive displacement pump (Super Pump model SP3891, Cardiac Development 
Laboratories) is used to produce the pulsatile flow. The lead screw of this piston pump 
is driven by a velocity servo system which is controlled by a specially adapted 
programmable waveform generator. The shapes of the pump velocity waveforms, 
derived from data described by Walker et at (1984), are shown in figure 1 for the five 
different flow conditions used. 
The waveforms reproduce the main characteristics of the cardiac cycle, such as a 
systolic period of approximately 300 ms, a reducing diastolic period with increasing 
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heart rate. an as%mmetric . v. tolic 11ow Nape, and an end diastolic flow peak at low 
heart rates due to atrial contraction. 
The layout of the test rag is shown in Iigure 2 for testing Mahe. in either the mitral 
or aortic position. The shape of the mitral test sections conforms to the specification 
Eisen hl Weittnc t 19h9 tt figure ? 1. The downstream pressure tappings A. 13 and C are 
25.40 and 75 mm respectively from the'al%c. 
The ventricular chamber used is a straight cylindrical pipe t Weiting 196Q. Yoganathan 
er at 19791 and does not simulate the boundary conditions for flow produced in the 
ventricular cavity a Kohler 1975.1975 t. 
All the test sections were machined from acrvlie blocks and the internal surfaces 
polished to give maximum visibility of the valve under test. Flow straightners (a lattice 
of 2 mm diameter polypropylene drinking strawst are used 150 mm upstream of each 
valve to produce a uniform flow pattern. The valves are mounted in acetal flanges 







Figure 2. Layout of the test rig 1.1P shows the differential pressure taps and P the direct pressure taps). 
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peripheral circulation and afterload is used. Normal saline t0.9 sodium chloride 
solution) is used for testing mechanical valves in order that the results can he compared 
with similar tests on tissue sakes. 
An electromagnetic flow meter IGould Statham SP :. 011 with a :6 mm diameter 
probe i% used to measure the Ilow through the %al%e under test. It is positioned in .t 
straight tube a distance of eight diameters downstream of the sale. Its accuract is 
green as --6 ml s' for uniform flow patterns and has a frequency response of -is dh 
at 50 Ili. The pressure in three sections of the test rig, the atrium, the ventricle and 
the aorta, are measured using Heomatic i [-'%17: 1i transducers. A differential trans. 
ducer iCiaeltec 3( T speciali is used to measure the small forward Ilo%, pressure 
ditlercnce across the talc. The transducer is used in the -5 to T_u min Hg range to 
gitc maximum sensitnitt. It has a specified accuracy of st). i mm 11g. The transducer 
is connected to the test rig with ' mm diameter rigid tubing. Under these conditions 
the transducer has a measured resonant frequency of 110 Ht which agrees closelt ttith 
the theoretical talue dcri%ed from the tolume displacement. The four transducers are 
driven by E: Icomatic (EM amplifiers. The four pressure signals, the flow signal 
and the position and velocity signals from the piston pump, are fed into an Apple II 
microcomputer through an analogue to digital ( \-oi converter t lnteracti%e Structures 
Inc. Al 02). The "x-i) converter reads each signal eterv 5 ms and has a resolution of 
256 increments for the signal amplitude. This resoles the differential pressure signal 
into 0.1 mm H- increments and the flow signal into '_ ml s' increments. A sofittare 
package has been developed for the data acquisition and processing which will he 
described in detail elsewhere. Basically, the package consists of four programs, a 
calibration mode, a real-time display mode for setting up the conditions in the rig, a 
data acquisition and processing mode, and a calculations and analysis mode. 
3. Test procedures 
The pressure transducers are calibrated statically and calibration factors stored in the 
computer. The displacement and velocity of the pump are calibrated by oscillating a 
column of fluid in a calibrated cylinder. The pump is then used to calibrate the 
electromagnetic flowmeter for each of the flow waveforms used. The zero position of 
the flow and pressure signals are set immediately prior to the measurements being 
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The computer is used in the real-time mode to set the conditions in the rig. Three 
signals, the pump rate, stroke volume and mean aortic pressure, are displayed on a 
colour monitor. The pump velocity waveform, stroke volume and rate are set by 
adjusting the programmable waveform generator and the mean aortic pressure set to 
95 mm Hg by adjusting the afterload. Each mitral valve is tested under the flow 
conditions shown in figure 1. When the rig conditions are stable, the acquisition 
programme is run and the six signals are stored over a period of 20s. The average 
waveform is then calculated for each signal, stored on floppy discs and plotted on an 
Annadex printer. The flow and differential pressure signals are analysed by defining 
five reference points on the cycle: point 1, the start of forward flow; point 2, the start 
of positive pressure difference; point 3, the end of positive pressure difference; point 
4, the end of forward flow, and point 5, the end of the large reverse flow due to the 
valve closing (figure 4). For a mechanical valve, points I and 2 coincide and the mean 
pressure and a. ts forward flow are calculated between points I to 3 and I to 4. The 
regurgitant volumes are measured between points 4 to S whilst the valve is closing and 
points 5 to I whilst it is closed. 
In this initial study, the function of seven popular mechanical valves (table 1) has 
been investigated in the mitral position. The mean pressure difTerence during forward 
Table I. Function of sewn popular mechanical ales. 
Vale 
manufacturer T. pe Size Ahhre%iabon 
Rjork-Shiley Sphencal disc 27 RSS 27 
Rjork-Shiley Conseso-Concaso DISC Ml- 27 RSC 7 
Rjork-Shiley Sphencal disc :9 BSS :9 
Rjork-Shiley Conseio-Concaso Disc too, :9 RSC :9 
Omniscience Tilting disc :9 0% . '9 
I)uromedice Rileatlet 29 D%1: 9 
St Jude Rileatlet 29 Si _9 
flow was measured at pressure tappings A. B and C for the BSS 29 and DM 29 valves. 
All the valves were tested in different orientations. The disc valves were tested with 
the disc opening in the horizontal plane and the pressure tapping in the major and 
minor orifice and also with the disc opening in the vertical plane with the major orifice 
lowest. The bileaflet valves were tested in the horizontal and vertical planes. 
4. Results 
The pressure and flow signals for the BSS 29 valve are shown in figure 4 for test 
conditions C. Pressure oscillations occur when the valves are opening and closing due 
to them being tested in rigid chambers. The ventricular pressure increases rapidly at 
the start of systole as there is no compliance in the ventricular or pump chambers. 
The pressure oscillation (frequency about 20 Hz) decays over two cycles. It is primarily 
caused by the inertia of the column of fluid in the flow meter; the fluid decelerates 
rapidly when the mitral valve closes. The inertia of the fluid in the rigid aorta also 
contributes to the aortic pressure oscillation which has a smaller amplitude. A small 
oscillation is also shown in the aortic pressure at the end of systole as the aortic valve 
closes. Figure 5 shows the mean pressure difference for the three different pressure 
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Figure 5. The mean pressure dill erence plotted against K5ts forward flow for the BSS 29 eal%e. ", Prr. wrc 
tapping C.  , tapping B. A. tapping A. The error ban show =_ st) =0.15 mm Hg. 
C was less than at the other two tappings. The reduction of approximately 1000 is 
significant at the two highest flows. The error bars (t2 so±0.15 mm Hg) show the 
repeatability of 10 measurements at each flow taken over a period of four weeks. 
Similar results were found for the DM 29 valve. Pressure tapping B was used as the 
standard position for all other tests. 
The mean pressure difference measured in the major orifice of the Bjork-Shiley 
tilting disc valves was lower than in the other two orientations (figure 6). The difference, 
approximately 15%, is significant above 200 ml s-' for the BSS 29 valve. The Os 29 
and bileaflet valves showed no significant change in pressure difference with valve 
orientation. For all the tilting disc valves, the closing volume was less in the vertical 
plane with gravity assisting the valve closure. This is shown in figure 7 for the BSS 29 
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Figure 6. The mean pressure difference plotted against R%ts flow (or different orientations of the BSS 29 
valve. 0. horizontal plane, major orifice; A. horizontal plane. minor ontice;  . vertical plane. The error 











Figure 7. The closing volume of the BSS .9 valve in the honzonial I ht and vertical 1% 1 planes. The error 
bars show a_sosO. 6ml. 
valve. The error bars : 0.6 ml show the repeatability taken over 10 measurements. The 
closing volume also varied slightly with the flow conditions. No significant variation 
with valve orientation was found in the closing volume of the bileatlet valves. 
The pressure flow graphs are shown in figure 8 for all the valves opening in the 
horizontal plane, with the pressure measured in the minor orifice of the tilting disc 
valves. The mean pressure difference is increased by approximately 10% if the average 
is taken between the zero pressure points (1 and 3) as opposed to the zero flow points 
(1 and 4). Figure 9 shows the average regurgitant volumes (closing and closed) for 
the valves in the horizontal plane. 
5. Discussion 
The test rig allows prosthetic heart valves to be tested under standard pulsatile flow 
conditions. The repeatability of the flow and pressure measurements is very good and 
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harc -- ] ft). 
the overall accuracy is limited by the systematic errors due to non-linearity and 
hysteresis in the flow and pressure signals. These errors have been estimated at : 0.3 mm 
Hg and =6 ml s-'. 
The pressure waveforms measured in the ventricle and aorta are not ideal 
and are a consequence of measuring the flow through the valve in rigid chambers. The 
largest oscillation in the ventricular pressure occurs when the mitral valve is almost 
closed, and does not atiect the forward flow measurement. The oscillation is similar 
to waveforms described by Scotten er al (1983) and its amplitude and frequency are 
dependent on the type, size and closing characteristics of the mitral valve under test. 
This initial study shows that the position of the pressure tapping, the valve orienta- 
tion and the time interval selected for averaging the signals all have a significant effect 
on the mean pressure difference. The reduced pressure difference measured at tapping 
C is probably caused by a small fraction of the kinetic energy from the jet being 
recovered as potential energy (Kohler 1975) as previously described in the aortic 
position (Tindale er al 1982). Inside a physiologically shaped ventricle the flow patterns 
will be significantly different, and static pressure measurements will consequently vary. 
For this reason, tapping B closer to the valve has been selected as a standard measure- 
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Figure 9. The average regurgitant volumes for all seven valves opening in the horizontal plane. Z shows 
the values obtained by Scotten et al (1983.19841. Error bars :2 sn. 
ment point. In this position, valve orientation also affects the measurement. The 
reduced pressure measurements found in the major orifice of the Bjork-Shiley valves 
are caused by the jet impinging on the downstream pressure tapping. This effect is 
not detected in the other valves where the discs and leaflets have larger opening angles. 
The mean pressure difference is approximately 10% higher if the averages are taken 
between the zero pressure points (I and 3) instead of the zero flow points 11 and 4). 
This is not surprising as during the short period of time between points 3 and 4 when 
the now is decelerating, the differential pressure is significantly negative (figure 4). 
The graphs of pressure and RMS flow (figure 8) show that valves of the same size have 
similar characteristics. At an RMMS flow of 300 ml s'', the most obstructive valve. BSS 29, 
has a mean pressure difference of 4 mm Hg whilst the least obstructive, BSC 29, has 
a mean pressure difference of 3 mm Hg (zero pressure measurements). The size 27 
valves have an increased pressure difference of 1 mm Hg at 300 ml s-' over the size2_9 
valve due to their smaller orifices. The results from other test centres are shown in 
figure 8. Good agreement is found with the results of Stevenson er a! (1982) and 
Gabbay er al (1978) but the results of Scotten er a! (1983,1984) are systematically 
higher. This could be caused by the different geometries used in the test apparatus or 
the different test fluids used. Figure 7 shows that when gravity assists the valve closure 
in the vertical plane, the closing volume is reduced by between 20 and 30%. In the 
bileaflet valves, no net difference is found in the closing volume as one leaflet is assisted 
by gravity and the second leaflet has to work against gravity. However, synchronised 
photography shows that the lower leaflet closes 30 ms earlier than the upper leaflet. 
This may be an explanation for asynchronous closing described elsewhere (Yoganathan 
et a! 1984). The comparison of the regurgitant volumes in figure 9 for the different 
valves shows that the volumes are less for the smaller valves and also less for the more 
obstructive valves (BSS 29 compared with BSC 29). The closing volumes agree closely 
with the results of Scotten er al (1983,1984). The slightly higher leakage when the 
valve is closed can be explained by a higher ventricular pressure. The effect of the 
shape of the ventricular pressure signal on the closing volume of the mitral valve has 
not been investigated in this study, but the rapid increase in ventricular pressure (figure 
173 
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4) at the start of systole may force additional fluid through the mitral valve before it 
is fully closed. This may explain why results for the closing volume of valves measured 
in an elastic system are lower (Kohler ei a! 1981, Kohler and Schroder 1982). 
The results in this study show that variation in the test conditions can have a 
significant effect on valve function. It is imperative that all the test conditions are 
defined precisely so that the variation between different types of valves can be correctly 
assessed. The variation found between valves of the same size was quite small and it 
is unlikely that differences in pressure measurements of less than 1 mm Hg or differences 
in regurgitant volumes of less than I ml would be noticed clinically. 
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Risume 
Mise au point dun appareil pcrmcttant ('etude dcs protheses ardiaques. Risullats initiaus en position 
mitrale. 
Les auteurs ont developpe un apparcil pcrmetiant d'etudicr It fonctionnemcni des protheses cardt. equcs 
dins des conditions de debit vanable. Cc disposalf utilise une pumpe semo"contrdtcc pour simuler uni 
variation 'physiologique' de debit i travers la valve. La difference de pression dc pan et d'autte de la valve. 
ainsi que It debit ,i tracers Ia valve. sons mesures pour evaluer son 
fonctionnement. La difference dc pression 
moyenne. It debit direct efficace et Its volumes dc regurgitation soot alcules i 1'aide d'un ordinateur. Au 
coup dune etude intuale. sept protheses mecaniques courantes (dimensions 9 et 27 mml ont ete evaluees 
en position morale pour ctnq conditions differences de debit. t-a difference de pression moycnne em function 
de la pression de courant insene. de I'onentaaon de Ia valve et de l'intersalle de temps d'echint illonage 
necessaire pour Its signaux. A%cc cenaines valves. Icur onentation attccte let volumes dc regurgtuuon. 
Ces variations (I0-25': ) sont comparables aus differences mesurees entre its valves individuelles. Les 
conditions de test doisent donc eire specifiies avec beaucoup de solo afin de permetire une comparaison 
precise du fonatonnement des salves. 
Zusammenfassung 
Entwicklung eines Funktionstestgerätes für Herzventil-Prothesen. Erste Ergebnisse bei mitraler Lage. 
Eine behelfsmäßige Vorrichtung zur Untersuchung der Funktion von Herzventil-Prothesen unter pulsieren- 
den Strömungsbedingungen wurde entwickelt. Bei der Vorrichtung wird eine Pumpe mit Servoregelung 
verwendet, um eine physiologische Welleniorm der Strömsung durch das Ventil zu erzeugen. Die Druck- 
ditterenz quer zum Ventil und die Strömung durch die Ventile wurde zur Bestimmung der Funktion des 
Ventils gemessen. Die mittlere Druckdifferenz, der mittlere 
quadratische Fehler bei der Vorwärtsströmung 
und die zurückfließenden Volumina wurden mit Hilfe eines Computers berechnet. In der Anfangsphase 
wurden sieben bekannte mechanische Prothesen (Größe 29 und 27 mm) in mitraler Lage unter fünf 
verschiedenen Strömungsbedingungen ausgewertet. Die mittlere Druckdifferenz war dabei abhängig von 
der Stelle, an der hinterher der Druck gemessen wurde, sowie von der Ausrichtung des Ventils und dem 
Zeitintervall, das für die Mittelwertbildung der Signale verwendet wird. Die Ausrichtung einiger Ventile 
beeinflusste sogar die zurückfließenden Volumina. Diese Schwankungen (10-25%) waren von ähnlicher 
Größenordnung wie die zwischen einzelnen Ventilen gemessenen Unterschiede. Um die Funktion der Ventile 
genau vergleichen zu können, müssen die Testbedingungen sehr sorgfältig gewählt werden. 
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In Vitro Evaluation of Six Mechanical and Six Bioprosthetic Valves 
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Summary 
The in vitro function of 6 tissue valves and 6 mechanical 
valves (all size 29) was assessed in a purpose-built pulse du- 
plicator under different pulsatile flow conditions. Valve 
function was analyzed by measuring the mean pressure d, f" 
ference across each valve during forward flow, and the re- 
VIM flow through each valve during valve closure (dynamic 
regurgitation) and in the fully closed position (static regurg, - 
ration). Although valves of the same type showed similar 
characteristics, there were significant differences in function 
between different types of valves. Porcine valves showed 
much higher forward flow pressure gradients than pericardial, 
tilting disc, or biteaflet mechanical valves. However, the por- 
cone valves showed least regurgitation, with pericardial valves 
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evaluation 
In vitro testing of heart valves remains the only way of en- 
suring satisfactory function prior to production for animal 
and human implantation. The established methods of in 
vitro evaluation involve function testing at steady and pul- 
satile flows with assessment of pressure drop and regurgita- 
tion, and also durability studies in fatigue testers. 
The literature abounds with data on individual valves at 
various sizes (2.6.9), but it is often difficult to compare 
this data due to variations in the apparatus and methods 
used to test the valves. Furthermore, the rapid progress 
made in heart valve designs, with a greater number of 
valves available for use, has led to further difficulty in cor- 
relating the profusion of data available. 
The recent introduction of low profile pericardial valves 
(6), modified orifice porcine valves (7) and bileaflet me- 
chanical valves (5) illustrates the various design options 
available to valve manufacturers in order to enhance valve 
performance. 
This study was undertaken in order to consolidate knowl- 
edge concerning the in vitro performance of these newer designs by comparing 6 mechanical and 6 bioprosthetic designs in the same function test system. The 29 mm mi- 
tral valve was selected as being representative of a useful 
valve size which is often selected clinically and which falls in the middle of the size range available from the manufac- 
Received for publication: November 14,1986 
turers. The newer valves were compared to those which are 
in widespread use throughout the world in order to produce 
a clear insight into their possible functional advantages. 
Methods 
The function of 6 tissue valves and 6 mechanical valves (I I size 
29 mm and one size 30 mm) was assessed under pulsatile flow 
conditions in the mitral position of a purpose built pulse duplica- 
tor. Details of the valve tested arc given in Table 1. Valve function 
was assessed by measuring the differential pressure across each valve 
during forward now and by measunng the reverse flow through 
each valve. The reverse flow was measured in 2 parts. dynamic re- 
gurgitation during valve closure and static regurgitation when the 
valve was closed. The function test apparatus (I)) is shuwn schema- 
tically in Fig. I. The essential features of the apparatus were as 
follows: 
The pulsatile floss was produced by a purpose built servo con- 
trolled piston pump' 161. The flow through the valve wa. measured 
with an electromagnetic flossmeter=. The mean pressure difference 
across the test valve was measured with a differential ttansducer3 
with the upstream pressure measurement falters 25 mm from the 
valve and the downstream pressure measurement taken 50 mm 
from the valve. Direct measurements were made of the pressure 
in the ventricular. aortic and atrial test sections to establish the 
correct test conditions. 
The mechanical valves were positioned so that opening and closure 
occurred in the horizontal plane in order to eliminate the effects 
of gravity. The downstream pressure measurements were made in 
the minor orifice of the tilting disc. a major orifice of the bilcatlet 
valves adjacent to the strut in the ball and cage valve and adjacent 
to a post in the tissue valves (Fig. 21. The measured pressure and 
flow signals and the displacement and velocity signals from the 
pump were collected for a period of 20 seconds on an Apple 11 
microcomputer and stored for subsequent analysis. Each valve was 
tested under 5 different pulsatile now conditions (Fig. 3) corres- 
ponding to cardiac outputs of between 3 and 9 1. min-'. The fluid 
medium used for all tests was 0.9% sodium chlonde solution. A 
video camera (Panasonic WVP Al) was used to analyze the open- 
ing and closing action of each valve during the test cycle allowing 
still frame assessment at intervals of 20 ms. The pressure difference 
and flow signals were analyzed by calculating the average waveform 
from the data collected and by defining 5 points on these wave- 
forms during each cycle (Fig. 4). Point I defines the start of for- 
ward flow and Point 2 the start of positive differential pressure. 
For a mechanical valve these points coincide but for the tissue 
valves a small positive forward flow is observed before a positive 
differential pressure could be measured. This is due to forward 
displacement of the fluid as the valve leaflets relax when the pres- 
sure in the ventricle is reduced. Point 3 defines the end of the posi- 
tive pressure signal and Point 4 the end of forward flow. The dif- 
ferential pressure becomes negative for a short period at the end 
'Cardiac Development Laboratories, 
2Gould SP 2201, 
3Caeltec 3CT special, 
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Fig. 1 Diagram of the function test apparatus 
of forward flow as the flow is decelerating. In this study the mean 
pressure difference and root mein square (RMtS) forward flow were 
calculated between points 2 and 3 and points 2 and 4. Point 5 de- fine, the end of the reverse flow through the valve dunng closure. The dynamic regurptant during valve closure was calculated between Points 4 and 5 and the static regurgitittun. when the valve was 
Closed. was calculated between points 5 and 1. 
The effective unties area for each valve was calculated for each flow 
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Bi leaflet Tissue 
Fig. 2 Orientation of the valves and position of the pressure meas. 
urements for the tilting disc, bileatlet and tissue valves 
Results 
The mean pressure difference across each valve was plotted 
as a function of R. %IS forward flow and given for the mech. 
anical valves in Fig. 5 and for the tissue valves in Fig. 6. 
The repeatability of the measurement was found to be 
=SD : 0.15 mmHg. The pressure measurements were sys" 
tcmatically lower during the longer interval between points 
and 4. The measurement included the short period of 
time that the flow was decelerating when there was a small 
negative differential pressure. This negative pressure starts 
the closure of the valves while there is still some forward 
flow. Four of the mechanical valves. 13SM. OS. ST and 
O. M. had almost identical forward flow pressure differ- 
ences while the BSS valve, which is no longer manufac- 
tured. had a marginally higher pressure drop (Fig. 5). 






0 0.2 0.4 0.6 0.8 0 0.2 0.4 0.6 
Times Times 
Fig. 3 Five flow waveforms used for test- 
ing valves (negative flow shows flow 
through the mitral valve). Waveform A- 
60 beats per min (BP Min), stroke volume 
(SV) 60 m1 
Waveform B- 70 BP Min. SV 70 ml 
Waveform C- 80 BP Min, SV 80 ml 
0 0.2 0.4 0.6 Waveform D- 100 BP Min, SV 80 ml 
Time-s Waveform E: 120 BP Min. SV 80 ml 
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Table 2 Variation in effective orifice areas with flow for tissue valves 















Tilting disc Blork"Shiley Disc 29 
Bjoric Shiley Monastrut 29 
Tilting disc Ommiscience 29 
B. ieaflet St. Jude 29 
Bileaflet Duromedics' 29 
Ball and cage Starr Edwards 30 
Pericardial lonescu Shiley low profile 29 
Pericardial Hancock pericardial 29 
Pericardial Mitral Medical 29 
Porcine Carpenuer"Edwards 29 
Porcine Hancock 29 

















2.3 2.1 1.5 
2.3 2.3 1.7 
2.6 2.7 1.9 
2.8 3.2 2.0 
3.0 3.5 2.0 
Fig. 4 Pressure and flow signals for 
BSS29 valve (test conditions - wave- 
form C) showing the time intervals 


























The SE ball and cage valve had a much larger forward flow 1 mm at the highest flows. The 3 porcine valves all showed 
pressure drop, confirming that the ball causes a significant much higher pressure differences with the 
CE valve marginal- 
obstruction to forward flow. All 3 pericardial valves had ly lower than the H or W valves. At the 
lower flows, the 
similar pressure differences with a variation of less than leaflets of the tissue valves did not open 
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Fig. S Mean pressure difference plotted 
against PMS forward flow for 6 mechan" 
iCal values. " mean pressure measured 
between points 2 and 3. a mean pressure 
measured between points 2 and 4 
Fig. 6 Mean pressure difference plotted 
against RMS forward flow for 6 tissue 
valves. " mean pressure measured between 
points 2 and 3, " mean pressure measured 
between points 2 and 4 
reduced effective orifice area (Table 2). The marked differ- valves (between 0.5 and 1.5 mmHg lower). Porcine valves 
ences in the pressure drops between the 3 types of valves have consistently greater pressure differences. 
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Fig. 7 Mean pressure 
difference plotted 
against RMS forward 
flow for the 3 groups 
of valves mechanical 
(excluding SE30 and 
BSS29) pericardial 
and porcine 
urements was t2 SD t 0.7 ml. Reverse flow through the 
closed mechanical valves occurred between the rigid occluder 
and the annular ring. In the closed porcine valve, reverse 
flow occurred between the tissue and the cloth on the in- 
side of the stent. There was negligible leakage through the 
closed pericardial valves (Fig. 8). Dynamic regurgitation. 
while the valve was closing, was similar in the mechanical 
and pericardial valves. between b and 8.5 ml, whilst in the 
porcine valves it was much less. The total regurgitation was 
lowest in the porcine valves. 5 to 7.2 ml. slightly higher in 
the pericardial valves. 7 to 7.8 ml. and largest in the mech- 
anical valves, 7 to 11.2 ml. 
Dicussion 
It is difficult to simulate the complex physiological condi- 
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making accurate measurements of the pressure across, and 
}low through! the valves under test. This is reflected in the 
different types of test apparatus that have been used to as- 
sess valve function (1,2,3,6,8). Both positive displace- 
ment pumps which control flow (I, 2,6) and pneumatic 
actuators which control pressure (3,8) have been used. In 
some test rigs left ventricular geometry has been modelled 
(3,6) while in others rigid cylindrical test sec: ions have 
been used (1,2,8). The rigid cylindrical chambers used in 
our test apparatus allowed the instantaneous flow through 
the mitral valve under test to be measured with an electrc- 
magnetic flow probe positioned in a tube several centimeters 
downstream of the valve under test. The boundary condi- 
tions for flow in the left ventricle were not simulated and 
the inertia of the fluid in the rigid test sections caused pres- 
sure peaks and oscillations when the flow was accelerated 
and decelerated as the valves opened and closed (Fig. 4). 
The oscillations do not occur clinically or in a test rig 
with an elastic ventricle which is pressure controlled (3). 
In particular. the rapid rise in ventricular pressure found 
in our test rig at the start of systole may have had an ef- 
fect on the closing characteristics of the mitral valves. 
The 
results obtained from these studies demonstrate a clear 
stratification in in-vitro performance between the 3 major 
valve types. 
The mechanical valves (excluding the Starr Edwards valve) 
showed a consistently lower pressure drop than the biolo- 
gical valves at each flow studied. The porcine valves were 
associated with the highest pressure drop and the pericar" 
dial valves fell between these 2 but pressure drops were 
closer to those observed with mechanical valves. The close 
banding of the pressure drop results for each valve group 
(typically less than Z mmHg at high flows) suggests that 
valves in the same group would not be differentiated clini" 
cally. The variation of the orifice area with [low for the 
tissue sakes is caused by the larger pressure differences 
forcing the leaflets further open at high glows. This con- 
firms that flows should he specified when using derived ori" 
lice areas as a parameter of valve function (8). 
Studies of the dynamic regurgitation during closure again 
produced stratification of the results of the 3 valve types 
Fig. 8 The average regurgitant volumes 
for the valves. The dynamic regurgitant 
volume is shown as the valve is closing 
and the static regurgitant volume while 
the valve is closed 
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with no major difference within each valve group. The por- 
cine group had a significantly lower dynamic regurgitation 
than the other 2 types but this is not surprising as the leaf- 
lets did not open as wide. 
While some regurgitation during valve closure is characteris- 
tic of all valves, this is influenced by the rate of closure 
and showed some variation with the different flow-time 
waveforms used. The measurements of dynamic regurgita- 
tion during closure are similar to the results of Itblker and 
co-workers (6,7) but were higher than those found in a 
test rig with an elastic pressure-controlled ventricle (3,4). 
In our test rig the rapid rise in ventricular pressure and the 
pressure peak at the start of systole may have forced more 
fluid back through the valves during closure than would 
normally occur clinically. It is very likely that the dynamic 
regurgitation during mitral valve closure is dependent on the 
rate of rise of ventricular pressure. Other factors, such as 
orientation (1,5) of the valve, will also affect measurement 
of dynamic regurgitation. 
Static regurgitation was lowest in the pericardial valves. 
When completely closed. fluid leakage occurred through 
the porous material of the frame-covering of the biopros- 
thetic valves and was greater in the porcine valves where 
there is continuity between the porous material below and 
above the attachments of the porcine aortic leaflets. This 
phenomenon would be present early after implanation but 
should rapidly diminish with the build-up of fibrin deposits 
on and within the frame and as the process of endotheliali- 
zation of the frame-covering progresses. The pericardial 
valves have almost no continuity of the frame-covering on 
each side of the closed leaflets and the leaflets form a con- 
tinuous surface over the outside of the frame which seals 
the valve closed. In addition. they have a suture placed so 
as to bring the pericardium of the leaflets into apposition 
at the top of the posts. thus eliminating static regurgitation 
to a great extent. 
With the mechanical valves, static regurgitation occurs be- 
tween the occluder and the annular ring and is considered 
to be an essential feature of the design. allowing "washing" 
of the sealing area. Static regurgitation with mechanical 
valves remains constant after implantation. 
In this study, we have used 2 parameters to analyze valve 
function. forward flow pressure drop and total regurgitation. 
For pressure drop. the order of merit for the valve is mech. 
anical, pericardial and porcine (lowest to highest), whilst for 
total regurgitant volume, the order is reversed, i. e., porcine. 
J. Fisher. I. J. Reece. and D. J. Wheatley 
pericardial and mechanical (lowest to highest). In recent 
studies, a single parameter has been used to analyze valve 
function by combining energy losses during forward and 
reverse flow (6). In vivo, the heart may tolerate energy los- 
ses across the mitral valve, due to relatively small regurgita- 
tion, better than energy losses due to pressure drops during 
forward flow. This is because a normal left ventricle is able 
to compensate for energy losses due to regurgitation by in- 
creased work, whereas the consequences of energy loss asso- 
ciated with forward flow pressure drop are reflected in raised 
left atrial and pulmonary venous pressures. When considering 
the in-vivo function of these valves in the mitral position, 
we believe that forward flow pressure drop is the more im- 
portant determinant of satisfactory function and cardiovas- 
cular hemostasis. 
We have studied the mechanical function of these valves in 
vitro. The overall clinical function of the newer valves must 
await the results of clinical implantation studies currently 
underway. 
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Comparison of Doppler ultrasound velocity 
measurements with pressure differences across 
bioprosthetic valves in a pulsatile flow model 
IA SIMPSON, ' J FISHER, t IJ REECE, t AB HOUSTON, ' I HUTTON, ' DJ WHEATLEYt 
From the University Departments of *Medical Cardiology and tCardiacSurgery, Royal Infirmary, Glasgow 
SUMMARY Continuous wave Doppler ultrasound was used in vitro to assess the pressure differences 
across four different cardiac bioprosthetic valves in a pulsatile flow test apparatus. Valves were tested 
under four different flow conditions. Pressure differences were calculated from the maximum flow 
velocity measured by Doppler ultrasound and correlated well with the pressure differences measured 
directly in the flow model (r=0.98). Thus Doppler ultrasound can accurately measure pressure 
differences across bioprosthetic valves in vitro. 
There has been much interest in assessing 
bioprosthctic valve function in vitro by determining 
flow profiles and pressure gradients across the valve 
prostheses in order to assess forward now 
characteristics and degree of mechanical obstruction. I 
The valuable information gained from these studies is. 
however, limited. since they cannot easily be 
extrapolated to the clinical situation, and few in vivo 
haemodynamic data are available. Doppler ultrasound 
has been used accurately to measure blood flow 
velocities both in vivo and in vitro= and has potential 
therefore in measuring the velocity of the flow jet 
across prosthetic valves. This has been successfully 
used in the clinical situation in a small number of 
patients to assess prosthetic valve gradients3'3 and 
compare them with results obtained at cardiac 
catheterisation. No in vitro data are, however. 
currently available to support the correlation of 
Doppler ultrasound flow velocity measurements with 
pressure differences across these prostheses. 
Appreciable differences in valve function and design 
exist between the traditional porcine bioprostheses and 
the new pericardial bioprostheses, ° and it is therefore 
of considerable importance to establish the validity of 
the Doppler technique for different bioprosthetic 
valves under a variety of pulsatile flow conditions. 
Address for correspondence and reprints: Dr IA Simpson. 
University Department of Medical Cardiology. Royal Infirmary, 
Glasgow G31 2ER. Scotland. 
Ke, " words: Doppler ultrasound; velocity measurements; 
pressure differences; bioprusthcses; flow model. 
Material and methods 
ýý 317 
A pulsatile flow apparatus had been designed to assess 
the forward now pressure drops and regurgitant 
volumes through prosthetic valves in the mural 
position. The layout of the test model is shown in rig 1. 
The pulsatile flows are produced by a purpose built 
servo controlled piston pump (Superpump Cardiac 
Development Laboratory. Victoria. Canada). The 
pressure difference across the valve is measured with a 
differential transducer (Gaeltec 3CT special. 
Dunvegan. Scotland) with the upstream pressure 
tapping 25 mm from the valve and the downstream 
pressure tapping 50 mm from the valve mounting ring. 
The flow through the valve is measured with an 
electromagnetic flowmeter (Gould SP2201) with a 24 
mm probe. The pressure and flow signals are digitised 
and stored on an Apple microcomputer for subsequent 
analysis. Data are collected over a period of 20 cycles. 
and a mean waveform calculated for each signal. 
In this study the valves were tested under four 
different flow conditions (fig 2) corresponding to 
cardiac outputs of between 4.5 and 9 litre-min-t. The 
peak flow and peak pressure differences were 
measured for all four waveforms, and in addition the 
end diastolic flow and pressure were measured for 
waveforms A and B. The Doppler ultrasound 
transducer was positioned in a Perspex plate aligned 
along the axis of the test section parallel to the through 
valve flow and the transducer sealed in position 
throughout the study (fig 3). The valves were tested in 
0.9% saline that was repeatedly aerated during the 
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Doppler ultrasound in a bioprosrheric flow model 
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study in order to provide satisfactory ultrasound 
reflection for the Doppler recordings. The Doppler 
transducer used was a2 MHz continuous and pulsed 
wave double piczoelcctnc crystal probe (Vingmed, 
Norway) used in the continuous wave mode, where 
ultrasound is continuously transmitted from one 
crystal and the reflected ultrasound continuously 
received by the other. The Doppler unit used was a 
Vingmed Alfred velocimeter, which incorporates a 
quadrature demodulator enabling analysis of both the 
direction and magnitude of the Doppler velocity shift. 
The Doppler velocimeter was interfaced to a Doptek 
spectrum analyser. which includes a flow separation 
outphaser allowing acceptance of the quadrature 
Doppler signal for subsequent analysis. For more 
accurate real time analysis of the Doppler signal the 
spectrum analyser provides a visual display of the 
whole range of frequency shifts throughout the 
simulated cardiac cycle. The spectrum analyser 
incorporates a conversion of frequency shift to 
velocity for the 2 MHz transducer used, and from the 
spectral display therefore the peak flow velocity could 
be directly measured using a real time movable cursor. 
From the measured peak flow velocity the pressure 
difference across the prosthetic valve was then 
calculated from the peak flow velocity measured by 
Doppler using the modified Bernoulli equation. ' " To 
319 
allow for the lower mass density of 0.9% saline 
compared with blood, the equation used was P= 
3.75V' where P= pressure drop in mmHg and V- 
peak velocity in m s'' rather than P= 4V' as would be 
used in vivo. These results were compared with those 
obtained from direct pressure measurement within the 
pulsatile now model. 
Four bioprosthetic valves (size 29 mm) were studied 
in the test apparatus. They included two new 
pencardial bioprostheses. Hancock pericardial and 
low profile loncscu-Shiley. and two porcine 
bioprostheses, the new Wessex bioprosthesis and the 
more traditional Carpe ntier"Edwards. 
Results 
Satisfactory Doppler signals were obtained from all 
four valve prostheses, and the Doppler recording (fig 
4a) reproduced similar flow waveforms to those 
obtained from the electromagnetic flow meter (fig 4b). 
Measured Doppler velocities ranged from 76 cm-s-' to 
264 cm"s-I with a mean of 152 cm-s-' for the poreine 
bioprostheses and from 50 cm- s-' to 184 cm-s- with a 
mean of 105 cm-s-' for the pericardial bioprostheses. 
These correspond to the measured pressure differences 
of 2.5-27 (mean 10.4) mmHg for the porcine 




0 pericardial bioprostheses. As expected. using both Doppler and direct in vitro measurements significantly 
higher velocities and pressure differences were 
obtained with the porcine bioprostheses than with the 
pericardial prostheses. The relation between the 
measured pressure difference and that derived from the 
Doppler flow velocity for all valves is shown in fig 5. 
The correlation between the two methods was 0.98 
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FIG 5 Comparison of the pressure differences at each flow 
waveform measured by Doppler ultrasound and directly in 
theJlowmodel. (S)Carpentier-Ed. wards: (C)Hancock 
pericardial: (  )Iow profile lonescu-Shiley; (C)Wesse. c 
bioprostheses - 
Doppler ultrasound has major potential in the 
non-invasive haemodynamie assessment of 
bioprosthetic valve function, and its accuracy in 
assessing transvalvar now velocities and pressure 
gradients in these valves must be clearly established. 
In order to derive the pressure difference from the 
Doppler now velocity using the modified Bernoulli 
equation several assumptions have to be made. The 
equation fails to account for viscous losses due to 
fraction. non-Streamlined through vale now. losses 
due to turbulence. contraction of the selocuy het, and 
velocity of fluid proximal to the vakc. Despite these 
assumptions, however. our results were within 3 
mmHg of the measured pressure difference in all 
cases. Doppler ultrasound tended to slightly 
overestimate the me sured pressure difference in three 
of the vales studied, which may be explained by the 
velocity profile of the jet. ° This was not found with the 
Wcssez bwprosthesis, which has a prominent muscle 
shelf and may slightly affect the orientation or velocity 
profile of the het. 
Though we found a goixi correlation in vitro the 
potential for greater variation exists in vivo 
particularly with the orientation of the ultrasound 
beam in the direction of maximum through valve flow. 
Examination of mitral bioprosthescs from the apical 
position and aortic bioprosthcscs from the 
suprasternal. right parastemal. and apical positions 
should. however, allow the Doppler ultrasound beam 
to be oriented sufficiently close to the direction of 
blood flow to prevent appreciable underestimation of 
pressure gradients. The few available studies using 
Doppler ultrasound to assess valve function in vivo 
have shown a reasonably good correlation with results 
obtained at cardiac cathctcnsation and would therefore 
suggest that in most cases this does not present a major 
problem. is 
Further in vivo studies are ncccssarx to validate the 
technique in the clinical situation, but we have shown 
that Doppler ultrasound can accurately measure 
pressure differences in vitro, and the potential 
therefore exists to provide a non-invasive 
haemodynarnic assessment of biopro`thetic function 
in vivo. 
185 
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A comparison of experience with the Hancock and Ionescu-Shiley 
low-profile pericardial bioprostheses 
I. J. Reece. J. Fisher. B. Sethia. K. I. MacArthur. and D. J. Wheatley 
Department of Cardiac Surecry. Royal Infirmary. Glasgow (Scotland) 
The evolution and refinement of the design and patients completed a comprehensive questionnaire 
construction of bioprosthetic heart valves have pro- at regular intervals and were contacted directly if 
gressed so rapidly that the surgical community has there were any unresolved problems or difficulties 
been unable to keep pace in terms of clinical oval- with interpretation of questionnaire responses. Fol- 
uation. While porcine vales with improved hic- low-up closed at the end of November 1984. 
modyamics (6). lower profile (9) and zero pressure 
chemical fixation (2.3.7) represent one path of Mortality 
development. the introduction of the pericardial Lms'rri /i/' ýr)nttt'll-. SJiiýc't'. ernllr 
bioprosthesis (8) and. more recently. its low profile ßct%%ccn February 1982 and September 1984.98 variants represents another (I3). The arguments for 
and against bioprostheses as opposed to mechanical 
Li IS sakes were implanted in 36 patients. Patient 
valves arc not considered in this discussion. rather, 
data are given in Table I and the operations per- 
this paper addresses the questions: I. Is there any 
formed in Table 2. 
significant difference in early clinical results oh- 
In the LPIS group there ýýerc four hospital deaths 
tamed with the loa-profile lonescu-Shiley and the 
( ithin 30 days) (4.7u ). Three of these deaths %%ere 
Hancock pericardial vales in the first two scars non-valve-related: one 
from septicaemia. one from 
and. 2. Does the early performance of* these ýalvcs 
lo" cardiac output and possible allergic reaction 
indicate possible advantages over other clinical and one renal 
failure and gastro-intestinal haemor- 
rhage. However. the fourth death was secondary to '' types ofbioprostheses 
The surgeons of the University Department of Fable I. Fallen, data of imrlaniauon of lou profile fonescu- Cardiac Surgery at the Glasgow Royal Intirman, Shiley tLPISI and tlanrock rencardial ttiP) htopro+the e, 
Scotland. began a prospective evaluation of the low 
profile lonescu-Shiley pericardial bioprosthesis LPIS HP 
(LPIS) in February 1982. This valve was selected Patients 86 81 
for evaluation because of its low gradients at small Mean age 54.8= 10.8 57_ 11.2 
annulus diameter, its uniform full open orifice and Age range 26-72 21-75 
the symmetrical characteristics of cusp movement. 
M: F ratio 0.95: 1 0.84: 1 
Total follow-up 146 pt. years 69.3 pi. years It was felt that this valve offered some advantages Mean follow-up 1.3 yrs pt 0.89 yrsrpt 
over the Carpentier-Edwards porcine and Standard 
lonescu-Shiley valves then in use. in particular in 
terms of haemodynamics. thromboembolic rates Table 2. Operations performed. 
and ease of insertion. Some six months later a pro- LPIS HP 
gramme of evaluation of the Hancock pericardial Mitral replacement 36 (42%) at (51%) bioprosthesis (HP) was begun, for the reasons stated 37 (43%) 31 (38%) above and to compare the results of these two 
Aortic replacement 
valves in similar groups of patients over a similar Mitral & aortic replacement 12 (14%) 9 (11%) 
time frame in the same unit. At about the same Tricuspid replacement 1 (1%) 0 
time we began using new porcine bioprostheses and Replacement+ 11 (13%) 8 (10%) 
the results obtained with these three valves form revascularisation 
the basis of this study. All patients were followed Aortic replacement requiring 4119(8%) 3,40(7.5%) 
closely and were reviewed regularly. In addition. patch annuloplasty 
I 
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a stroke at four dais post-operati%cly and is consid- 
ered embolic. though post mortem as inconclu- 
sive and the mitral prosthesis and atrium were free 
of thrombus. Late death occurred in four patients 
(4.9%. 10 of hospital survivors). Death was considered 
to be valve-related in three cases (2.1%/patient 
year). Two deaths occurred at reoperation. one for 
removal of centrally regurgitant aortic and mitral 
prostheses at three months and the other for 
prosthetic endocarditis at 32 months. 
One patient died with cardiogenic shock from in- 
farction. No post mortem was obtained and this 
death was assumed to be valve-related. The fourth 
patient died from a subdural haematoma following 




Between November 1982 and September 1984. 
90 HP valves \%-ere implanted in S1 patients. Pa- 
tient data are given in Table I and operations per- 
formed in Table 
_'. There %%ere three hospital deaths (3.70. None of 
these \%ere considered vale-related. One patient 
died from left %entricular rupture during mitral re- 
placement. one from respirator failure and an- 
other from respirator\ failure and gastro-intestinal 
haemorrhage. Late death occurred in three patients 
(3.3"ö of hospital sur%i\ors). To of these deaths 
were considered to he \ahc-related (_. 9" patient 
%ear). One patient died of cerebral emholi, m see- 
ondarý to prosthetic endocarditis at one month. an- 
other from sý ncope and cardiac failure at one 
month. Post mortem ' as not obtained. The third 
death \/as due to arrh\thmi; t it to month.. 
Comparison of mortalith 
While both croups of patients ha'e an acceptably 
lo'. c hospital mortalit'. 'yith only one "'. al, e- 
related" death in the LPIS croup. the'. al%e-related 
late mortality has also pro'. ed to be similar at 
2. S"n patient year for the HP group and 2. I ' pa- 
tient year for the LPIS group. This difference is not 
statistically significant and is yert similar to results 
obtained with the new porcine valve in Glasgow in 
the same time-frame (1.7%' patient year) and with 
bioprostheses reported from other centres (1.10. 
I I). 
Complications 
Loin profile /orrescu .S rrlý r,, rrý; rp 
Over the follow-up period, five episodes of endo- 
carditis occurred in five patients (3.411, 'o patient 
year), three required reoperation (2.19/o/ patient 
year) and one patient died. In two patients. (both 
aortics) endocarditis was controlled medically and 
valve function remains satisfactory. If the one pa- 
tient in whom late endocarditis occurred is exclud- 
ed (32 months), all other episodes occurred within 
"3., 
three months of operation. The actuarial freedom 
from endocarditis as 96 at 30 months. 
Thromboembolism occurred in three patients 
(three episodes) all within three months of opera- 
tion. One episode occurred at four days after mitral 
replacement and was fatal: another six weeks after 
mitral replacement and the other one month after 
mitral replacement. These last two patients have 
made a satisfactory recovery. All patients were an- 
ticoaeulated at the time of the embolism. The inci- 
dence of thromboembolism was 2. l% patient year 
and the incidence of fatal thromboembolism 
0.7°ýipatient year. Actuarial freedom from throm- 
boembolism was 96' b at 30 months. The incidence 
of haemorrhagic. anticoagulant-related episodes is 
considered by mans to be a valve-related complica- 
tion and is included here for completeness. This 
complication occurred in three patients (2. I"° pa- 
tient year) and episodes were minor in all cases. 
Paravalvular leak occurred in four patients (4.9"n of 
hospital survivors) and required reopcration in 
three. One patient had paratalhul. ir leak associated 
sloth recurrent endocarditts three seeks after aortic 
replacement. another des eloped a leak three 
month, after aortic replacement and one patient 
had a mitral para, alsul, tr leak and undensent re- 
operation at one sear. In one other patient , with an 
aortic implant. the leak is haemodýnamicall} un- 
important at present. 
\'al\e failure not related to endocarditis but re- 
quiring reoperanon %sas ob, en cd in three patients 
(lour sakes). In one patient documented prosthetic. 
aortic and mitral leaks. presumed to he transsalsu- 
lar. \sere oh, ened at three month,. This patient 
Asa, in cardiac fatlure and at reoperatton. from 
%%hteh he did not recoser. no parasalsular leak, 
%sere found. Both vale, \%ere e\planted and re- 
placed \sith l3jörk-Shile\ , ales but he died in low- 
output. These vales "ere e\amined thoroughly 
but did not appear to he rccureitant. In the second 
patient. one leatlet ut the 2) mm mitral sale as 
torn and prolapsed at 27 month, (Figures la and h). 
Fit;. Ia.. 9 mm LPIS mural %ake excixd at 227 months kith a 
torn cusp. Other cusp attachments appeared sausiactor% 
I 
234 / A, ullr /c . 1u/gýl -. l'iNh 
I i.: I Ii. Lcjl. cf produiine m. ijor 
the same calk. 
This tear %%*as similar to those obsencd %%ith the 
Standard lonescu-Shilcy %alkc and reported bý 
Gabbas et al. (5). In the third patient. tears at both 
posts produced a prolapsed leaflet and smaller tears 
'ýcrc visible in one attachment of each of the other 
leallcts (Ficures 2a and h). This patient ýýas knoý%n 
U. 'a. Similar prulap, c in .i "+ mm LI'IJ mrtral anc týplart- 
cd at ý' rnunt`t-,. 
Fig. 2b. In this case (see 2a) scmmetrical tears ý%ere found on 
each side of the prolapsed leaflet and on one attachment of each 
of the other leaflets. 
to ha%c mural prosthetic rceureitation at 14 
months hut required urgent operation when sudden 
deterioration occurred at 32 months. The incidence 
of vale failure was therefore 2. l% patient car and 
freedom from valve failure 96°ö at 30 months. 
In the LPIS group of patients. mean NYHA 
Functional Class improved from 2.7 = 0.6 (60% of 
patients in Class III or IV) to 1.3 - 0.2 postopera- 
tively and only one patient in Class III (none in 
Class IV). Event-free survival was 839% at 20 
months. 
Ilanc'ock jrericarclial grotip 
Four patients developed endocarditis in the fol- 
low-up period (5.7"Impatient year). Reoperation 
was required in one patient at three months follow- 
ing aortic replacement. This patient presented ý%ith 
cerebral embolism. In two other patients. early en- 
docarditis (at t"o and three months) as successful- 
ly treated mcdicallý but one other patient died 
from septic cerebral embolism one month alter aor- 
tic and ntitral replacement. One of the medicallý- 
treated patients also had in embolism to the Icnio- 
ral ir, cr\ requiring opcrati%e remo\al. The inci- 
dence of endocarditis requiring re-replacement as 
therefore 1.4"n patient 'Sean but in three ofthe four 
patients. endocarditis as associated \%ith emho- 
lunt (4. ', "n patient year). The incidence of fatal en- 
docarditis \%as I. 4"n patient scar. : \ctuarial I-ree- 
Jont from endocarditis %ýas')4'i at :0 month,. 
Thromhocmholi, tn occurred in four patients 
(5,71n patient sear) hut as associated \%iih endo- 
carditis in three instance,. The only non- 
endocarditis-related episode occurred iiiree months 
.liter 1111M 1i replacement. One patient died of cere- 
bral i irowboernholism and cndocardius (I. 4"n pa- 
tient 'ear incidence of fatal thromboembolism). 
Actuarial freedom from thromboembolism as 
at 30 months. llaernorrhaeic complications 
'ere not seen in the HP group. Paraýakular leak 
was obser\ed in four patients (5"n of hospital 
sunisors) though none have Lei required reopera- 
non. 
There have been no value failures in the Han- 
cock group though the total follow-up is sill small 
and the period where tissue failure may begin to 
occur has vet to be reached for the majority of pa- 
tients. 
Mean preoperative Functional Class was 
2.5 - 0.6 (60% of patients in Class III or IV) and 
this improved to a mean post-operative value of 
1.2 = 0.3 with only one patient in Class 111. Ac- 
tuarial event-free survival wyas 87116 at 20 months. 
Comparison of results 
Table 3 summarises the results for both the peri- 
cardial valves a new porcine bioprosthesis in use 
since December 1982 (12). There was no statistical- 
i:;, ) 
RtYt t" rf J/. .1t unlJ'U/fta/l rr/t"lf't"Ift"ift t' tllf%1 
Me %%Jlp ry 4 t/qlllr'gt'tt If"S/tlh't 
'rable 3. Summan- of result... 
LPIS 
Operative mortality 4.7"6 
Late mortality 4.9"60 
Valve related 2.1". 6"" 
late mortality 
Role of thrombo- 2.1%0" 
embolism (TE) 
Actuarial freedom 96% 
from TE 
Rate of endocarditis 3.4%00 
HP tý'ýýxcý 
3.7". 0 6.5"ö 
3.8^ö' a°0' 




Actuarial freedom 96% 94 b 
from endocarditis 
Rate of rcoperation 4.806"" 





E, cnt"I'rcc survi%al 85"6 87'b 93^n 
2 3: 
group and is probably a manifestation of the 
shorter follow-up interval which tends to increase 
the rate of those complications which tend to occur 
early. The tendency for endocarditis to be associat- 
ed with thromboembolism is well-known but was 
only manifest in the HP group. This association is 
of considerable interest and was not observed in the 
porcine valve patients. Rather surprisingly. all 
those patients with endocarditis and thromboembo- 
lism had aortic rather than mitral prostheses in 
situ. In those patients in the ISLP group who had 
endocarditis. three out of five had aortic replacc- 
mcnts but none presented with thromboembolism. 
Only further observation over an extended period 
will determine whether this is a real problem or a 
manifestation of short follow-up and limited num- 
bers. 
The second obvious difference between the two 
pericardial valves is the occurrence of tissue failure 
' of hospital survivors only in the LPIS group. The two mitral valves with 
^b per patient )car torn leaflets in the LPIS group arc similar in char- 
Iv significant differences in the rates of endocardi- 
tis. endocarditis requiring reoperation. parayalyular 
leak. thromboembolism. or event-free survivals. 
Not only did the two pericardia( valves exhibit sim- 
ilar satisfactory early results but we could demon- 
strate no difference between these values and the 
Wessex porcine vale. Similarly. in those patients 
who have undertone recatheterisation. gradients 
obtained were similar in all groups (Table -1) 
though numbers were too small for statistical anal- 
ysis. 
Table 4. Po. t-operau%c cathctcniatwn data. 
LPIS HP \%cssct porcrnc 
size gradient size gradient size gradient 
mm mmHg mm mmHg mm mmHg 
AV R 











29 31 0 
31 2 31 3 
29 6 33 
' this valve was excised with a torn and prolapsed leaflet at 34 
months. 
Obvious difTerences in 'results obtained with the 
two pericardial valves were observed in the rate of 
thromboembolism and tissue failure. Thromboem- bolism appeared to occur at a much higher rate (2.1% LPIS: 5.8% HP) in the HP patients and was 
associated with endocarditis in three of the four pa- tients in whom it occurred. However, this rate is 
not significantly higher than the rate for the LPIS 
actcr to those sometimes seen with the Standard 
lonescu-Shiley valve (I. 5) and appeared to arise 
near the top of the posts. The mean time to failure 
of these valves was just o, er $0 months. No tissue 
failures were seen in either the HP or '\'esser 
groups. Obciously. the dilterence in follow-up du- 
ration has a major influence on the rate of such 
complications and few patients with HP or Wessex 
mitral talcs ha, e reached the ?0 month point. 
The recent a ithdr %%al of the Hancock pericardial 
mitral prosthesis followed tic episodes of tissue 
failure (4) with a mean follow-up of just o, er two 
sears. The similar nature of the tissue failure, in 
the LPIS mitral cal es reported herein must lead to 
the conclusion that these %ales should be used 
with some caution and implanted only in centres 
where detailed follow-up is maintained. 
Actuarial event-free sun-kal is not significantly 
different between the three groups and indicates ex- 
celfent level of* survival and freedom from compli- 
cations in the early period. It would therefore ap- 
pear that in the early period of these studies. i. e.. 
within the first two to three years. there is no de- 
tectable difTerence in the results between the por- 
cine valve and the low profile pericardial valves 
and the two different pericardial valves. It will be of 
considerable interest to follow these groups to de- 
termine the possible emergence of such differences. 
Addendum 
Since the preparation of this manuscript. addi- 
tional important complications have occurred. One 
patient in the LPIS group, known to have a diasto- 
lic murmur one year after aortic replacement. re- 
quired urgent reoperation after rapid deterioration. 
The explanted valve had tears similar to those seen 
in the mitral explants mentioned. The internal 
from implantation to explantation was 34 months. 
190 
'3 (i X. Kdr(hnl 'S. Surr/ :. 4'mh 
In addition. one patient in the HP group has re- 
quired reopcration for mitral paravalvular leak. 
This valve was in excellent condition with no eyi- 
dence of leaflet tears at two years. 
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ABSTRACT 
The hydrodynamic testing of prosthetic heart valves in the 
laboratory under pulsatile flow conditions remains the only way of 
obtaining detailed information about valve function. Test procedures 
have become increasingly sophisticated with a variety of different 
test conditions and detailed analysis of the pressure and flow 
signals. 
A computerised data acquisition system has been developed for use 
with the Glasgow pulsatile flow test apparatus. The computer 
collects seven signals from the test rig over a period of 20 seconds, 
and calculates the average waveform for each signal. Standard 
parameters, such as mean pressure differences, mean flows, regurgitant 
volumes and ener.; y losses, are calculated autanatical1y. The 
complexity of the analysis and the need for standardised doc unentation 
makes canputerisation essential. The system has been used 
extensively for functicn tests on over 160 prrst.: etic heart valves. 
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INI'ImOU(. TIQN 
Although prosthetic heart valves have been used clinically- for 
over 25 years, the ideal heart valve has not yet been developed. 
Hydrodynamic testing of prosthetic heart valves under pulsatile flow 
conditions in the laboratory remains the only way of assessing valve 
function prior to implantation for evaluation in animals or-clinical 
trials in patients. The tests provide detailed information which 
cannot be obtained clinically. Valve test methods have become 
increasingly sophisticated in recent years (1-3) and the pressure and 
flow signals measured in the apparatus require detailed analysis. As 
each valve has to be tested in different sizes, and under a range of 
flow conditions, a computerised data acquisition system is an 
essential feature of any valve test facility. 
The valve test apparatus developed in Glasgow has been described 
elsewhere (4-6). A diagram of the system is shcwn in Figure 1. 
The valve under test can be positioned in either the aortic or mitral 
position, and a standard control valve is placed in the other 
position. Essentially it consists of a servocontrolled piston pump 
(Super-pump, Cardiac Development Laboratories) - (2), driven by a 
programmable waveform generator. Two separate test chambers are used 
(aortic and mitral) in which the pressure difference across, and flows 
through, the valve under test can be measured directly. A standard 
afterload and atrial reservoir complete the apparatus. 
The computerised data acquisition system was required to perform 
the following operations: 
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Monitor seven signals from the test rig (three direct pressure 
signals, the differential pressure and flow signal for the valve, 
under test, and the displacement and velocity signals from 
the pump) and display them in real time. 
ii Collect data from the seven signals over a period of 20 seconds, 
store the data and calculate an average waveform for each signal. 
iii Store the average waveforms on disk and produce graphical 
printouts of the waveforms. 
iv Calculate from the average wavefor. s, the mean pressure 
difference, the mean and the root mean square flows, the volume 
of fluid displaced through the valve under test, the energy loss 
and the effective orifice areas (TA) for different ti: -ne 
intervals in the cycle. 
Description of the System: 
i Ccrrouter hardware 
The Apple II microcomputer system includes a 12" colcur mcniter, 
dual disk drives and Anadex printer (Figure 2). The seven 
signals to be monitored are connected to a 16 channel 8 bit ADC 
Card (Interactive structures Al). Timing for the data 
acquisition is controlled by a clock card which generated an 
interrupt every one millisecond. Each channel of the ADC card 
was read 200 times a second (every 5 ms). The ADC gives a 
resolution of 0.2 =Hg on the differential pressure signal, 1 
mnEg on the three direct pressure signals and 2 or 6 ml s-1 on 
the low or high range for the flow signal. This is similar to 
the accuracy quoted for the transducers. 
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ii Software 
The prograns are menu-driven and are divided up into sections 
with each section of the program being loaded separately from 
disk. 
The various modes selectable from the menu are: 
i Calibration 
ii Display and acquisition 
iii Graphs 
iv Calculations 
In the calibration node each signal can be calibrated by either. 
entering a predetermined conversion factor or by calibrating the 
transducer with reference signals. This node also allows 
reconfiguration of the signal inputs when changing fran the mitral to 
aortic test positions. Calibration is carried cut before each valve 
is tested and the zero reset on the pressure and flow channels 
imaediately before the data is acquired in an attempt to eliminate 
drift in the transducers. Calibration factors are stored on the 
program disk. 
In the display mode the monitor displays any three signals in 
real time along with a digital display of the pump rate, the stroke 
volume of the pump, and the mean aortic pressure. These are the 
critical parameters in setting the test conditions. In a test run, 
data is acquired over a period of twenty seconds and is stored in a 
temporary file. The variation in the period of the cycle is 
calculated over the acquisition period and the average cycle period 
is calculated from the displacement signal of the pump. The data 
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from each signal is processed automatically to calculate an average 
waveform. The time reference point for each cycle is taken from the 
pump displacement signal. When the data fray all seven signals has 
been processed the average waveforms are stored on a data disk file. 
In the print graphs mode, any of the seven average waveforms can 
be plotted on the Anadex printer. Examples of the pressure and flow 
waveforms are shown in Figure 3. Both the x and y axis scales can be 
varied for the printouts. 
In the calculation code, the differential pressure waveform and 
the flow waveform are displayed consecutively on the screen in order 
to set the time intervals over which the analysis is carried out. On 
the flow waveform a vertical cursor is placed automatically at the 
start of forward flow (point 1), the end of forward flow (point 4) and 
the end of the closing regurgitation (point 5) (see Figure 3). The 
cursor position can also be moved from the keyboard. For the 
differential pressure waveform the start of positive pressure (point 
2) and the erd of positive pressure (point 3) are also determined 
(Figure 3). In addition, the peak differential pressure and forward 
flow are identified with horizontal cursors. These reference points 
are stored in the memory and the following parameters are calculated: 
the rate and stroke volume of the pump, and the volumes displaced 
through the valve during forward flow (points 1 to 4), during the 
closing regurgitation (points 4 to 5) and during the period the valve 
was closed (points 5 to 1). Four time intervals during foward flow 
are defined (points 1 to 3,1 to 4,2 to 3, and 2 to 4) and the mean 
pressure difference, mean and root mean square (RMS) forward flow 
through the valve, and the effective orifice area of the open valve 
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(3) are calculated for each interval. In addition, the energy loss 
associated with the flow through the valve is calculated for each of 
the time intervals. An example of a printout of the results of these 
calculations is shown in Figure 4. 
The system takes approximately 15 minutes to acquire and process 
the data, print the graphs and carry out the calculations. 
Most of the programs are written in BASIC with assembly language 
routines to speed up the data acquisition and display, the calculation 
of averages, and graph plotting on the printer. A Basic Interface 
Area with resident variables is defined in memory to allow 
ccmnunicaticn between the program segments that are loaded from disc. 
DISCLSSICN 
Evaluation of the hydrodynamic function of prosthetic heart 
valves under pulsatile flow conditions requires detailed analysis of 
the flow and pressure signals associated with the fluid flcw through 
the valves. This involves calculating an average waveform over 
several cycles, calculating mean and root mean square values for the 
signals, and integrating the signals to obtain the volume displaced 
and the energy loss. Although real time displays can be obtained on 
oscilloscope or analogue printers and the calculation carried out 
manually, the complexity of the analysis and the need for standardised 
documentation makes computerisation necessary. The system which has 
been developed has been extensively used with function tests carried 
out on over 60 different commercial valves, over 100 prototype valves 
of a new design of prosthetic valve, and a series of explanted 
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clinical prosthetic valves. The important parameters which are 
determined during 'these function tests are the mean pressure 
difference across the valve during forward flow and its effective 
orifice area, the volume of regurgitation passing back through the 
valve during closure, the leakage backflow through the closed valve, 
and the energy losses associated with both forward and reverse flow 
phases of the cycle. 
The main advantages of the system are rapid calculation and 
analysis, compared with manual processing, efficient storage of data 
with easy access, and the production of standardised documentation of 
results and graphs. The real time displays and calibration modes 
simplified the operation of the test apparatus. 
Although the system has the disadvantage of limited memory and 
graphics handling facilities, it represents good value fcr ricrey and 
perforas efficiently and reliably. 
This software is freely available for Health Service users. 
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Figtise 1: Diagram of the pulsatile flow test apfla. "3tuS. P shows the 
pcsiticn of the direct pressure measur-eents, A? s'lcws 
the position of the differential pressure transducer fcr 
either the acrtic or the mitral pcsiticn. 
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Piggy re 3: Examples of the print-ants fcr the average wavefcr: zs for 
the differential pressure acrtic flcw, vent_"icJlar 
pressure and acrtic pressure. The tire scale on t. ex 
axis is 100 ms per divisicn. 
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Figure 4: An example of the c aputer print-out of the calculation 
and analysis which gives the valve reference nurrcer and 
date of test; the reference times for different phases of 
the cycle; the time period (PER) in milliseccnds (MS) and 
volume ('CL) in millilitres (ML); the mean pressure 
(PRESS), mean flow (FLGW), root mean square flow (RMS 
FILW), and effective orifice area (DOA) calculated for 
four time periods during forward flow defined by zero 
points of the flow waveform MAW), pressure waveforms 
(PRESS), start of the pressure and end of the flow (PR, 
FL), and start of the flow and end of the pressure (FL,, 
PR); the energy loss in millijoules (MJ) and volume 
passing through the valve are also given; REQJI defines 
the period of closure of the valve and LEAKAGE the period 




CAIL JIATION OF ENEFGY IL6S 
The energy loss is calculated from the product of the pressure 
difference across the valve, and flow through the valve, integrated 
with respect to time during each phase of the cycle (39). During 
forward flow the energy loss is calculated from the differential 
pressure signal and flow signal digitised at 5 mS intervals on the 
computer (115,116). During reverse flow the reverse pressure 
difference is much greater and is outwith the range of the 
differential pressure transducer. During the closing and closed 
phases of the cycle the computer calculates the pressure differences 
fran the two direct pressure measurements on either side of the valve 
which are digitised at 5 mS intervals. This is multiplied by the flow 
through the valve at each time interval to give the power loss, which 
is then integrated with respect to time during each phase of the 
cycle. During closing regurgitation there is little energy loss until 
the reverse pressure increases rapidly just before the valve is fully 
closed. At this point there is a peak in the power loss curve (39) as 
the pressure rises rapidly and the flow reduces rapidly. In tissue 
valves, where the valve and leaflets are canpliant, energy is stored 
in the valve as the leaflets and frame are displaced under the back 
pressure. This can make it difficult to define the precise point at 
which the valve has closed to distinguish between the closing and 
closed regurgitant energy losses. In addition the rapid rise in 
pressure and pressure oscillations which are dependent on the 
canpliance of the valve under test make it difficult to determine 
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the exact time when the valve is fully closed. 
The loss of energy calculated is in effect the loss of potential 
energy between the two pressure measurement points. Most of this is' 
converted into kinetic energy. in the mitral position this kinetic 
energy is dissipated downstream of the valve so the loss of potential 
energy measured is the total, energy loss. In the aortic valve, 
pressure recovery can occur which results in the recovery of potential 
energy beyond the downstream pressure measurement point. The fraction 
recovered is dependent on the geometry and dimensions of the aorta. 
This is not calculated in my system. During regurgitant flow it is 
assumed that all the kinetic energy is dissipated, so the loss of 
potential energy is the total energy loss. 
Care has to be taken in interpreting energy loss calculations. 
In the mitral position reverse flow energy losses are due to work 
carried out by the left ventricle, while high forward flow energy 
losses are a consequence of high pressures in the left atrium. 
Clinically it may be more important to minimise the forward flow 
energy losses in prosthetic mitral valves. In the aortic position 
energy losses during forward and reverse flow are due to work carried 
out by the left ventricle. During closing regurgitation the pressure 
difference across the valve and, consequently, energy loss is shall. 
However, if the energy loss was calculated as the additional work 
needed to move the equivalent volume of fluid forward through the 
valve to canpensate for the regurgitation it would be much greater. 
